Program

Transcription

Program

Final Progr am
2014 Annual Meeting
“Coming Together To Serve Our Patients”
February 19–23, 2014
Miami Beach, FL
Eden Roc
5019 W. 147th Street
Leawood, KS 66224
1
Telephone: 913-402-7102
Fax: 913-273-9940
Email: [email protected]
Web: www.ahpba.org
February 19–23, 2014 | Miami Beach, FL — Eden Roc
Advanced
Energy
Committed to bringing
open and laparoscopic
solutions to HPB surgery
AHPBA
Booth
1
#
www.medtronicadvancedenergy.com
2
SLA-14-002573
TABLE OF CONTENTS
3
6
Meeting Support
7–9
Leadership & Administrative Team
10–13 General Meeting Information
14 CME & Learning Objectives
15–17 Distinguished Service Award
18–22 Research Award
23–25
Traveling Fellowship Recipients
26
International Relations Travel Grants
27
HPB Certificates of Completion
28–33 Chapter Information
34–37 AHPB Foundation
39–106
Meeting Agenda
108–111 Speakers & Faculty
114–115 Hotel Floorplans
116–126 Exhibitor Showcase Information
128–133 Membership Information
136 HPB Journal
135–137 IHPBA Kenneth Warren Foundation
138 Disclosures
140–141 In Memoriam
142–143
AHPBA Future Meetings
President’s Letter
Welcome back to Miami and the Eden Roc for the
2014 Congress of the Americas Hepato-PancreatoBillliary Association. I’m excited to be hosting this
year’s conference and to highlight the success of our
association.
William C. Chapman, MD
As we begin our annual meeting I would like to give
a special thank you to Bryan Clary and the entire
Program Committee for their tireless work in bringing
together a top-notch conference. The program will
include a wide variety of topics, highly experienced
speakers and some spirited debates.
President Elect Elijah Dixon has coordinated this year’s Postgraduate Course
with controversial HPB topics, expansive case studies and a list of international
experts. We hope you’ll join us for this invaluable experience.
Each year we invite some of the top leaders in our field to be guest speakers.
We will welcome Göran Klintmalm, Chairman and Chief of the Baylor Regional
Transplant Institute in Dallas/Fort Worth. Our historical lecturer will be J. Michael
Henderson, Chief Quality Officer at the Cleveland Clinic Health System.
We’ve made a few enhancements to the meeting this year including changes to
the CME process and a new meeting application. We’ll offer our CME program
on-line. This new process should make getting your CME and self-assessment
credits much easier. The meeting app provides meeting content, scheduling
and logistic information, as well as general information and frequently asked
questions.
AHPBA has continued to evolve and grow. The evidence of our success is seen
across the board through committee work and management. We’ve recently
transitioned to a new management company. LP etc has been working to improve
our internal systems and processes to better manage all the details that go into
running our organization at peak efficiency.
This year our Membership Committee is focused on expanding into the Americas
and as a result we have added five new chapters in 2014: Canada, Guatemala,
Mexico, Panama and Uruguay, to add to our four existing chapters of Argentina,
Brazil, Chile and Ecuador. Currently we have six additional chapters pending:
4
President’s Letter
continued
Bolivia, Costa Rica, Nicaragua, Peru, Dominican Republic, and Paraguay. This new
expansion brings more resources, knowledge and experiences to our membership
and is an exciting new direction for AHPBA. Welcome to all our new AHPBA
members throughout the Americas.
We’ve also worked extensively on upgrading our web presence with a more userfriendly layout and a new Case of the Month feature. Our social media has been
greatly expanded with the addition of an AHPBA YouTube channel, FaceBook page
and a Twitter feed. Check our web page for links to all these features.
We encourage you to get involved in AHPBA by joining a committee. AHPBA
offers over 225 committee positions. Regardless of your area of interest, you’ll
find a position that fits and you’ll help support our growing organization.
Thank you for the opportunity to serve as President. Enjoy the meeting!
AHPBA President
5
The AHPBA wishes to thank the following organizations
for their support of the 2014 Annual Meeting:
Gold
silver
bronze
General Meeting Support
6
AHPBA LEADERSHIP
EXECUTIVE COUNCIL OFFICERS
COMMITTEE CHAIRS
President
Committee on Surgical Innovation
James Moser, MD
President-Elect
Elijah Dixon, MD, BSc, MSc
Development
Nicholas Zyromski, MD
Secretary
Javier Lendoire, MD, PhD
Education & Training
Rebecca Minter, MD
Treasurer
Gazi B. Zibari, MD
Finance Committee
Gazi B. Zibari, MD
PAST PRESIDENTS
HPB Program Directors
D. Rohan Jeyarajah, MD
Immediate Past President
William R. Jarnagin, MD
International Relations
Sean Cleary, MD
Past President
Jean-Nicolas Vauthey, MD
Membership
Felipe Jose Fernandez Coimbra, MD
MEMBERS AT LARGE
Professional Development
John D. Christein, MD
Horacio Asbun, MD
Jeffrey Barkun, MD
Todd Bauer, MD
Carlos Chan, Sr., MD
Michael D’Angelica, MD
Luiz Augusto Carniero D’Albuquerque, MD
Craig Fischer, MD, MPH
David A. Iannitti, MD
David Kooby, MD
Robert C.G. Martin, II, MD
Susan L.Orloff, MD
Charles Rosen, MD
Roderich E. Schwarz, MD, PhD
Charles M. Vollmer, MD
7
Program
Bryan M. Clary, MD
Publications
Timothy M. Pawlik, MD, MPH, PhD
Research
Sharon Weber, MD
EX-OFFICIO
Foundation President
W. Scott Helton, MD
AHPBA LEADERSHIP
AHPBA PAST PRESIDENTS
2012-2013
Jean-Nicolas Vauthey, MD 2011-2012
Reid B. Adams, MD 2010-2011
W. Scott Helton, MD 2009-2010
Mark P. Callery, MD 2008-2009
Bruce D. Schirmer, MD 2007-2008
Sean J. Mulvihill, MD 2006-2007
Theodore N. Pappas, MD 2005-2006
C. Wright Pinson, MD, MBA 2003-2005
Steven M. Strasberg, MD 2001-2003
Henry A. Pitt, MD 1999-2001
William C. Meyers, MD 1997-1999
J. Michael Henderson, MD 1995-1997
8
continued
Program Committee
Bryan M. Clary, MD
2014 Committee
Chair
Thomas A. Aloia, MD – Co –Chair
Christopher D. Anderson, MD
Eugene P. Ceppa, MD
Clifford S. Cho, MD
Quyen D. Chu, MD, MBA
Sean P. Cleary, MD
Elijah Dixon, MD
Maria B. Majella Doyle, MD, MBA
Derek DuBay, MD
Ryan C. Fields,MD
Pamela J. Hodul, MD
Matthew H. Katz, MD
Milan Kinkhabwala, MD
Jennifer LaFemina, MD
Ajay V. Maker, MD
Henry B. Randall, MD
Srinevas K. Reddy, MD
Flavio G. Rocha, MD
Sharona B. Ross, MD
Courtney Scaife, MD
Shimul Shah, MD
Margo C. Shoup, MD
Conrad H. Simpfendorfer, MD
Kevin F. Staveley-O’Carroll, MD, PhD
Lee W. Thompson, MD
Ching-Wei D. Tzeng, MD
Charles M. Vollmer, Jr., MD
Rebekah White, MD
AHPBA LEADERSHIP
continued
AHPBA Administrative Team
Nonie Lowry
Director, Association Management
[email protected]
Laura Fitzgerald
Financial Manager
[email protected]
Martha Lawrence
Meetings Manager
[email protected]
Kirsten Rencher
Meetings Coordinator
[email protected]
Jill Kawulok
Meetings Coordinator
[email protected]
Molly Edmondson
Administrative Coordinator
[email protected]
Denise Higgs
Registration & Membership Coordinator
[email protected]
Donia Robinson
Webmaster
[email protected]
Heather Roderick
Exhibits & Sponsorship Coordinator
[email protected]
Amy Matthews
CME Coordinator
[email protected]
Americas Hepato-Pancreato-Biliary Association
Leawood, KS 66224 USA
9
Telephone: 913-402-7102
Fax: 913-273-9940
Web: www.ahpba.org
meeting information
Hotel Information
Eden Roc
4525 Collins Avenue
Miami Beach, Florida 33140 USA
Telephone: 305-531-0000
Web: www.edenrocmiami.com
AHPBA Registration Desk Hours
Location: Ocean Tower I Foyer
Registration will be open throughout the meeting to provide assistance.
Please let us know if there is anything we can do to help make your
meeting experience more valuable.
Hours of Operation
Wednesday
6:30pm – 8:00pm
Thursday
6:30am – 6:30pm
Friday
6:30am – 6:00pm
Saturday
7:00am – 6:00pm
Sunday
7:30am – 1:00pm
Speaker Ready Room
Location: San Marino
Technicians will be available in the Speaker Ready Room for assistance
with presentations. Please have your presentation in the room at least
four hours prior to your presentation time.
Hours of Operation
10
Wednesday
6:00pm – 8:00pm
Thursday
6:30am – 6:30pm
Friday
6:30am – 5:30pm
Saturday 7:00am – 6:00pm
Sunday
7:30am – 11:00am
meeting information
continued
Safety & Security
We take every precaution to assure the safety and security of our attendees and
their guests. However, we urge you to be aware and take simple steps to guard
your possessions. Therefore, we suggest the following:
• Do not leave your purse or briefcase unattended.
• Do not leave your laptop, phone or PDAs on the floor or out of your sight.
• Be aware of your surroundings.
• If you do misplace or lose something, please contact the
AHPBA Registration Desk immediately.
• To connect to hotel security please pick up a house phone or
dial 305-531-0000.
VIDEO SALES
MEDCALDTV will be onsite providing videotaping of the educational sessions.
You may place orders onsite, or via order form. The sales desk will be located
near the AHPBA Registration area.
Web: www.medicaldtv.com
MEETING APP
AHPBA 2014 Annual Meeting has gone mobile! Be sure to download the 2014
AHPBA Meeting App for free on any smart device. To download, simply type
www.eventmobi.com/ahpba into your web browser. A pop up button will appear
asking you to download the app to your home screen. The AHPBA logo will appear
as an app icon on your home screen and will allow you to instantly access the
meeting app. Join the AHPBA 2014 Annual Meeting virtual community – it is an
experience you won’t want to miss!
11
meeting information
continued
QR CODES
Each registrant will receive a card with a unique QR CODE, which includes
your name, institution and email address. You may choose to share your contact
information with exhibitors or colleagues at the conference, and may do so
simply by downloading a QR Code Scanner, which is available as a free app on
your smart phone.
SOCIAL MEDIA
Stay current with meeting updates, discussions and colleague networking by
connecting with AHPBA Social Media. It is easy! Follow us on Twitter (www.
twitter.com/ahpba) and be sure to use the HASHTAG #AHPBA2014 to link your
comments to the AHPBA community. We are on Facebook too, www.facebook.
com/ahpba. Simply “Like” our page and you will start receiving status updates on
your newsfeed. Let’s get AHPBA trending, spread the word!
Website
AHPBA is proud to re-introduce you to our website, www.ahpba.org! Many
enhancements, additions and updates have been made to improve quality and
boost user experience. Is there something you would like to see added to the
website? Let us know! Email [email protected]. We value your feedback in our
continued efforts to make each web visit friendly and helpful!
12
meeting information
continued
Translated Sessions
Translation from English to Spanish will be offered for the following sessions
Friday
7:00am - 7:55am
Parallel Education Breakfast Symposium:
NAFLD - Implications for Liver Surgery
11:45am - 1:00pm
Parallel State of the Art Lecture:
Downsizing of HCC Prior to Transplant
Saturday
8:00am - 9:15am
Parallel Symposium II: Screening for Pancreatic Cancer
9:15am - 10:00am Leslie H. Blumgart Historical Lecture
10:00am - 10:45am Parallel Update Lecture: ALPPS - An Update
11:15am - 12Noon Parallel Debates I: MIS Whipple - Viable Options
in Today’s Economic Climate
12Noon - 1:00pm
State of the Art Lecture:
—Update on Intrahepatic Cholangiocarcinoma
1:00pm - 2:00pm Parallel Educational Lunch Symposia - Spanish Session
*Spanish to English translation will be offered for this session
7:45pm - 9:30pm Parallel Educational Dinner Symposia: PNET Update
Audience Response Sessions
A limited number of sessions held in Tower I will include audience response on Thursday, Friday and Saturday. Handsets will be distributed throughout the room for these sessions.
13
CME Information
CME Accreditation
This activity has been planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of PESI, Inc. and the Americas Hepato Pancreato
Billiary Association (AHPBA). PESI, Inc. is accredited by the ACCME to provide
continuing medical education for physicians.
AMA PRA Designation Statement
The PESI, Inc. designates this educational activity for a maximum of
38 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Physician Assistants
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP,
and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by
ACCME.
Learning Objectives and Outcomes
The AHPBA 2014 Annual Meeting has been structured around various tracks,
representing the liver, pancreas, biliary system and transplant. At the conclusion
of the 2014 Annual Meeting of the AHPBA, the Association expects its attendees
to have gained knowledge and skills that will lead to changes or enhancements
in their own practices and improve physician training. The AHPBA expects that
the 2014 Scientific Program’s educational interventions will result in measurable
improvements in patient care.
CME AND SELF-ASSESSMENT
You may claim CME and Self-Assessment credits online at www.ahpba.org.
Please complete the surveys and print your certificates BY FRIDAY, MAY 30TH .
Up to 35 hours of self-assessment credit will be offered as a part of this
educational activity.
14
Distinguished Service Award
Steven M. Strasberg, MD
Washington University
St. Louis, MO
This year the AHPBA Council has unanimously
chosen Dr. Steven Strasberg as the well-deserved
recipient of the 2014 Distinguished Service Award.
“This award is a great honor. There are so many
people I look up to and respect in this organization.
To be recognized by those important contributors in
our field is such a privilege,” says Dr. Strasberg.
Medical Center
St. Louis, MO
15
Dr. Strasberg is a graduate of the University of
Toronto Medical School and the Gallie Course
in Surgery. He was an attending surgeon at the
University of Toronto rising to the position of
Professor of Surgery and was the first director of
the Surgical Scientist Program. In 1992 he moved
to Washington University in Saint Louis where he
became Pruett Professor of Surgery and founding
head of the Section of HPB Surgery. He has
published approximately 250 peer reviewed papers
and 50 book chapters and has held grants from the
MRC and NIH. His current subject areas of interest
continued
are avoidance and management of biliary injury, classification and quantification
of surgical complications, and development of novel anatomic approaches in HPB
surgery.
The achievement most gratifying to Dr. Strasberg is bringing procedures
into surgery to increase safety and efficacy. He has worked extensively on
laparoscopic cholecystectomy using the “Critical View of Safety,” which has
increased the safety of the operations. He has introduced new operations for
cancer of the pancreas including a novel approach for resection called RAMPS. “If
I had to pick what I am most pleased with when I look back on my career, it would
be having a direct impact on surgery in terms of safety.”
Dr. Strasberg has been a long-time supporter of AHPBA and was involved in the
formation meetings for the organization starting in 1994 as a member of the
original Council. He organized the first AHPBA sponsored Post-Graduate Course
during the 1994 AASLD meeting in Chicago. He fondly remembers the inaugural
AHPBA meeting in 1997 at the Doral Resort in Miami. “There were only 97
members at the meeting and we used three rooms. The council members would
take turns rotating into each room so they didn’t look empty.”
From 2001 to 2003 Dr. Strasberg served as AHPBA’s fourth President. During
that time membership numbers grew to more than 400. Since his tenure as
President, he has been an active participant in the organization and consistently
attended the Annual Meeting. “Although the HPB field seems specialized, the
AHPBA Annual Meeting brings together so many experts on very specific areas of
knowledge and techniques. I come away from the meetings full of new knowledge
and energized and excited about my work.”
Dr. Strasberg is optimistic about the future of AHPBA. Along with the close
relationship with IHPBA, he sees a focus on continued close involvement with
South and Central American chapters as critical to developing new strategies
for managing HPB diseases. This global approach is developing new ideas,
techniques and modalities for improved patient care.
Another area Dr. Strasberg would like to see expansion is through relationships
with Industry. “These connections are so beneficial to our field. We can work
with industry to bridge gaps in equipment and educational support.”
16
continued
This progressive approach is also reflected in AHPBA’s strong focus on teaching
and development of fellows and residents. Dr. Strasberg hopes these programs
continue to attract the best and brightest in the HPB field and to expose them to
the benefits of joining AHPBA. According to Dr. Strasberg, “AHPBA is successful
because of a devoted group of people. I would like to encourage the younger
members to put in effort and keep us moving forward.”
As AHPBA expands, Dr. Strasberg appreciates the organization’s ability to retain
it’s personality. “Although our membership and meeting continue to grow, the
character of the organization hasn’t changed. We still feel like a big club.”
Dr. Strasberg enjoys time with his wife, children and grandchildren. “I would
like to thank my wife, Yona, for her support. The Distinguished Service Award
recognizes my service to our field and our patients. Without Yona’s support in all
the other areas of our lives, I would never have had the time and focus to provide
that service.”
REDUCE
POST-SURGICAL COMPLICATIONS
Hemodynamic optimization through Perioperative Goal-Directed Therapy in moderate
to high-risk surgery enhances recovery and is associated with a significant reduction in
post-surgical complications and length of stay.1
Common surgical complications include acute kidney injury (AKI), anastomotic leaks, surgical
site infections (SSI), urinary tract infection (UTI), pneumonia, and major/minor GI complications.
REDUCED
MORBIDITY BY
32
%
1.16
REDUCED
LENGTH OF STAY BY
Visit us at booth #21.
1. Grocott et al. Perioperative increase in global blood flow to explicit defined goals and
outcomes after surgery: a Cochrane systematic review. Br J Anaesth 2013
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences
Corporation. © 2014 Edwards Lifesciences Corporation. All rights reserved. AR10820
Edwards Lifesciences | edwards.com
Irvine,
USA
17 California 92614
February
19–23, 2014
| Miami Beach, FL — Eden Roc
D AY S
Perioperative Goal-Directed Therapy
2012 RESEARCH AWARD UPDATE
Kevin C. Soares, MD
Johns Hopkins
Baltimore, MD
From the Tumor Immunology Program, Departments of Surgery
and Oncology, Johns Hopkins University School of Medicine
Kevin C. Soares, MD
PD-1/PD-L1 blockade antibodies coordinate
with vaccine therapy to overcome multiple
immunosuppressive pathways and improve
effector T cell infiltration in pancreatic
adenocarcinoma
Research Synopsis: Pancreatic cancer (PDA) is highly resistant to standard
treatment regimens and new therapies are sorely needed. Our phase I/II human
clinical trials utilizing a GM-CSF secreting allogeneic pancreas tumor vaccine
(GVAX) have been shown to be safe and tumor antigen specific responses
have correlated with prolonged survival. However, pancreatic tumors consist
of a strong immunosuppressive network, enabling tumor immune evasion and
blunting vaccine-induced responses. Programmed cell death 1 (PD-1) and its
ligand programmed cell death ligand 1 (PD-L1) constitute a major tolerance
mechanism. Clinical trials of αPD-1 and αPD-L1 antibodies have proven effective
in solid tumors, although objective responses were not seen in a small subset
of PDA patients. GVAX treated patients have demonstrated infiltration of
PD-1+ T cells, which is a major immunosuppressive mechanism in the tumor
microenvironment. We aimed to manipulate the PDA tumor microenvironment
through the blockade of PD-1 or PD-L1 in combination with GVAX. We
hypothesized that the use of PD-1 or PD-L1 blocking antibody and GVAX will
improve vaccine therapy and pancreatic cancer survival.
Immunohistochemistry analysis of human PDA resected from patients two weeks
after GVAX therapy revealed significant upregulation of PD-L1 membranous
staining compared to unvaccinated patients. Similarly, in a preclinical metastatic
model of murine PDA, GVAX therapy significantly upregulated PD-L1 expression
on neoplastic cells. We subsequently demonstrated that combinatorial therapy
of GVAX with PD-1 blockade significantly improves survival and cure rates
compared to vaccine and checkpoint monotherapy in a highly stringent pancreatic
cancer murine model. Combinatorial therapy significantly increased effector T
cell trafficking to the tumor microenvironment and overcame additional immune
checkpoint mechanisms. Taken together, our findings support the combination of
GVAX vaccine therapy with αPD-1 or αPD-L1 blockade in pancreatic cancer patients.
18
2013 RESEARCH AWARD UPDATE
Stephanie H. Greco, MD
New York University School of Medicine,
Department of Surgery
New York, NY
Regulation of Acute Pancreatitis by C-type
Lectin Receptors (Physiology/Biology)
Research Synopsis: My laboratory studies the role
of
the innate immune system in pancreatic and liver
Stephanie H. Greco, MD
inflammation as well as in carcinogenesis. We have
previously shown that blockade of certain pattern
recognition receptors (PRRs), in particular, Toll-Like Receptors 4 and 7 (TLR4
and TLR7), mitigates pancreatic inflammation and the progression to pancreatic
cancer. My research focuses on the importance of Mincle, a novel PRR, in the
above disease processes. The Mincle receptor is present on many different
antigen-presenting cells (APCs), and has been shown to be critical for the
immune response to mycobacteria and fungi. However, its role in models of
pancreatic inflammation has never been studied.
I have found that Mincle and its signaling intermediates are upregulated in a
mouse model of acute pancreatitis. In addition, Mincle blockade decreases
pancreatic immune infiltrate. Most significantly, I have discovered that Mincle and
TLR4 co-associate on the cell surface, and that Mincle-/- mice have an increased
response to TLR4 stimulation. These data suggest that Mincle negatively
regulates TLR4 signaling. Regulation of TLR responses is extremely important
in maintaining physiologic homeostasis and in limiting septic injury, tissue
damage, and autoimmunity. My work seeks to elucidate the cellular mechanism
of Mincle and TLR4 cross-talk and its importance in the pathogenesis of
pancreatic inflammation. Knowledge of this interaction can ultimately lead to the
development of therapeutic interventions for pancreatitis and pancreatic cancer.
The 2015 Research Award Application Deadline is January 5, 2015
Supported in part by the
AHPBA Foundation and
Sirtex Medical, Inc.
19
Past RESEARCH AWARD Recipients
2013
Physiology/Biology Research Grant
Stephanie Greco, MD
Regulation of Acute Pancreatitis by C-type Lectin Receptors
New York University School of Medicine - Department of Surgery
Supported by AHPBA
2012
Oncology Research Grant
Kevin Soares, MD
Combinatorial Immunotherapy and the Manipulation of Tumor Microenvironment
in the Treatment of Pancreatic Cancer
Johns Hopkins Hospital Surgery
Supported by AHPBA
2011
Michele Babicky, MD
Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer
University of California, San Diego Medical Center
Supported by: AHPBA
2008
Surgical Technology Assessment and Outcomes Research Grant
Peter Nau, MD
Development of a Novel Repair Technique for latrogenic Common Bile Duct
Injuries with a Biosynthetic Absorbable Graft
The Ohio State University Medical Center
Center for Minimally Invasive Surgery
Supported by: Covidien and AHPBA
2008
Physiology/Biology Research Grant
Kendra D. Conzen, MD
The Role of HMGB1 in Steatotic Livers following Ischemia/Reperfusion
Supported by: Ethicon, Inc. and AHPBA
20
continued
2008
Wigdan Al-Sukhni, MD
An Analysis of Germline Genomic Copy-number Variation to Identify DiseaseAssociated Gene(s) in Familial PancreaticCcancer
University of Toronto
Supported by: Sanofi Aventis and AHPBA
2007
Covidien Surgical Technology Assessment
Lia Roque Assumpcao, MD
Application of Novel, High Resolution, and Freehand Ultrasound Elasticity Imaging
in Liver Surgery
Johns Hopkins University Hospital
2007
Sanofi-Anventis HPB Oncology
Bedabrata Sarkar, MD
Characterization of Pancreatic Cancer Stem Cells
University of Michigan Medical School
2007
Ethicon HPB Physiology/Biology
Lee Ocuin, MD
Immune Activation of Human Liver Dendritic Cells
Memorial Sloan-Kettering Cancer Center
2006
Luis Garcia, MD
Targeted Inhibition of VEGF Prevents Development of Tumor Antigen-Specific
T-Cell Tolerance in the Murine Liver
The Milton S. Hershey Medical Center
2006
Sanofi-Aventis HPB Oncology
Jon Cardinal, MD
Crossroad in Cancer Signaling: Regulation of Human iNOS Expression by the
WNT B-Catenin Path
University of Pittsburgh
21
continued
2005
Sunil K. Geevarghese, MD
The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion
Injury following Syngeneic Rat Liver Transplantation
Vanderbilt University Medical Center
2005
Sanofi-Aventis HPB Oncology
Jon Dorfman, MD
Positron Emission Tomography to Monitor HSV-2 Viral Oncolysis
Massachusetts General Hospital
2004
Ethicon HPB
Jennifer Lynn Irani, MD
The Role of CEACAM6 in Pancreatic Cancer Invasion
Brigham and Women’s Hospital
2003
Ethicon HPB
Shiva Sarraf-Yazdi, MD
Anti-angiogenic Therapy of Murine Liver Metastases by Tie2 Inhibition
Duke University Medical Center
2002
Ethicon HPB
Charles M. Vollmer, MD
Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer
2001
Ethicon HPB
Nicole Chandler, MD
Overcoming Chemoresistance in Human Pancreatic Cancer
Beth Israel Deaconess Medical Center
22
2013 Traveling Fellowship Recipients
Adnan A. Alseid, MD, EdM
Digestive Disease Institute
Destination: National Institute of Medical Science and
Nutrition Salvador Zubiran, Mexico City, Mexico.
Hosts: Carlos Chan Nunez, MD , Miguel a Mercado, MD
INNSZ Fellows: Ismael Dominguez Rosado, MD,
Daniel Zamora-Valdés, MD
I had the sincere privilege of being awarded the
AHPBA 2013 traveling Fellowship award. This
generous gift allowed me to travel to Mexico City
to work with and learn from my amazing hosts Drs Carlos Chan and Miguel
Mercado at the national Institute of medical science and nutrition Salvador
Zubiran (INNSZ). While the focus of my travel was initially educational with the
intention to study and work on their HPB Fellowship, a clinical component to the
trip naturally materialized.
Adnan A. Alseid, MD, EdM
Educationally; it was truly refreshing to see a rather energetic educational
atmosphere with a very vibrant and strong residency and HPB education for
both Fellows and residents. I had the opportunity to participate in tumor boards,
multidisciplinary HPB rounds, observe both residents and Fellows in the operating
room with incredible autonomy, and I was given the privilege of lecturing to the
house-staff on curricular design of educational programs and methods to improve
and assess psychomotor skills and learning.
Clinically; I was rather impressed with the HPB experience that exists at INNSZ.
Particularly with the incredibly high volume, almost 2 to 3 per week, of bile duct
repairs that were being reformed. This is clearly recognized as a public health
problem at INNSZ. I was honored to be allowed to participate in the creation of a
bile duct injury prevention workforce. This workforce will be an integral part of the
Mexican-AHPBA meeting in December of 2014. Action items to include a formal
assessment of the problem, educational literature in Spanish for general surgeons
to change the culture of open/laparoscopic cholecystectomy, and methods of
prevention and early recognition of injuries were created and are already being
worked on.
In the end I am truly in debt to my hosts for allowing me into their busy schedules
and their homes, for the generosity, and for allowing me to participate in their
public health measures. I also would like to thank the AHPBA Foundation for
selecting me for this important award.
23
continued
Ruben Rodrigo Lozano-Salazar, MD
Hospital Regional De Alta Especialidad de
La Peninsula de Yucatan
Destination: Seattle, WA
I feel really honored to be awarded with the 2013
AHPBA Travelling Fellowship Award. I have known
Dr. Scott Helton for many years, as he has been part
of several hepato-pancreato-biliary (HPB) meetings
in Mexico, during my training years. I am working in
a relatively new Hospital, and tasked with developing
Ruben Rodrigo LozanoSalazar, MD
an HPB program, so I felt that this could be a great
opportunity to observe a fully operational HPB service.
Therefore, I made my plans to visit the Liver, Pancreas and Biliary Surgical Center
of Excellence at the Virginia Mason Medical Center (VMMC) in Seattle.
During my visit, I witnessed how the surgery, endoscopy, radiology, oncology
and pathology services work as a team, with fluent and rapid communication, in
order to give the patient the best treatment with a warm human touch. This was
particularly evident in the evaluation and management of patients with localized
and borderline resectable pancreatic cancer. In my two-week stay in Seattle, I
took part of the clinical rounds; I participated in the gastrointestinal and pancreas
tumor board, the morbidity & mortality sessions, and conferences to discuss their
current outcomes and research. I attended several surgical procedures including
benign and malignant HPB disease, and during all those moments in the operation
room, the surgeons and all the staff in there made me feel like part of their team. I
even had the chance to support the Seahawks on their road to the Super Bowl.
I am really grateful to all the people at the VMMC who spent their time and
share their knowledge with me. Thank you very much to Scott Helton, MD, Flavio
G. Rocha, MD, Tom Biehl, MD, Adnan Alseidi, MD and Bart Rose, MD in the
Department of Surgery, Michael Larsen, MD in the Department of Therapeutic
Endoscopy. I would like to thank the AHPBA Foundation and the AHPBA Executive
Council for this unique opportunity in my academic formation. I hope that I could
return to the AHPBA in a nearby future with the first achievements of a newly
created HPB service in my Hospital in Mérida, México.
The 2014 Traveling Fellowship Application Deadline is April 1, 2014
Supported in part by the
AHPBA Foundation and
24
continued
Jiping Wang, MD, PhD
Brigham and Women’s Hospital
Destination: Buenos Aires, Argentina
Host: Alberto R. Ferreres, MD, PhD, FACS
It was a great honor to receive this travel fellowship
and had the precious opportunity to visit the HPB
programs in Argentina.
My visit started with a full day with Drs. Javier
Lendoire, MD, PhD and Fernando Duek, MD. They
gave me an introduction of the HPB program in Buenos
Aires and demonstrated the 2nd phase of liver resection
for a 2-stage operation on a patient with CRCLM at a community facility. The 2nd
day, I was introduced to Dr. Oscar Imventarza at Hospital de Pediatria “Dr. Juan
P. Garrahan”. I observed a pediatric liver transplantation case and learned the
difference between adult and pediatric liver surgeries. Then, I went to Sanatorio
Colegiales, where I observed a gallbladder cancer case with portal dissection and
segment IVb and V resection by Dr. Fernando Duek. I spend two days at Hospital
Italiano de Ruenos Aires. On the first day, Dr. Juan Pekojl demonstrated a case of
laparoscopic CBD exploration for intrahepatic lithiathis case and left lateral liver
resection. This was followed by a case of laparoscopic enucleation of a cystic
lesion in the head of pancreas. On the second day, a planned Klatskin tumor case
was cancelled due to metastatic disease. This gave me a precious opportunity
to have case discussion with Dr. Pekojl and he showed me some pearls and
tricks in liver surgery including ALLPS. Then I visited Hospital Universitario
Austral and observed an extended right hepatectomy for a CRCLM involving
the middle hepatic vein. My visit was highlighted by my visit at “Dr. Carlos A.
Bocalandro” Hospital. I participated in the discussion with Dr. Alberto Ferreres
and his residents for a patient with Mirrizi’s syndrome and an operative case of
neuroendocrine tumor at the body of pancreas with liver metastasis.
Jiping Wang, MD, PhD
In summary, this was an incredible experience and it won’t happen without
AHPBA’s support. More importantly, without Dr. Alberto R. Ferreres’s generosity
in arranging all the activities, it will not be so productive. In a very short amount
of time, I had the tremendous opportunity to observe other experts’ work, share
ideas and exchange clinical experience in patient management. Indisputably,
through the professional relationships developed, future collaboration will be
fostered. The technique pearls that I learned during this visit will be incorporated
into my future practice and will benefit patients. I would like to thank the AHPBA
again for this exceptional opportunity.
25
International Relations
Travel Fellow Grants
2014 Recipients
Sergio Manuel Lopez Torrez, MD, MSc
Nicaragua
Alvaro Andres Duarte Garces, MD
Columbia
Jaime Arthur Pirola Kruger, MD
Brazil
Hoover Rodyl Henriquez Cooper, MD
Honduras
Supported in part by the AHPBA Foundation
26
2013 HPB CERTIFICATES OF COMPLETION
REcipients
Congratulations to the following members who have successfully
completed their fellowship training and have fulfilled the surgical
curriculum requirements, as set forth by the AHPBA and Fellowship
Council. These individuals will be recognized during Friday’s opening session.
Saleh Al-Abbad, MD
McGill University Health Center
Neil H. Bhayani, MD, MHS
Penn State Milton S. Hershey
Medical Center
Erin C. Maynard, MD
Washington University School
of Medicine
Sung W. Cho, MD
Providence Portland Medical Center
Houssam Osman, MD
Methodist Dallas Medical Center
Sameer Damle, MD
Virginia Mason Medical Center
Erik M. Dunki-Jacobs, MD
University of Louisville School
of Medicine
Juan C. Mejia, MD
Medical Center
Daniel Eduard Kleiner, MD
Washington University School
of Medicine
Massimo Arcerito, MD
University of Michigan Health System
Pablo E. Serrano, MD
Toronto General Hospital
Bassam Abu Wasel, MD
Dalhousie University, Queen
Elizabeth II Health Sciences Centre
Kevin M. El-Hayek, MD
Cleveland Clinic
Janak A. Parikh, MD
Indiana University Hospital
Charles H.C. Pilgrim, MD, PhD
Medical College of Wisconsin
Andrei Cocieru, MD
Ching-Wei David Tzeng, MD
MD Anderson Cancer Center
Kerri A. Simo, MD
Carolinas Medical Center
Victor Michael Zaydfudim, MD
Mayo Clinic
27
2014 Newly Established AHPBA Chapters
Canada
Sean P. Cleary, MD
Sean P. Cleary, MD
The Canadian Hepato-Pancreatico-biliary Association
was formed over a decade ago by Francis Sutherland
and Michael Marcaccio as an organization to promote
and coordinate professional, educational, research and
social activities among HPB surgeons in Canada. The
CHPBA works closely with the Canadian Association
of General Surgeons to provide HPB related content,
invited lectureships and continuing medical education
to Canadian surgeons through local and national
meetings.
There are currently 62 Canadian members of the
AHPBA that also belong to the CHPBA. While
Canadian members have always played a prominent
role and made significant contributions to the AHPBA,
the incorporation of the CHPBA as a chapter of the
AHPBA is a tremendous honour that will provide
important support and guidance in expanding
the educational activities for HPB surgeons in
Canada through consensus conferences, meetings,
lectureships and courses.
The Executive committee of the CHPBA consists
of a President (Sean Cleary), President-elect (Shiva
Jayaraman), Vice President (Jeff Barkun), Secretary
(Chad Ball) and 2 members-at-large (Elijah Dixon and
Francis Sutherland). This group meets bi-annually
in person at the Canadian Surgical Forum and the
AHPBA Annual meeting.
28
continued
Guatemala
Erick Roberto Soto Solís, MSc., MACG
Erick Roberto Soto Solís,
MSc., MACG
With my participation in the 2nd. Congress AHPBA
Chapter Ecuador in The Galapagos Islands, began the
dream of establishing the Guatemalan Chapter, with
the unconditional support of Dr. Nestor Gomez and
with the collaboration of Dr. Javier Lendoire, I returned
to my country with this goal. I talked about that
possibility with some colleagues and on December
2013 with the participation of 6 members, the dream
came true.
Our expectation is to increase our members both
nationally and Central America area and the primary
purpose is the benefit of all patient with HPB
pathology through the exchange of knowledge and
improving the skills of already trained specialists and
encouraging future generations.
Con mi participación en el 2do. Congreso AHPBA
Capítulo Ecuador en las Islas Galápagos, inició el
sueño de establecer el Capítulo Guatemalteco, con
el apoyo incondicional del Dr. Néstor Gómez y con la
colaboración del Dr. Javier Lendoire, regresé a mi país
con esa meta. Hablé de esa posibilidad con algunos
colegas y en Diciembre 2013 con la participación de
06 miembros, el sueño se hizo realidad.
Nuestra expectativa es incrementar nuestros
miembros tanto a nivel nacional como del área
Centroamericana y el objetivo primordial es el
beneficio que obtendrá todo paciente con patología
HPB por medio del intercambio de conocimientos ,
mejorando así las capacidades de los especialistas ya
entrenados e incentivando a las futuras generaciones.
29
continued
Mexico
Carlos Chan, MD
Mexico National Chapter was created in July 2013
during the first Congress of the Mexican Hepato
Pancreato Biliary Association in the city of Cancun.
Carlos Chan, MD
We had a great meeting with speakers from all the
Americas from Canada to Argentina. We had the
presence of William Chapman, President of AHPBA
and many members of the executive council.
During this meeting many new members for AHPBA/
IHPBA were recruited.
We are very happy to start this new adventure with
the creation of the new Mexican Chapter of AHPBA/
IHPBA.
El Capitulo Mexico de la AHPBA, fue creado en Julio
del 2013 durante el primer congreso de la Asociacion
Mexicana Hepatopancreatobiliar en la Ciudad de
Cancun.
Tuvimos un extraordinario congreso con profesores
de toda America desde Canada hasta Argentina.
Tuvimos el honor de tener al Dr. William Chapman,
presidentede la AHPBA asi como a varios miembros
del comite ejecutivo.
Durante este evento, se afiliaron muchos miembros
nuevos tanto para AHPBA como IHPBA.
Nos sentimos muy contentos de empezar esta nueva
aventura con la creación de este nuevo Capitulo
Mexicano de la AHPBA/IHPBA.
30
continued
Panama
Moises Cukier, MD
Moises Cukier, MD
The Panama Chapter of the AHPBA was created
in August, 2013. Following the advice and support
of Dr. Sean Cleary (International Relationships)
and Dr. Nestor Gomez (founder of the Ecuatorian
Chapter) at the AHPBA Annual Meeting 2013, the
panamenian surgeons members of the AHPBA
decided to create and formalize a group with the goal
of promoting academic HPB surgery in Panama as
well as exchanging experiences with colleagues in the
Americas. This chapter has begun with 7 members
and is looking forward to collaborate actively with the
AHPBA and other Chapters. The current president is:
Moises Cukier, MD (Surgical Oncologist - HPB)
El Capítulo de Panamá de la AHPBA fue creado en
Agosto, 2013. Siguiendo el apoyo y los consejos del
Dr. Sean Cleary (Relaciones Internacionales) y del Dr.
Nestor Gomez (fundador del Capítulo de Ecuador)
en la Reunion Anual del AHPBA 2013, los cirujanos
panameños miembros del AHPBA decidieron crear
y formalizar un grupo con el objetivo de promover la
cirugía hepatopancreatobiliar académica en Panamá
así como intercambiar experiencias con colegas del
continente americano. Este capítulo ha empezado
con 7 miembros y espera colaborar activamente con
la AHPBA y otros capítulos regionales. El presidente
actual es: Dr. Moises Cukier (Cirugía Oncológica HPB).
31
continued
Uruguay
Hernan E. Parodi, MD
Hernan E. Parodi, MD
The Uruguayan Society of Surgery, founded in 1920,
it is a scientific and professional association that
congregates all surgeons of our country. As a apart
of this Society, in July of 2012, the HBP Chapter was
created, with its own authorities, monthly meetings
and an annual course in the Uruguayan Surgery
Congress.
In November of 2013 we have organized the 1st International Course of AHPBA
in Montevideo, with the assistance of Canadian and Argentine surgeons and the
support .
Dr. Luis Ruso Martinez was the first president of this Chapter, role recently
attributed to Dr. Hernan Parodi. Our Chapter have nowadays 12 partners of both
AHPBA and IHPBA.
The main objective of this chapter is to offer an advanced continuous medical
education in the field of HPB for all surgeons of the country, as well as, provide
opportunities to young surgeons and exchange experience in an international
level.
La Sociedad de Cirugia del Uruguay , fundada en 1920 es la asociación científica
y profesional que congrega a todos los cirujanos del país.- Como parte de la
misma en julio de 2012 fue creado el Capitulo HPB con sus autoridades propias,
reuniones científicas mensuales y un curso anual en el Congreso Uruguayo de
Cirugia.
En noviembre de 2013 se realizo el 1º curso internacional de AHPBA en
Montevideo, con la asistencia de cirujanos argentinos y canadienses.- El Dr.Luis
Ruso Martinez, fue el primer presidente y recientemente ha sido electo el
Dr.Hernan Parodi.- Nuestro Capitulo tiene actualmente 12 socios que integran la
AHPBA y la IHPBA.
El objetivo del Capitulo es ofrecer CME de avanzada en el campo HPB a todos los
cirujanos del país, asi como oportunidades de formación a los cirujanos jóvenes e
intercambio de experiencia a nivel internacional.
32
Existing AHPBA Chapters
Argentina
Oscar Imventarza, MD
Brazil
Orlando Jorge Martins Torres, MD
Chile
Heran De la Fuente, MD
Ecuador
Eduardo Rivas, MD
33
Americas Hepato-Pancreato-Biliary
Foundation
Advancing Research, Education, Training & Philanthropic Endeavors
The AHPBF has made great strides
towards reaching its short term goal
of generating a $1 million endowment.
Your contribution will help us get
one step closer in reaching our goal.
Donate
Today
34
ahpba.org/ahpba-foundation
ABOUT THE AHPBA
Research and education are the cornerstones
to advancing the treatment of hepatopancreato-biliary diseases. The AHPBA
Foundation is dedicated to funding research
and education opportunities so our colleagues
can directly impact HPB diseases.
Established in 2010, the Americas HepatoPancreato-Biliary Foundation (AHPBF) seeks
to support the academic careers of young
researchers in the study of diseases of the
liver, bile duct and pancreas. By fostering
and advancing the educational, research and
training activities of the Americas HepatoPancreato-Biliary Association, we enhance
the quality of hepato-pancreato-biliary
surgery and patient care.
Research, education and training are
dramatically increasing the quality of surgery
and treatment. Most importantly, our patients
see the direct results of our commitment to
relieve the human suffering caused by HPB
disorders throughout the world.
Foundation projects include
• International Outreach Grants allowing South, Central and
Latin American members to attend the Annual Meeting.
•Annual Research Grants working toward treatment and
surgery innovations.
•Traveling Fellowship Grants for U.S. Fellows traveling abroad.
•Historical Lecturer Honorarium to bring leading-edge speakers
to the Annual Meeting.
•Humanitarian projects providing access to HPB care for patients.
35
AHPBA Foundation
Gift Levels
The AHPBF has made great strides towards reaching its short term goal of
generating a $1 million endowment. Your contribution will help us get one step
closer in reaching our goal.
Diamond $10,000 and above
Platinum $5,000 and above
Gold $1,000 and above
Silver $500 and above
Bronze $250 and above
Contributors under $250
Multi-Year Pledge Opportunities
Multi-year pledges provide a long-term giving commitment to AHPBF projects
and allow donors a low-maintenance planning tool. Designate
a Diamond, Platinum or Gold gift over a five year period.
Commemorative Giving
AHPBF donors may designate gifts in honor or memory of an individual.
Designees will receive a notice of your gift and its use toward supporting surgical
research. We provide your name and address unless otherwise indicated,
however, gift amounts remain confidential. Designees will be listed in all relevant
AHPBF programs and public information materials.
The Americas Hepato-Pancreato-Biliary Foundation (AHPBF) is a 501(c) (3), not-for profit
organization. Donations are fully tax-deductible to the extent allowed by law. Please consult your
accountant for details. Tax ID: 27-4355142
36
AHPBA Foundation DONORS
Contributions as of January 31, 2014
We are proud to recognize our donors and would like to thank all
of the Organizations and Individual Supporters whose continued
generosity allows us to promote the research on diseases of the
liver, pancreas and biliary tract.
DIAMOND
Silver
AHPBA
Roche Pharmaceutical
John Christein
Felipe Coimbra
Alessandro Diniz
Andrew Lowy
Purvi Parikh
Gold
Reid Adams
Adnan Alseidi
Mark Callery
William Chapman
Sean Cleary
Michael D’Angelica
Elijah Dixon
O. James Garden
Paul Greig
William Helton
David Iannitti
IHPBA
Michael Jacobs
William Jarnagin
Daniel Kleiner
Keith Lillemoe
Rebecca Minter
Michele Molinari
Sean Mulvihill
Susan Orloff
C. Wright Pinson
Henry Pitt
Charles Burke Rosen
Bruce Schirmer
Roderich Schwarz
Jean-Nicolas Vauthey
Charles Vollmer
Gazi Zibari
37
Bronze
Jeffrey Barkun
Cristina Ferrone
Javier Lendoire
Susan Logan
Juan Pekolj
Flavio Rocha
Ponnandai Somasundar
Steven Strasberg
Kevin Watkins
Contributor
Thomas A. Aloia
Christopher Anderson
Todd Bauer
Melanie-Antoinetta Brown
Efrain Cambronero
Mark Cattral
Yun Shin Chun
Bryan Clary
Wilson Luiz Costa Jr
Raul Cutait
Yoshio Deguchi
Douglas Evans
Riad Haddad
Ellen Hagopian
D. Ryan Hall
Ruth Haynes
Paulo Herman
Defei Hong
Oscar Imventarza
D. Rohan Jeyarajah
Tara Kent
Kourosh Kojouri
David Kooby
Bernard Langer
Jeffrey Lee
Donald Lesslie
Lucas McCormack
Peter Muscarella
Attila Nakeeb
Marshall Orloff
Martin Palavecino
Hernan Parodi
Mayank Roy
Margo Shoup
David Sindram
Atsushi Sugioka
Rebekah White
Randall Zuckerman
Firefly™ Fluorescence Imaging
EndoWrist® One™ Vessel Sealer
EndoWrist ® Stapler 45
Experience da Vinci Technology
at the Intuitive Surgical Booth
agenda
39
39
Wednesday, February 19, 2014
7:00am - 8:00am
Ultrasound Registration and Breakfast
Mona Lisa Foyer
7:45am
Departures for Golf & Fishing
Main Lobby
8:30am - 1:00pm
AHPBA Foundation - Golf Tournament
Miami Beach Golf Course
Fee: $200 per person
8:00am - 1:00pm
AHPBA Foundation – Fishing Tournament
Fee: $200 per person
7:00am - 5:30pm
Ultrasound Didactic Course
Support for this course provided by Angiodynamics, BK Medical,
Hitachi Aloka Medical, Ltd., Inner Optic, Kyoto, Medtronic Advanced Energy,
Pathfinder Technologies, Inc., and 3D Med
Mona Lisa – Didactic Course
Key Biscayne A/B – Hands-On Session
Moderator & Organizer: Ellen J. Hagopian, MD
7:00amRegistration & Breakfast
40
8:00am
Welcome & Introduction
Ellen J. Hagopian, MD
8:05am
Importance of Ultrasound in HPB Surgery
8:15am
US Principles & Instrumentation
Eren Berber, MD
8:45am
US Scanning Techniques: TAUS, IOUS & LAP
Reid B. Adams, MD
9:05am
Liver US: Normal Anatomy & Pathologic Findings
Paul D. Hansen, MD
9:45am
Break
10:00am Gallbladder & Bile Duct US: Normal Anatomy & Pathology
O. James Garden, MD, FRCSEd
10:20am Pancreas US: Normal Anatomy & Pathologic Findings
10:40am Introduction to Hands-On Sessions
10:50am Break
11:00am HPB Anatomy & Technique: TAUS
All Faculty
12Noon - 1:00pm
Lunch
Belle
1:00pm
Techniques in Ultrasound Guidance: TAUS, IOUS & LAP
David A. Iannitti, MD
1:20pm
Methods of Tumor Ablation in HPB Surgery
Robert C.G. Martin, II, MD, PhD
1:40pm
US Coding & Billing for the Surgeon
Robert C.G. Martin, II, MD, PhD
2:00pm
Getting Started & Credentialing
2:20pm
Break
2:30pm
Scanning Methods & Ultrasound Guidance: IOUS & LAP
Hands-On Lab using inanimate and phantom models
2:00pm - 3:00pm
Membership Committee Meeting
LaGorce
41
2:00pm - 3:00pm
Professional Development Committee Meeting
Fisher A
2:00pm - 3:00pm
Development Committee Meeting
Fisher B
3:15pm - 4:15pm
Publications Committee Meeting
LaGorce
3:15pm - 4:15pm
International Relations Committee Meeting
Fisher B
3:15pm - 4:15pm
Finance Committee Meeting
Fisher A
4:00pm - 6:00pm
Allied Health Care Symposium
Watson Room
Moderators: Timothy Pawlik, MD, PhD & Lindsey Manos, PA-C
4:00pm
Introduction
4:10pm
Integrating Allied Health Providers to a Busy,
Successful HPB Practice
Dave Geller, MD
4:30pm
Standardization of Postoperative Management for
Whipple & Distal Pancreatectomy Patients
Erin McIntyre, PA-C
4:50pm
Philanthropy: A Collaborative Approach
Sharon Weber, MD
Mary Beth Henry, CRNP
42
5:10pm
Inpatient Management of HPB Patients:
The Wake Forest Baptist Health Experience
Nathan Ogilvie, PA-C
5:30pm Open Discussion
4:30pm - 5:30pm
Program Committee Meeting
Fisher A
4:30pm - 5:30pm
Education & Training Committee Meeting
La Gorce
4:30pm - 5:30pm
CSI Committee Meeting
Fisher B
5:45pm - 6:45pm
Research Committee Meeting
Fisher B
5:45pm - 6:45pm
AHPBA Foundation Board Meeting
LaGorce
5:45pm - 6:45pm
HPB Program Directors Meeting
Fisher A
6:00pm - 8:00pm
Speaker Ready Room Open
San Marino
6:30pm - 8:00pm
AHPBA Registration Open
Ocean Tower 1 & 2 Foyer
7:00pm - 9:00pm
AHPBA Executive Council Meeting
Ocean Ballroom IIA
43
THURSDAY, FEBRUARY 20, 2014
6:30am - 6:30pm
6:30am - 6:30pm
San Marino
7:00am - 9:00am
AHPBA Executive Council Meeting
Ocean Ballroom IIA
9:30am - 5:00pm
Postgraduate Course: Cases, Complications & Controversies
Support for this session provided by Medtronic Advanced Energy
Ocean Tower 1 A-C
Moderator & Organizer: Elijah Dixon, MD, BSc, MSc
9:30am
Pancreas
Moderator: Charles M. Vollmer, MD
Panelists & Case Discussion
Mark S. Talamonti, MD
Chad G. Ball, MD
David E. Linehan, MD
Nicolas P. Jarufe Cassis, MD
Katherine Morgan, MD
44
10:45am
Debate: Optimal Whipple Outcomes: System or Surgeon
Andrew L. Warshaw, MD
Mark S. Talamonti, MD
11:30am
Lunch Break
FEBRUARY 19–23, 2014 | MIAMI BEACH, FL — EDEN ROC
Thursday, February 20, 2014
12:30pm
Hepatic
Moderator: Paul D. Hansen, MD
Thomas A. Aloia, MD
Alice C. Wei, MD
Paulo Herman, MD
1:45pm
Debate: Management of Disappearing Liver Metastases
David M. Nagorney, MD
2:30pm
Break
3:00pm
Transplantation
Moderator: Paul D. Greig, MD
Alan W. Hemming, MD
Oscar Cesar Imventarza, MD
Susan L. Orloff, MD
Michele Molinari, MD
4:15pm
Debate: Living Donor Liver Transplantation
Should Be Offered to All Wait-Listed Patients
11:30pm - 1:00pm
New Member Lunch (By invitation only)
Spa Gardens
(Rain Backup: Lapidus/Watson)
5:15pm - 6:45pm
Welcome Reception
Pompeii/Promenade
45
5:15pm - 6:45pm
Industry Exhibits Open
Pompeii/Promenade
6:00pm - 7:30pm
Educational Dinner Symposium: Robotics in HPB Surgery
Support for this session provided by Intuitive Surgical
Ocean Tower 1 A-C
Moderator: Eugene P. Ceppa, MD
Introduction
Eugene P. Ceppa, MD
Current Status of Robotic Hepatectomy/Biliary Recostruction
John B. Martinie, MD
Current Status of Teaching Robotic Pancreatectomy
Melissa E. Hogg
Advantages and Disadvantages of Robotic Pancreatectomy
C. Max Schmidt, MD
Panel Discussion
John B. Martinie, MD; Melissa E. Hogg, MD; C. Max Schmidt, MD
6:45pm - 7:45pm
HPB Fellows Subcommittee Meeting
LaGorce
46
7:45pm - 10:15pm
Bernard Langer Fellows and Residents Symposium:
Why to Choose HPB Surgery, How to Get a Job in HPB
Support for this session provided by Ethicon, Inc.
Ocean Tower 1 A-C
Moderator: D. Rohan Jeyarajah, MD
—Part 1: Why Choose HPB Surgery?
Noaman Ali, MD & D. Rohan Jeyarajah, MD
Do We Really Need More HPB Surgeons?
Noaman Ali, MD
How Do I Become an HPB Surgeon?
a. Transplant - Raashid Sheikh, MD
b. Surgical Oncology – Amanda Cooper, MD
c. HPB Fellowship – Noaman Ali, MD
How Are We Training HPB Surgeons?
Panel Discussion
—Part 2: How Can I Get an HPB Job?
Ramanathan Seshadri, MD & Maria B. Majella Doyle, MD, MBA
Introduction
Ramanathan Seshadri, MD
47
My Practice- Recent Graduate Presentation
Erin Maynard, MD (ASTS/AHPBA)
Kevin Lowe, MD (AHPBA)
Ryan C. Fields, MD (SSO)
Panel Discussion
—Part 3: What Do I Need to Get an HPB Job?
Ramanathan Seshadri MD, Erin Hanna, MD & Maria B. Majella Doyle, MD, MBA
Introduction
Erin Hanna, MD
Presentations
Lauren Rorabaugh (Administrative)
Mark S. Talamonti, MD (Clinical)
Panel Discussion
Maria B. Majella Doyle, MD, MBA & David A. Iannitti, MD
—Part 4: What Kind of Job Do I Want?
Susanne Warner, MD & Paul Hansen, MD
If You Build It, They Will Come – Key Elements of a Successful HPB Practice
Paul D. Hansen, MD
Veterans Speak
Hybrid Academic / Private Practice – David A. Iannitti, MD
Academic – David C. Linehan, MD
Private Practice – Ellen J. Hagopian, MD
Panel Discussion
Paul D. Hansen, MD
10:30pm
Fellows & Residents Cocktail Gathering
Central Bar
48
Friday, February 21, 2014
6:30am - 6:00pm
6:30am - 5:30pm
San Marino
7:00am - 8:00am
Oral Poster Presentations I - Setup
Mona Lisa
7:00am - 8:00am
Continental Breakfast in Exhibit Hall
Pompeii/Promenade
7:00am - 2:00pm
Pompeii/Promenade
7:00am - 7:55am
Systemic Therapy for Pancreatic Cancer: An Update
Support for this session provided by NewLink Genetics Corporation
Ocean Tower II A-B
Moderator: Roderich E. Schwarz, MD, PhD
49
Learning By Trial: Recent Successes and Failures
Roderich E. Schwarz, MD, PhD
Experience With Vaccine-Based Adjuvant Systemic Therapy
John C. Mansour, MD
Future Treatment Selection Strategies
Jason B. Fleming, MD
7:00am - 7:55am
NAFLD - Implications for Liver Surgery
Ocean Tower 1 A-C
Moderator: Srinevas Reddy, MD
Introduction
Srinevas K. Reddy, MD
Epidemiology of NAFLD
William R. Hutson, MD
Implications of NAFLD for Liver Surgeons
Allan Tsung, MD
7:00am - 8:00am
IHPBA/AHPBA Joint Executive Meeting
Executive Boardroom
8:00am - 9:00am
President’s Plenary Session
Ocean Tower 1 A-C
Moderator: William C. Chapman, MD
PP.01. THE NEAR INFRARED TECHNIQUE FOR CHOLANGIOGRAPHY:
10 REASONS THAT SUPPORT THE SYSTEMATIC UTILIZATION OF
THE METHOD
F. Dip, M. Roy, C. Simpfendorfer, E. Lo-Menzo, S. Szomstein, R. Rosenthal
Cleveland Clinic Florida, Weston, FL
Discussant: William R. Jarnagin, MD
PP.02. IN SEARCH OF THE BEST RECONSTRUCTIVE TECHNIQUE IN
THE WHIPPLE OPERATION – PANCREATICOJEJUNOSTOMY VERSUS
PANCREATICOGASTROSTOMY. A RANDOMIZED CLINICAL TRIAL
J. Grendar, J. F. Ouellet, F. Sutherland, O. Bathe, C. Ball, E. Dixon
Department Of Surgery, University Of Calgary, Calgary, ALBERTADepartment
Of Surgery, Quebec City University Hospital, Quebec City, Quebec, Canada
Discussant: Sean J. Mulvihill, MD
50
PP.03. PROGNOSTIC ROLE OF PLASMA VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF) IN PATIENTS WITH HEPATOCELLULAR
CARCINOMA UNDERGOING LIVER TRANSPLANTATION: EXPERIENCE
OF A SINGLE WESTERN CENTER
W. Zhang, C. Quintini, K. Hashimoto, M. Fujiki, T. Diago, D. Kelly, B. Eghtesad,
C. Miller, J. Fung, F. Aucejo
Cleveland Clinic Foundation, Cleveland, OH
Discussant: Jean-Nicolas Vauthey, MD
PP.04. THE EFFECT OF PREOPERATIVE RENAL INSUFFICIENCY ON
POSTOPERATIVE OUTCOMES FOLLOWING MAJOR HEPATECTOMY:
A MULTI-INSTITUTIONAL ANALYSIS OF 1170 PATIENTS
M. H. Squires, N. L. Lad, S. B. Fisher, D. A. Kooby, S. M. Weber, A. S. Brinkman,
C. R. Scoggins, M. E. Egger, K. Cardona, C. S. Cho, R. C. Martin, M. C. Russell,
E. R. Winslow, C. A. Staley, S. K. Maithel
Winship Cancer Institute, Emory University, Atlanta, GA; University Of
Wisconsin, Madison, WI; University Of Louisville, Louisville, KY
Discussant: Bruce D. Schirmer, MD
9:00am - 9:30am
Opening Session
Ocean Tower 1 A-C
• New Member Recognition
• HPB Certificate Completion Presentation
• Research Award & Traveling Fellowship Presentation
• 2014 Distinguished Service Award Recipient
9:30am - 10:00am
Presidential Address:
Opportunities Ahead for the AHPBA
Ocean Tower 1 A-C
Washington University Medical Center
St. Louis, MO
51
10:00am - 10:30am
Morning Beverage Break
Pompeii/Promenade
10:30am - 11:30am
Anesthetic Management in Liver Surgery
Support for this session provided by Edwards Lifesciences
Ocean Tower 1 A-C
Moderators: Mary E. Fischer, MD & William R. Jarnagin, MD
LCVP Assisted Hepatic Surgery
Mary E. Fischer, MD
LCVP Assisted Laparoscopic Hepatic Surgery
Chris Giordano, MD
Anesthetic Challenges for Liver Transplant
Ivan Kangrga, MD
Epidural Analgesia for Hepatic Surgery
Vijaja Gottumukkala, MD
10:30am - 11:30am
Update on Islet Cell Transplantation
Ocean Tower II A- B
Moderator: Christopher J. Sonnenday, MD
Presenter: Rodolfo Alejandro, MD
52
11:45am - 1:00pm
Parallel State of the Art Lecture: ERAS in HPB Surgery
Support for this session provided by Edwards Lifesciences
Ocean Tower II A-B
Moderator: Thomas A. Aloia, MD
ERAS Principles
Vijaya Gottumukkala, MD
Enhanced Recovery in Liver Surgery-UK Experience
Enhanced Recovery in Pancreas Surgery
Horacio J. Asbun, MD
Enhanced Recovery and Oncologic Outcomes-Moving Beyond
Shorter Length of Stay
Thomas A. Aloia, MD
Panel Discussion - Starting an ERAS Program in HPB Surgery
11:45am - 1:00pm
Downsizing of HCC Prior to Transplant
Ocean Tower 1A-C
Moderator: Maria B. Majella Doyle, MD, MBA
53
Overview of the New OPTN Criteria for
HCC Milan, UCSF and Beyond
Katherine Fowler, MD
Locoregional and Systemic Treatment Options to
Downstage HCC Beyond Milan - What Works Best?
Daniel Brown, MD
Liver Transplantation Beyond Milan
Alan W. Hemming, MD
1:00pm - 2:00pm
Boxed Lunch with Exhibits & Video Presentations
Pompeii/Promenade
Moderator: Carlos U. Corvera, MD
VL.01. ROBOTIC RESECTION OF CHOLEDOCHAL CYST WITH
HEPATICODUODENOSTOMY
S. G. Warner, K. T. Nguyen
University Of Michigan, Ann Arbor, MI
VL.02. ROBOTIC SEGMENTAL DUODENAL RESECTION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, D. A. Iannitti, J. B. Martinie
Carolinas Medical Center, Charlotte, NC
VL.03. LAPAROSCOPIC RIGHT HEPATECTOMY WITH HYDROJET
AND HARMONIC SCALPEL DISSECTION
J. B. Conneely, R. Smoot, S. Cleary
Toronto General Hospital, Tornto, Ontario, Canada
2:10pm - 2:55pm
Invited Presidential Lecturer:
Hepatocellular Carcinoma:
Liver Transplantation – The Hope for a Cure
Göran B. Klintmalm, MD, PhD
Baylor University Medical Center
Ocean Tower 1 A-C
Invited Presidential Lecturer
Göran B. Klintmalm, MD, PhD
Baylor University Medical Center
54
2:55pm - 4:55pm
Long Oral Abstract Session A: Liver
Ocean Tower 1 A-C
Moderators: Clifford S. Cho, MD; Eduardo de Santibanes, MD, PhD
LO-A.01. LAPAROSCOPIC HEPATECTOMY SIGNIFICANTLY SHORTENS
THE TIME TO POSTOPERATIVE CHEMOTHERAPY IN OBESE PATIENTS
UNDERGOING MAJOR HEPATECTOMIES
S. C. Agle, P. Philips, M. E. Egger, C. R. Scoggins, K. M. McMasters, R. C. Martin,
University Of Louisville, Louisville, KY
LO-A.02. SURVIVAL ANALYSIS OF PATIENTS WITH STAGE I AND II
HEPATOCELLULAR CARCINOMA FOLLOWING LIVER TRANSPLANTATION
AND LIVER RESECTION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo,
D. A. Iannitti
Discussant: William C. Chapman, MD
LO-A.03. VENOUS THROMBOEMBOLIC PROPHYLAXIS FOLLOWING
HEPATIC RESECTION: PATTERNS OF CARE AMONG LIVER SURGEONS
M. Weiss, A. Ejaz, G. Spolverato, Y. Kim, K. Hirose, C. Wolfgang, M. Choti, T. M. Pawlik
Johns Hopkins Hospital, Baltimore, MD
Discussant: Michael D’Angelica, MD
LO-A.04. HYPOPHOSPHATEMIA AFTER MAJOR HEPATECTOMY AND
THE RISK OF POSTOPERATIVE HEPATIC INSUFFICIENCY AND MORTALITY:
AN ANALYSIS OF 719 PATIENTS
M. H. Squires, G. C. Dann, N. L. Lad, S. B. Fisher, B. M. Martin, D. A. Kooby,
J. M. Sarmiento, M. C. Russell, K. Cardona, C. A. Staley, S. K. Maithel
Winship Cancer Institute, Emory University, Atlanta, GA; Emory University, Atlanta, GA
Discussant: Peter Kingham, MD
55
LO-A.05. BORDERLINE OPERABILITY IN HEPATECTOMY PATIENTS
IS ASSOCIATED WITH HIGHER RATES OF FAILURE TO RESCUE AFTER
SEVERE COMPLICATIONS
C. D. Tzeng, A. B. Cooper, S. A. Curley, J. N. Vauthey, T. A. Aloia
University Of Kentucky, Lexington, KY; University of Texas MD Anderson Cancer
Center, Houston, TX
Discussant: Maria Russell, MD
LO-A.06. RENAL FUNCTION AFTER LOW CENTRAL VENOUS PRESSURE
ASSISTED LIVER RESECTION. ASSESSMENT OF 2116 CASES
C. Correa-Gallego, A. Berman, S. C. Denis, V. Arslan-Carlon, T. Kingham, M. I. D Angelica,
P. J. Allen, Y. Fong, R. P. DeMatteo, W. R. Jarnagin, J. Melendez, M. Fischer
Memorial Sloan-Kettering Cancer Center, New York, NY
Discussant: Chad Ball, MD
LO-A.07. ADJUVANT STEREOTACTIC BODY RADIATION FOLLOWING
CHEMOEMBOLIZATION IMPROVES SURVIVAL IN PATIENTS WITH NONRESECTABLE HEPATOCELLULAR CARCINOMA OVER 3 CENTIMETERS
R. Jacob, K. Keene, F. Turley, D. T. Redden, M. K. Bryant, D. P. Dorn, L. Dover, J. White,
S. H. Gray, D. E. Eckhoff, D. A. DuBay
University of Alabama at Birmingham, Birmingham, AL
Discussant: Paul Greig, MD
LO-A.08. SURGICAL MANAGEMENT OF HEPATIC HEMANGIOMAS: AN
INTERNATIONAL MULTI-INSTITUTIONAL EXPERIENCE
J. T. Miura, A. Li, R. Schmocker, S. Nichols, D. Sukato, E. Winslow, G. Spolverato, A. Ejaz,
M. H. Squires, D. Kooby, S. Maithel, J. M. Sarmiento, M. Bloomston, K. K. Christians,
F. M. Johnston, S. Tsai, K. Turaga, A. Tsung, T. Pawlik, M. Wu, T. C. Gambli
Medical College Of Wisconsin, Milwaukee, WI; Eastern Hepatobiliary Surgery Hospital,
The Second Military Medical University, Shanghai, Shanghai, China; Emory University
School Of Medicine, Atlanta, GA; University Of Wisconsin School Of Medicine And
Public Health, Madison, WI; The Ohio State University, Columbus, OH; Johns Hopkins
University School Of Medicine, Baltimore, MD; University Of Pittsburgh School Of
Medicine, Pittsburgh, PA
Discussant: Susan Orloff, MD
56
LO-A.09. PREDICTING TRANSPLANT-ELIGIBLE RECURRENCE AFTER
INITIAL RESECTION OF HEPATOCELLULAR CANCER
S. Lee, I. Konstantinidis , T. P. Kingham, M. I. D’Angelica, P. J. Allen, Y. Fong,
R. P. DeMatteo, W. R. Jarnagin
Memorial Sloan-Kettering Cancer Center, New York, NY
Discussant: Maria B. Majella Doyle, MD, MBA
LO-A.10. SYNCHRONOUS PRIMARY COLORECTAL CANCER AND
LIVER METASTASIS: IMPACT OF OPERATIVE APPROACH ON CLINICAL
OUTCOMES AND HOSPITAL COSTS
A. Ejaz, G. Spolverato, E. Semenov, D. Tanner, J. Hundt, T. M. Pawlik
Johns Hopkins Hopsital, Baltimore, MD
Discussant: Todd Bauer, MD
2:55pm - 4:55pm
Long Oral Abstract Session B: Pancreas
Ocean Tower II A- B
Moderators: Margo C. Shoup, MD; Jason Bates Fleming, MD
LO-B.01. PATIENT SELECTION AND THE VOLUME EFFECT IN
PANCREATIC SURGERY: UNEQUAL BENEFITS?
L. A. Bliss, C. J. Yang, K. Lagisetty, Z. Chau, S. Ng, T. S. Kent, A. J. Moser,
D. W. McFadden, M. P. Callery, J. F. Tseng
Beth Israel Deaconess Medical Center, Boston, MA; University Of Massachusetts
Medical School, Worcester, MA; University Of Connecticut Health Center, Farmington,
CT
Discussant: Ching-Wei Tzeng, MD
LO-B.02. REDUCING READMISSIONS FOLLOWING PANCREATECTOMY:
COORDINATION OF THE CARE CONTINUUM
E. P. Ceppa, H. A. Pitt, A. Nakeeb, C. M. Schmidt, N. J. Zyromski, M. G. House, B. Brand,
D. Weidert, K. D. Lillemoe
Indiana University School Of Medicine, Indianapolis, IN; Temple University Health
System, Philadelphia, PA; Massachusetts General Hospital, Bostom, MA
Discussant: Timothy Pawlik, MD, MPH, PhD
57
LO-B.03. PATENCY RATES OF PORTAL VEIN/SUPERIOR MESENTERIC
VEIN RECONSTRUCTION AFTER PANCREATECTOMY FOR PANCREATIC
ADENOCARCINOMA
A. N. Krepline, K. Duelge, K. K. Christians, B. George, P. Ritch, B. Erickson, A. Mahmoud,
E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gambliin, D. B. Evans, S. Tsai
Medical College Of Wisconsin, Milwaukee, WI
Discussant: Matthew Katz, MD
LO-B.04. PANCREATIC TRAUMA IN THE UNITED STATES:
A CONTEMPORARY APPRAISAL
B. R. Englum, A. M. Ganapathi, P. J. Speicher, J. E. Scarborough
Duke University School Of Medicine, Durham, NC
Discussant: Sebastian de la Fuente, MD
LO-B.05. DEFINING THE POSTOPERATIVE MORBIDITY INDEX FOR
DISTAL PANCREATECTOMY
M. K. Lee, R. S. Lewis, S. Strasberg, B. L. Hall, P. Study Group, C. M. Vollmer
Washington University In St. Louis School Of Medicine, St. Louis, MO; Perelman School
Of Medicine, Philadelphia, PA
Discussant: Michael Farnell, MD
LO-B.06. THE ROLE OF HEPATIC ARTERY LYMPH NODE METASTASIS IN
PANCREATIC CANCER: PROGNOSTIC FACTOR OR SURGICAL SELECTION
CRITERIA
P. Philips, S. C. Agle, C. R. Scoggins, R. C. Martin
University Of Louisville, Louisville, KY
Discussant: Daniel Abbott, MD
LO-B.07. PROPHYLACTIC OCTREOTIDE FOR PANCREATODUODENECTOMY:
MORE HARM THAN GOOD?
M. T. McMillan, J. D. Christein, M. P. Callery, S. W. Behrman, J. A. Drebin, T. S. Kent,
B. C. Miller, R. S. Lewis, C. M. Vollmer
University Of Pennsylvania, Philadelphia, PA; University Of Alabama At Birmingham
Medical Center, Birmingham, AL; Beth Israel Deaconess Medical Center, Boston, MA;
University Of Tennessee Health Science Center, Memphis, TN
Discussant: Mark Talamonti, MD
58
LO-B.08. INTERNATIONAL CONSENSUS GUIDELINE PARAMETERS CARRY
UNEQUAL WEIGHT AND ARE NOT CUMULATIVE IN INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASM MALIGNANT RISK PREDICTION
A. M. Roch, E. P. Ceppa, J. M. DeWitt, M. A. Al-Haddad, C. M. Schmidt
Indiana University School Of Medicine, Indianapolis, IN; Indiana University Health
University Hospital, Indianapolis, IN
Discussant: John Martinie, MD
LO-B.09. UPREGULATION OF S1P-RECEPTOR-1 IN PANCREATIC DUCTAL
ADENOCARCINOMA
A. Cardenas, D. Cucher, T. Jie, . , R. Heimark, E. Ong
University Of Arizona College Of Medicine, Tucson, AZ; University Of Arizona Cancer
Center, Tucson, AZ
LO-B.10. A STANDARDIZED CARE PLAN IS ASSOCIATED WITH
SHORTER HOSPITAL LENGTH OF STAY IN PATIENTS UNDERGOING
PANCREATICODUODENECTOMY
D. P. Nussbaum, K. Penne, P. J. Speicher, S. S. Stinnett, A. Cocieru, D. G. Blazer, S. Zani,
B. M. Clary, D. S. Tyler, R. R. White
2:55pm - 4:55pm
Long Oral Abstract Session C: Biliary & Transplant
Ocean Tower IIC
Moderators: Javier C. Lendoire, MD, PhD; Oscar Cesar Imventarza, MD
LO-C.01. ABSORBABLE BIOPROSTHESIS FOR THE TREATMENT OF BILE
DUCT INJURY IN AN EXPERIMENTAL MODEL
E. E. Montalvo Javé, A. R. Jaime Limon, M. J. Kim Koh, M. A. García Pineda, B. León
Mancilla, F. Rojas Mendoza , J. Tapia Jurado, C. Montalvo Arenas, J. A. Saavedra
Universidad Nacional Autónoma de México, Mexico City, Mexico; Medica Sur Clinic
Foundation, Mexico City, Mexico; Hospital General De México, Mexico City, Mexico
59
LO-C.02. NATIONAL VIEW ON BILIARY CANCER: RISING RESECTIONS
AND CONSIDERABLE COMPLICATIONS
C. J. Yang, L. A. Bliss, W. B. Al-Refaie, A. R. Evenson, K. Khwaja, S. C. Ng, J. F. Tseng
Beth Israel Deaconess Medical Center, Boston, MA; MedStar Georgetown University
Hospital, Washington, DC
Discussant: Flavio Rocha, MD
LO-C.03. IS LOCAL RESECTION ADEQUATE FOR T1 STAGE AMPULLARY
CANCER?
A. Amini, J. Miura, T. Jayakrishnan, F. Johnston, S. Tsai, K. Christians, C. Gamblin,
K. Turaga
Discussant: Mark Bloomston, MD
LO-C.04. MODEL TO PREDICT SURVIVAL AFTER SURGICAL RESECTION
OF INTRAHEPATIC CHOLANGIOCARCINOMA: THE MAYO EXPERIENCE
S. M. Ali, C. J. Clark, T. Mounajjed, T. Wu, W. Harmsen, K. M. Reid-Lombardo,
M. L. Kendrick, M. B. Farnell, D. M. Nagorney, F. Que
Mayo Clinic, Rochester, MN
LO-C.06. COMPARISON OF LONG TERM SURVIVAL BETWEEN LIVER
TRANSPLANTATION AND RESECTION IN PATIENTS WITH STAGE I AND
II CHOLANGIOCARCINOMA - A NATIONAL RETROSPECTIVE ANALYSIS
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo,
D. A. Iannitti
LO-C.07. HEPATIC ARTERIAL FLOW PREDICTS BILIARY COMPLICATIONS
AND SURVIVAL IN LIVER TRANSPLANT RECIPIENTS
P. T. Kim, G. Saracino, L. Jennings, M. Ramsay, G. J. McKenna, G. Testa, N. Onaca,
T. L. Anthony, R. Ruiz, M. Levy, R. Goldstein, G. Klintmalm
Baylor University Medical Center, Dallas, TX
Discussant: William C. Chapman, MD
60
LO-C.08. LIVER TRANSPLANTATION IS A HIGHLY EFFECTIVE TREATMENT
FOR MANAGEMENT OF HEPATOCELLULAR CARCINOMA, EVEN FOR
HIGHLY SELECTED ADVANCED STAGE PATIENTS
M. Doyle, N. Vachharajani, K. Fowler, K. Korenblat, J. Lowell, S. Shenoy, J. Crippin,
Y. Lin, J. Wellen, N. Saad, W. Chapman
Washington University School Of Medicine, St. Louis, MO
LO-C.09. IS LIVER TRANSPLANTATION SAFE AND EFFECTIVE FOR
GERIATRIC (>70 YEARS) RECIPIENTS? A CASE CONTROLLED ANALYSIS
G. C. Wilson, R. C. Quillin, K. Wima, J. M. Sutton, D. J. Hanseman, I. M. Paquette,
F. Paterno, E. S. Woodle, D. E. Abbott, S. A. Shah
University Of Cincinnati, Cincinnati, OH
Discussant: Christopher Anderson, MD
LO-C.10. RECIPIENT OBESITY ADVERSELY AFFECTS LONG-TERM
GRAFT AND OVERALL SURVIVAL IN A SINGLE INSTITUTION ANALYSIS
K. D. Conzen, N. Vachharajani, K. M. Collins, C. D. Anderson, Y. Lin, J. R. Wellen,
S. Shenoy, J. A. Lowell, M. Doyle, W. Chapman
Washington University School of Medicine, St. Louis, MO; University Of Mississippi
Medical Center, Jackson, MS
Discussant: Christopher Sonneday, MD, MHS
61
5:00pm - 6:30pm
Oral Poster Presentations I
Support for this session provided by Sirtex Medical, Inc.
Mona Lisa
Moderators: Ching-Wei Tzeng, MD; Michael G. House, MD
GROUP: LIVER I
OP-I.01. HIDA SCAN OF THE FLR IS SUPERIOR TO VOLUMETRY TO
ASSESS LIVER FUNCTION IN ALPPS
E. Schadde, M. Lesurtel, N. Schäfer, P. Clavien
University Of Zurich Hospital, Zurich, Switzerland
OP-I.02. MORBIDITY AND MORTALITY IN 1174 PATIENTS UNDERGOING
HEPATIC PARENCHYMAL TRANSECTION USING A STAPLER DEVICE
M. Raoof, T. A. Aloia, J. Vauthey, S. A. Curley
University Of Texas MD Anderson Cancer Center, Houston, TX; University Of Arizona,
Tucson, AZ
OP-I.03. MRI WITH GADOXETATE DISODIUM FOR COLORECTAL
LIVER METASTASIS: IS IT THE NEW “GOLD STANDARD”?
S. Patel, S. Cheek, H. Osman, T. Winston , D. Jeyarajah
Methodist Dallas Medical, Dallas, TX
OP-I.04. RACIAL DISPARITY OUTCOMES IN PATIENTS UNDERGOING
HEPATECTOMY:
IS RENAL FUNCTION THE DRIVING FORCE?
J. E. Dowden, D. J. Taber, J. W. McGillicuddy, C. Bratton, P. Baliga, K. D. Chavin
Medical University Of South Carolina, Charleston, SC
OP-I.05. IMPACT OF NEO-ADJUVANT CHEMOTHERAPY ON
PARENCHYMAL SPARING IN HEPATECTOMY FOR COLORECTAL LIVER
METASTASIS
S. Kaihara, K. Okada, K. Inoguchi, S. Yo, T. Yamamoto, S. Yagi, K. Uryuhara, R. Hosotani
Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
62
OP-I.06. FALLING BARRIERS TO LAPAROSCOPIC LIVER RESECTION
A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil, J. Buell
Tulane Transplant Institute, New Orleans, LA
OP-I.07. THE EFFECT OF ALCOHOL ON SIRT1 EXPRESSION AND FUNCTION
IN ANIMAL AND HUMAN MODELS OF HEPATOCELLULAR CARCINOMA
K. Thompson, J. Humphries, D. J. Niemeyer, D. A. Iannitti, D. Sindram, I. McKillop
Carolinas Medical Center, Charlotte, NC; University Of North Carolina At Charlotte,
Charlotte, NC
OP-I.08. RISK FACTORS FOR REPEAT CHEMOEMBOLIZATION FOR
HEPATOCELLULAR CARCINOMA
J. White, D. T. Redden, M. K. Bryant, D. P. Dorn, S. Saddekni, A. K. Aal, S. H. Gray,
D. E. Eckhoff, D. A. DuBay
University of Alabama at Birmingham, Birmingham, AL
OP-I.09. STARTING A NEW LAPAROSCOPIC LIVER SURGERY PROGRAM:
INITIAL EXPERIENCE AND IMPROVED EFFICIENCY
S. Liang, S. Jayaraman
University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre Toronto,
Toronto, Ontario, Candad
OP-I.10. LAPAROSCOPIC CAUDATE LIVER RESECTION
S. Lee, A. Hauch, E. Kane, E. Kandil, J. Buell
GROUP: LIVER II
OP-I.11. LIVER RESECTION IN THE ELDERLY FOR COLORECTAL LIVER
METASTASIS: OUTCOMES OF OCTOGENARIANS
E. Simoneau, M. Shaheen, A. Salman, P. Chaudhury, M. Kyres, P. Metrakos
McGill University Health Center, Montreal, Quebec, Canada
OP-I.13. SURGERY AND STEREOTACTIC BODY RADIOTHERAPY (SBRT):
A COMBINED APPROACH FOR LOCAL CONTROL OF LIVER CANCER
N. L. Thai, K. Tom, A. Khan, P. Abrams, J. Oliva, A. Kirichenko, M. Szramowski
Allegheny Health Network, Pittsburgh, PA
63
OP-I.14. NOVEL EVALUATION FOR HEPATIC FUNCTIONAL RESERVE
AFTER LIVER RESECTION IN COMBINATION WITH 3D-CT AND 99MGSA
SCINTIGRAPHY
M. TANIGUCHI, A. Okizaki, K. Watanabe, K. Uchida, K. Imai, N. Shuke, H. Furukawa
Asahikawa Medical University, Asahikawa, Hokkaido, Japan
OP-I.15. TUMOR SIZE INDEPENDENTLY IMPACTS SURVIVAL IN PATIENTS
UNDERGOING SURGERY FOR HEPATOCELLULAR CARCINOMA
O. C. Kutlu, M. Wachtel, S. Dissanaike
Texas Tech University Health Sciences Center, Lubbock, TX
OP-I.16. BLOCKING CD47 PROMOTES PHAGOCYTOSIS OF HUMAN
HEPATOCELLULAR CARCINOMA CELLS
Z. Xiao, K. Ott, Y. Lin, C. Chen, L. Lin, G. Upadhya, P. Manning, W. Frazier,
T. Mohanakumar , W. Chapman
Washington University School Of Medicine, Saint Louis, MO; Vasculox, Inc. St Louis,
Saint Louis, MO
OP-I.18. TACHOSIL® VERSUS SURGICEL® ORIGINAL FOR THE SECONDARY
TREATMENT OF LOCAL BLEEDING IN ADULT PATIENTS UNDERGOING
HEPATIC RESECTION
Y. Genyk, T. Kato, J. J. Pomposelli, K. W. Lophaven, W. C. Chapman, .
University Of Southern California, Los Angeles, CA; Columbia University Medical
Center, New York, NY; Lahey Clinic Medical Center, Burlington, MA; Takeda
Development Centre Europe, Langebjerg 1, Roskilde, Denmark; Washington University
School of Medicine, St. Louis, MO
OP-I.19. HEPATIC STELLATE CELL-DERIVED TENASCIN-C IS ASSOCIATED
WITH OBESITY-INDUCED HEPATOCELLULAR CARCINOMA
T. Li, J. H. Benbow, T. L. Walling, A. C. Smith, I. H. McKillop, D. Sindram,
K. J. Thompson, L. W. Schrum
OP-I.20. PREOPERATIVE ASSESSMENT OF REMNANT LIVER FUNCTION
FOLLOWING HEPATECTOMY BY HEPATOBILIARY SCINTIGRAPHY AND
INDOCIANINE GREEN CLEARANCE
K. Okada, H. Kinoshita, Y. Sakamoto, S. Yao, T. Yamamoto, K. Inoguchi, R. Hosotani,
S. Kaihara
64
GROUP: PANCREAS I
OP-I.21. CHARACTERIZATION OF PANCREATICO-ENTERIC
ANASTOMOTIC HEALING IN A PORCINE SURVIVAL MODEL
Y. S. Khajanchee, W. Johnston, C. B. Bifulco, M. A. Cassera, C. W. Hammill,
P. D. Hansen
Providence Portland Cancer Center, Portland, OR
OP-I.22. PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR)
AND SERUM CA19-9 AS SIGNIFICANT PREDICTORS FOR PANCREATIC
HEAD CANCER
T. Asaoka, A. Miyamoto, K. Yamamoto, N. Haraguchi, M. Miyake, K. Nishikawa,
M. Hirao, M. Ikeda, M. Sekimoto, S. Nakamori
Osaka National Hospital, Osaka, Osaka, Japan
OP-I.24. USE OF GLAND AND TUMOR CHARACTERISTICS AND
PREOPERATIVE CT SCANS TO PREDICT PANCREATIC FISTULA AFTER
C. Johnston, L. Harmon, L. Haykin, J. Shen, H. Hahn, D. Coy, M. Lasarev, C. Mathews,
M. Cassera, M. Brown, R. Wolf, P. Hansen, C. Hammill, A. Alseidi, P. Newell
Providence Portland Cancer Center, Portland, OR; Virginia Mason Medical Center,
Seattle, WA; Oregon Health and Science University, Portland, OR
OP-I.25. HIGHER LYMPH NODE RATIO PREDICTS EARLY RECURRENCE
AFTER CURATIVE RESECTION FOR PANCREATIC ADENOCARCINOMA
E. W. Gilbert, N. W. Bronson, T. Kaur, K. Billingsley, B. C. Sheppard
Oregon Health and Science University, Portland, OR
OP-I.26. SINGLE-INSTITUTION EXPERIENCE WITH RESECTION OF
SIDE-BRANCH IPMN: A REVIEW OF PRE-OPERATIVE CHARACTERISTICS
AND FINAL PATHOLOGIC DIAGNOSIS
J. D. Dortch, J. A. Stauffer, H. J. Asbun
Mayo Clinic-Florida, Jacksonville, FL
OP-I.27. PANCREATIC CANCER METASTATIC TO A LIMITED NUMBER
OF LYMPH NODES DOES NOT ADVERSELY AFFECT OUTCOME
M. Kukar, S. W. Badwin, K. Attwood, N. Wilkinson, S. N. Hochwald, B. Kuvshinoff II
Roswell Park Cancer Institute, Buffalo, NY
65
OP-I.28. VARIATIONS IN MEDICAL ONCOLOGY UTILIZATION
PRACTICES BY PANCREATIC CANCER PATIENTS IN A SINGLE
PAYER HEALTH CARE SYSTEM
S. Hurton, G. Porter, M. Walsh, M. Molinari
Dalhousie University, Halifax, Nova Scotia, Canada; Cancer Care Nova Scotia,
Halifax, Nova Scotia, Canada
OP-I.29. LONG TERM OUTCOMES FAVOR PYLORUS PRESERVING
PANCREATICODUODENECTOMY OVER DUODENUM PRESERVING
PANCREATIC HEAD RESECTION FOR CHRONIC PANCREATITIS:
A META-ANALYSIS AND SYSTEMATIC REVIEW
P. B. Sukharamwala, S. B. Ross, S. Parikh, C. E. Ryan, T. W. Wood, A. S. Rosemurgy
Florida Hospital Tampa, Tampa, FL; American University Of Antigua, New York, NY
GROUP: PANCREAS II
OP-I.30. NEOADJUVANT CHEMORADIATION DECREASES LYMPH
NODE RATIO IN BORDERLINE RESECTABLE PANCREATIC DUCTAL
ADENOCARCINOMA
J. S. Peng, N. Ali, G. Falk, D. Joyce, C. O’Rourke, J. McMichael, J. Wey, S. Chalikonda,
K. M. El-Hayek, R. M. Walsh
OP-I.31. DELAYED GASTRIC EMPTYING FOLLOWING
PANCREATICODUODENECTOMY: INCIDENCE, RISK FACTORS,
AND HEALTHCARE UTILIZATION
S. Mohammed, G. Van Buren, A. McElhany, M. Issazadeh, E. J. Silberfein, D. A. Anaya,
S. E. Hodges, W. E. Fisher
Baylor College Of Medicine, Houston, TX; Elkins Pancreas Center, Houston, TX
OP-I.32. PORTAL VEIN RESECTION IS ASSOCIATED WITH
IMPROVED SURVIVAL AFTER PANCREATICODUODENECTOMY
FOR PANCREATIC CANCER
P. B. Sukharamwala, K. D. Patel, R. L. Klein, T. W. Wood, A. F. Teta, A. S. Rosemurgy
Florida Hospital Tampa, Tampa, FL
66
OP-I.34. ROLE OF SURGICAL PALLIATION IN PATIENTS WITH PANCREATIC
DUCTAL ADENOCARCINOMA (PDAC)
A. Abbasi, R. Lo, A. J. Moser, J. F. Tseng, C. M. Vollmer, M. P. Callery, T. S. Kent
Beth Israel Deaconess Medical Center Boston, MA; University Of Pennsylvania,
Philadelphia, PA
OP-I.35. PROPHYLACTIC ANTICOAGULATION FOR SUPERIOR MESENTERIC
VEIN (SMV) OR PORTAL VEIN (PV) NARROWING/OCCLUSION IN
BORDERLINE RESECTABLE (BLR) PANCREATIC ADENOCARCINOMA
(PC) PATIENTS
A. N. Krepline, K. Duelge, B. George, P. Ritch, B. A. Erickson, A. Mahmoud,
E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gamblin, K. K. Christians,
D. B. Evans, S. Tsai
OP-I.36. REGIONALIZATION OF HEPATO-PANCREATO-BILIARY
CANCER TREATMENT WITHIN THE STATE OF FLORIDA ACCORDING
TO THE AMERICAN COLLEGE OF SURGEONS COMMISSION ON CANCER
ACCREDITATION
N. Agee, P. Veldhuis , S. Eubanks, P. Arnoletti, S. G. De La Fuente
Florida Hospital Orlando, Orlando, FL; University Of Central Florida, Orlando, FL
OP-I.37. OBESITY IS NOT ASSOCIATED WITH PANCREATIC CARCINOMA
OR INPATIENT MORTALITY AFTER PANCREATIC RESECTION
E. S. Glazer, E. S. Ong
The University Of Arizona, Tucson, AZ
OP-I.38. PANCREATODUODENECTOMIES IN COLOMBIA: A QUALITATIVE
STUDY OF THE PANCREATIC SURGERY FROM THE SURGEONS’
PERSPECTIVE
J. Sabogal Olarte, C. G. Ball, F. Sutherland, O. Bathe, E. Dixon
Foothills Medical Centre-University Of Calgary, Calgary, Alberta, Canada
67
GROUP: TRANSPLANT/OTHER
OP-I.40. PANCREAS TRANSPLANTATION OUTCOMES DIFFER BASED
ON AGE GROUPINGS: AN ANALYSIS OF THE UNOS DATABASE
E. Siskind, C. Maloney, M. Akerman, A. Shen, A. Basu, E. Molmenti, J. Ortiz,
North Shore Long Island Jewish Health System, Manhasset, NY; Albert Einstein Medical
Center, Philadelphia, PA
OP-I.42. INTERVENTIONAL RADIOLOGY STENTING AND TPA FOR
HEPATIC ARTERY THROMBOSIS IN LIVER TRANSPLANTATION REVISITED:
A FALSE HOPE WITH FREQUENT NEED FOR RETRANSPLANTATION
C. W. Michalski, J. Pasko, K. Roayaie, D. L. Scott, S. L. Orloff
Oregon Health and Science University, Portland, OR
OP-I.43. HPB SURGERY FROM SCRATCH: A SINGLE SURGEON’S ONE
YEAR EXPERIENCE IN ESTABLISHING A HIGH VOLUME HPB CENTER
J. S. Cardinal, S. Cho
West Virginia University, Morgantown, WV
OP-I.44. SURGERY TO THE EXTREME: THE CONCEPT OF “TRANSPLANT
ONCOLOGY”
T. Hibi, Y. Abe, O. Itano, H. Obara, M. Shinoda, M. Kitago, H. Yagi, Y. Kitagawa
Keio University School Of Medicine, Tokyo, Japan
OP-I.45. AMPULLARY AND EXTRA-AMPULLARY DUODENAL
ADENOCARCINOMAS HAVE COMPARABLE SURVIVAL AFTER
POTENTIALLY CURATIVE RESECTION
K. H. Dinh, V. Bathini, B. Switzer, V. Kasturi, W. Wassef, J. Zivny, M. Sullivan,
G. Whalen, J. LaFemina
University Of Massachusetts Medical School, Worcester, MA
OP-I.46. TIPS IS NOT NECESSARY FOR THE SUCCESSFUL MANAGEMENT
OF RUPTURED PARAUMBILICAL HERNIAS IN PATIENTS WITH ADVANCED
HEPATIC CIRRHOSIS AND REFRACTORY ASCITES
N. A. Chatzizacharias, J. A. Bradley, E. Huguet, A. Jah, N. V. Jamieson, R. K. Praseedom,
P. Gibbs
Addenbrooke’s University Hospital, Cambridge, United Kingdom
68
OP-I.47. A MULTI-DETECTOR CT ANALYSIS OF THE ABDOMINAL WALL
STRUCTURE AROUND THE UMBILICUS WITH SPECIAL REFERENCE TO
THE DEHISCENCE OF THE LINEA ALBA: COULD IT BE AN UNDERRECOGNIZED PREDISPOSING FACTOR FOR ADULT UMBILICAL HERNIA?
A. Shimizu, U. Mitsuhashi, M. Tanaka, Y. Yasuda
Koganei Central Hospital, Shimotsuke, Tochigi, Japan; Jichi Medical University,
Shimotsuke, Tochig, Japan i
5:00pm - 7:15pm
Pompeii/Promenade
6:30pm - 7:15pm
Cocktail Reception in Exhibit Hall & Highlighted Videos
Pompeii/Promenade
Moderator: Horacio J. Asbun, MD and Thomas A. Aloia, MD
VR.01. LAPAROSCOPIC REPAIR OF ERCP RELATED DUODENAL
PERFORATION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, J. J. Lewis, D. Sindram, J. B. Martinie,
D. A. Iannitti
VR.02. KLATSKIN TUMOR: LEFT HEPATECTOMY WITH CAUDATE
LOBE RESECTION USING LEFT HANGING MANEUVER
R. Sanchez Claria, n. Resio, o. Mazza, f. Alvarez, M. de Santibañes, S. Bilbao
Hospital Italiano Buenos Aires, Capital Federal, Buenos Aires, Argentina
VR.03. ROBOTIC ASSISTED CYST GASTROSTOMY AND EXCISION OF
A PANCREATIC PSEUDOCYST EXTENDING TO THE PELVIS
T. K. Nguyen, A. H. Zureikat
University Of Pittsburgh Department Of Surgery, Pittsburgh, PA
69
6:30pm
Oral Poster Presentations I - Teardown
Mona Lisa
7:15pm - 10:30pm
Congress Banquet
Ocean Garden
(Rain Backup: Ocean Tower II A-C)
70
Saturday, February 22, 2014
6:15am - 7:30am
AHPBA Foundation Fund Run
Meet at Spa Entrance
Fee: $50 per person
6:30am - 7:45am
Oral Poster Presentations II - Setup
Mona Lisa
7:00am - 6:00pm
7:00am - 6:00pm
San Marino
7:00am - 6:00pm
SAGES Working Group
Executive Board Room
7:00am - 8:00am
Continental Breakfast in Exhibit Hall
Pompeii/Promenade
7:00am - 11:15am
Pompeii/Promenade
71
7:00am - 8:00am
Parallel Long Abstracts D: Tricks of the Trade
Ocean Tower II A- B
Moderators: Conrad H. Simpfendorfer, MD; Nicolas P. Jarufe Casis, MD
LO-D.01. SPLENOPNEUMOPEXY: DECOMPRESSION OF PORTAL
HYPERTENSION IN THE SETTING OF PORTAL VENOUS OCCLUSIVE DISEASE
J. M. Sutton, S. L. Starnes, S. A. Shah
University Of Cincinnati Medical Center, Cincinnati, OH
Discussant: Alan Heming, MD, MSC
LO-D.02. EARLY VEIN RECONSTRUCTION AND RIGHT-TO-LEFT
PANCREATIC DISSECTION FOR LEFT SIDED PANCREATIC TUMORS
WITH PV/SMV OCCLUSION
J. M. Cloyd, B. C. Visser
Stanford University, Stanford, CA
Discussant: Susan Logan, MD
LO-D.03. LAPAROSCOPIC EXPOSURE AND LIGATION OF THE RIGHT
BRANCH OF THE PORTAL VEIN
S. Jayaraman
University Of Toronto, Toronto, Ontario, Canada
Discussant: Paul Hansen, MD
LO-D.04. LAPAROSCOPIC LIVER MOBILIZATION – TRICKS OF THE
TRADE TO AVOID COMPLICATIONS
N. Ikoma, G. Oshima, O. Itano
University Of Texas Health Science Center At Houston, Houston, TXKeio University
School Of Medicine, Tokyo, Tokyo, Japan
Discussant: Hiromichi Ito, MD
LO-D.05. TRANSGASTRIC PANCREATIC NECROSECTOMY - TRICKS OF
THE TRADE
N. J. Zyromski
Indiana University Department Of Surgery, Indianapolis, IN
72
7:00am - 8:00am
Parallel Long Abstracts E: Video Presentations
Pompeii/Promenade
Moderators: Courtney Scaife, MD; Derek A. Dubay, MD
LO-E.01. SEGMENT VIII RESECTION FOR COLON CANCER METASTASIS
USING THE IN SITU COLD PERFUSION TECHNIQUE WITH RIGHT AND
MIDDLE HEPATIC VEIN RECONSTRUCTION
M. Segedi, I. McGilvray, P. Greig, P. Kelly, A. Fung, G. Tait,
LO-E.02. TOTALLY LAPAROSCOPIC CAUDATE LOBECTOMY WITH PARTIAL
CAVAL RESECTION
C. U. Corvera, C. A. Galanopolus, A. Farzad, V. Kuo
University Of California San Francisco, San Francisco, CA
LO-E.03. ANTE SITUM HEPATECTOMY AND REPLACEMENT OF INFERIOR
VENA CAVA AND HEPATIC VEIN USING A TRANSITORY PORTO-CAVAL
SHUNT
A. Yanzon, A. Cristiano, L. Yazde, F. Rodriguez Santos, M. de Santibañes, J. Pekolj,
E. de Santibañes
Hospital Italiano de Buenos Aires, Ciudad Autonoma De Buenos Aires, Argentina
LO-E.04. ROBOTIC PANCREATICODUODENECTOMY WITH
ANOMALOUS HEPATIC ARTERIAL ANATOMY
A. H. Zureikat, T. K. Nguyen, H. J. Zeh
University Of Pittsburgh Department Of Surgery, Pittsburgh, PA
LO-E.05. INTRAOPERATIVE USE OF GOOGLE GLASS FOR
HEPATO-PANCREATO-BILIARY SURGERY
S. L. Bokshan, W. Chapman, M. Doyle
Washington University School Of Medicine, St. Louis, MO; BJC Health System,
St. Louis, MO
73
SATURDAY, FEBRUARY 22, 2014
7:00am - 8:00am
Parallel Long Abstracts F: Other
Ocean Tower IIC
Moderators: Nestor A. Gomez, MD
LO-F.01. DEVELOPMENT OF AN INTERNATIONAL ONLINE LEARNING
PLATFORM FOR HPB TRAINING – A NEEDS ASSESSMENT
S. G. Warner, S. J. Connor, C. Christophi, I. Azodo, T. S. Kent, D. Pier, R. M. Minter
University Of Michigan, Ann Arbor, MI; Christchurch Hospital, Christchurch, New
Zealand; University Of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia;
Royal Infirmary Of Edinburgh, Edinburgh, Scotland; Beth Isreal Deaconess Medical
Center, Boston, MA
LO-F.02. THE CURRENT STATE OF HPB FELLOWSHIP EXPERIENCE IN
NORTH AMERICA
H. Osman, D. Jeyarajah
Methodist Dallas Medical Center, Dallas, TX
Discussant: W. Scott Helton, MD
LO-F.03. SURGICAL MANAGEMENT OF METASTATIC COLON CANCER
IN ELDERLY: ANALYSIS OF THE SURVEILLANCE, EPIDEMIOLOGY AND
END RESULTS (SEER) DATABASE.
H. Khan, A. Olszewski, P. Somasundar
Roger Williams Medical Center, Providence, RI; Pawtucket Memorial Hospital,
Pawtucket, RI
Discussant: Nestor Gomez, MD
LO-F.04. INTRA-OPERATIVE LIVER BIOPSY PATHOLOGY IN PATIENTS
UNDERGOING WEIGHT LOSS SURGERY
A. Dan, M. Subichin, J. Clanton, M. Makuszewski, A. Bohon, M. Pozsgay, R. Shenoy,
S. M. Thompson, A. Venkataramani, C. Sievers, J. Zografakis
Summa Health System, Akron, OH; Northeast Ohio Medical University, Rootstown, OH
Discussant: Conrad Simpfendorfer, MD
LO-F.05. SURGICAL AND TOTAL COSTS OF HEPATO-PANCREATO-BILIARY
(HPB) SURGERY FOR US PATIENTS ENROLLED IN PRIVATE INSURANCE
J. R. Schubart, E. Schaefer, A. N. Kulaylat, C. S. Hollenbeak, N. J. Gusani
Penn State College Of Medicine, Hershey, PA
74
8:00am - 9:15am
Parallel Symposium II: Clinical Trials in Progress I: HB
Ocean Tower II A-B
Moderator: Sharon Weber, MD; Shishir K. Mathel, MD
1. Sequential TACE + PVE vs PVE Alone Before Major Hepatectomy
For Patients With Hepatocellular Carcinoma: A Randomised Control
Wong-Hoi She
The University Of Hong Kong, Hong Kong
2. A Phase II Clinical Trial Of Bavituximab And Sorafenib In Patients
With Advanced Hepatocellular Carcinoma (HCC)
Adam Yopp, MD
University of Texas Southwestern Medical Center, Dallas, TX
3. A Phase II Randomized Multicenter Placebo-Controlled Study of
Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant
(OLT) Recipients with Hepatocellular Carcinoma (HCC)
Fady Kaldas, MD
University of California Los Angeles, Los Angeles, CA
4. Phase IB/II Study of Pasireotide, Everolimus, and Selective Internal
Radioembolization Therapy (SIRT) for Unresectable Neuroendocrine
Hepatic Metastases
Malcolm H. Squires, MD
Winship Cancer Institute, Emory University, Atlanta, GA
5. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic
Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine
and Cisplatin (Gem-Cis)
Robert CG Martin, II, MD, PhD
University of Louisville, Louisville, KY
6. Multicentre Evaluation of a Novel Technique of Analgesia Following Open
Liver Resection: Medial Open Transversus Abdominis Plane (MOTAP) Catheters
Paul J Karanicolas, MD
University of Toronto, Toronto, Ontario, Canada
7. A Pilot Study to Optimize Imaging When Utilizing the PINPOINT Endoscopic
Fluorescence Imaging System for Identification of Biliary Anatomy During
Laparoscopic Biliary and Hepatic Operations
Ali Zarrinpar, MD
UCLA
75
8:00am - 9:15am
Parallel Symposium II: Screening for Pancreatic Cancer
Ocean Tower 1 A-C
Moderator: Rebekah White, MD
Who to Screen? Risk Factors for Pancreatic Cancer
Rebekah White, MD
How to Screen? Screening Modalities
Christopher Wolfgang, MD
Whether to Screen? Risk Models and Effectiveness
Steven Gallinger, MD
9:15am - 10:00am
Leslie H. Blumgart Historical Lecture:
A Historical Journey Through Variceal Bleeding
J. Michael Henderson, MD
Cleveland Clinic
Ocean Tower 1 A-C
Leslie H. Blumgart Historical Lecturer
J. Michael Henderson, MD
Cleveland Clinic
Cleveland, OH
10:00am - 10:45am
Parallel Update Lecture: Just When You
Thought You Understood Medicare Payment
Ocean Tower II A-B
Moderator: Bryan A. Clary, MD
76
ACS Update on Medicare payment
Andrew L. Warshaw, MD
10:00am - 10:45am
Parallel Update Lecture: ALPPS - An Update
Ocean Tower 1 A-C
Moderator: Shimul A. Shah, MD
Updates
Pierre-Alain Clavien, MD, PhD
10:45am - 11:15am
Morning Beverage Break & Video Presentations
Pompeii/Promenade
Moderators: Sharona Ross, MD; Jeffrey S. Barkun, MD
VB.01. ROBOTIC-ASSISTED PANCREATODUODENECTOMY FOR CANCER
E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares, R.
Caruso, R. Ceron, J. Plaza
Sanchinarro University Hospital, Madrid, Spain
VB.02. SYNCHRONOUS TOTAL LAPAROSCOPIC RIGHT HEPATECTOMY
AND RIGHT HEMICOLECTOMY
S. Jayaraman
VB.03. NEAR INFRARRED TECHNOLOGY GIVES A NEW TOOL TO
THE SURGEONS TO IDENTIFY BILIARY ANATOMY
F. Dip, M. Roy, C. Simpfendorfer, E. Lomenzo, S. Szomstein, R. Rosenthal
Cleveland Clinic Florida, Weston, FL
11:15am - 12Noon
Parallel Debates I: RFA for Colorectal Mets: Routine or Second Line?
Ocean Tower II A-B
Moderator: Sean P. Cleary, MD
77
Introduction and Case Presentation
Sean P. Cleary, MD
Pro: Allan E. Siperstein, MD
Con: Octavio Gil, MD
11:15am - 12Noon
Parallel Debates I: MIS Whipple Viable Options in Today’s Economic Climate
Ocean Tower 1 A-C
Moderator: Charles M. Vollmer, MD
Presenters: C. Max Schmidt, MD; W. Scott Helton, MD
12Noon - 1:00pm
Update on Intrahepatic Cholangiocarcinoma
Ocean Tower 1 A-C
Moderator: Flavio Rocha, MD
Presenters: Timothy M. Pawlik, MD, PhD & William R. Jarnagin, MD
12Noon - 1:00pm
Molecular Markers in the Prognosis of HPB Malignancies
Ocean Tower II C
Moderator: Ryan C. Fields, MD
Manipulating the Tumor Microenvironment in Pancreas Cancer
to Improve Outcomes
David E. Linehan, MD
Emerging Role of RAS Mutations in Colorectal Liver Metastases
Jean-Nicolas Vauthey, MD
1:00pm - 2:00pm
Parallel Educational Lunch Symposia - Difficult Cases in HPB
Ocean Tower II A-B
Moderators: Pamela Hodul, MD & Margo Shoup, MD
Panelists:
Sharon M. Weber, MD
Kaye M. Reid Lombardo, MD
Gabriel E. Gondolesi, MD
78
1:00pm - 2:00pm
Parallel Educational Lunch Symposia - Spanish Session
Ocean Tower 1 A-C
Moderators: Sebastian de la Fuente, MD & Javier Lendoire, MD, PhD
Manejo Laparoscópico de patología pancreática benigna
(Laparoscopic management of benign pancreatic disease)
Nicolas D. Jarufe Cassis, MD
Lesiones de vías biliares (Management of bile duct injuries)
Miguel Angel Mercado, MD
Hepatectomias laparoscópicas en América Latina
(Laparoscopic hepatic resections in Latin America)
Rodrigo Sanchez Claria, MD
2:30pm - 5:30pm
Parallel Oral Abstracts G: Liver / Other
Ocean Tower 1 A-C
Moderators: Ajay V. Maker, MD; Paul D. Greig, MD
O-G.01. EARLY IDENTIFICATION OF PATIENTS AT INCREASED RISK
FOR HEPATIC INSUFFICIENCY, COMPLICATIONS, AND MORTALITY
AFTER MAJOR HEPATECTOMY
J. W. Etra, M. H. Squires, S. B. Fisher, D. R. Rutz, B. Martin, D. A. Kooby, K. Cardona,
J. M. Sarmiento, C. A. Staley, S. K. Maithel, M. C. Russell
Discussant: Paxton Dickson, MD
O-G.02. EFFECT OF OBESITY ON PERIOPERATIVE OUTCOMES
FOLLOWING LAPAROSCOPIC HEPATECTOMY
S. Lee, A. Hauch, E. Kane, E. Kandil, J. Buell
79
O-G.03. MORTALITY IN HEPATECTOMY: MODEL FOR END-STAGE LIVER
DISEASE (MELD) AS A PREDICTOR FOR DEATH USING THE NATIONAL
SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP)
S. W. Ross, B. Oommen, M. Kim, V. A. Augenstein, A. L. Walter, B. T. Heniford,
D. A. Iannitti, J. B. Martinie, R. Z. Swan
Discussant: Joseph Buell, MD
O-G.04. ENUCLEATION OF HEPATIC NEUROENDOCRINE TUMOR
METASTASES: A VALUABLE ADJUNCT TO SURGICAL CYTOREDUCTION
N. N. Nissen, V. G. Menon, E. M. Wolin, R. Yu, S. D. Colquhoun
Cedars-Sinai Medical Center, Los Angeles, CA
O-G.05. EXPRESSION LEVELS OF INSULIN-LIKE GROWTH FACTORS
AND RECEPTORS IN HEPATOCELLULAR CARCINOMA
Y. S. Chun, M. Huang, L. Rink
Virginia Piper Cancer Institute, Minneapolis, MN; Fox Chase Cancer Center,
Philadelphia, PA
Discussant: Roderich Schwarz, MD
O-G.06. POSITIVE CROSSMATCH AND THE ROLE OF DONOR SPECIFIC
ANTIBODY IN LIVER TRANSPLANTATION
R. J. Lynch, N. Lysak, S. Perez, T. Roberts-Wilson, R. A. Bray, H. M. Gebel, S. J. Knechtle
Emory Transplant Center, Atlanta, GA
O-G.07. FINANCIAL BENEFITS OF A HEPATOPANCREATICOBILIARY
(HPB) PROGRAM
S. B. Ross, R.L. Klein, C.E. Ryan, T.W. Wood, P.B. Sukharamwala, A.S. Rosemurgy
O-G.08. INTRAOPERATIVE ULTRASOUND DURING RESECTION OF
COLORECTAL LIVER METASTASES: IMPACT ON DETECTION OF LESIONS,
CHANGE IN SURGICAL STRATEGY AND ACHIEVEMENT OF NEGATIVE
RESECTION MARGINS
S. A. Knowles, K. P. Croome, R. Hernandez-Alejandro
University Of Western Ontario, London Health Science Centre, London,
Ontario, Canada; Mayo Clinic, Rochester, MN
80
O-G.09. NON-INVASIVE PREDICTION OF SINUSOIDAL INJURY IN PATIENTS
TREATED WITH OXALIPLATIN FOR COLORECTAL LIVER METASTASES.
J. Urdzik, T. Bjerner, A. Wanders, F. F. Duraj, U. Haglund, A. Norén
Uppsala University, Uppsala, Sweden
O-G.10. PATIENT AND TUMOR BIOLOGY PREDICT SURVIVAL BEYOND
THE MILAN CRITERIA IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR
CARCINOMA
A. Andreou, P. Neuhaus, D. Seehofer
Charité Campus Virchow Klinikum, Berlin, Germany
O-G.11. A 20 YEAR REVIEW OF LIVER TRANSPLANTATION:
CHANGING INDICATIONS OVER 2 DECADES
M. Doyle, N. Vachharajani, J. A. Lowell, S. Shenoy, J. R. Wellen , Y. Lin, W. C. Chapman
O-G.12. A SIMPLIFED FRAILTY INDEX TO ACCURATELY PREDICT
MORBIDITY AND MORTALITY AFTER HEPATIC RESECTION
L. M. Louwers, G. Schnickel, I. Rubinfeld
Henry Ford Health System, Detroit, MI
Discussant: Ali Zarrinpar, MD
O-G.13. ASSOCIATING LIVER PARTITION AND PORTAL VEIN LIGATION
FOR STAGED HEPATECTOMY (ALPPS) VERSUS PORTAL VEIN
EMBOLIZATION IN THE MANAGEMENT OF COLORECTAL LIVER
METASTASES
K. P. Croome, R. Hernandez-Alejandro
University Of Western Ontario, London Health Science Centre, London, Ontario,
Canada; Mayo Clinic, Rochester, MN
Discussant: W. Scott Helton, MD
81
O-G.14. COMPARISON OF SURVIVAL AND TOLERABILITY OF LIVER
RADIOEMBOLIZATION IN ELDERLY VS. YOUNGER PATIENTS WITH
METASTATIC COLORECTAL CANCER
S. Tohme, G. Nace, D. Sukato, J. Steele, A. Zajko, N. Amesur, J. W. Marsh, D. Geller,
A. Tsung
University Of Pittsburgh School Of Medicine, Pittsburgh, PA
Discussant: Clifford Cho, MD
O-G.15. WHAT IS THE CURRENT ROLE OF PERIHEPATIC DRAIN
(PD) PLACEMENT IN LIVER SURGERY? A PROSPECTIVE ANALYSIS
J. M. Butte, J. Grendar, O. Bathe, F. Sutherland, C. G. Ball, E. Dixon
Foothills Medical Centre-University Of Calgary, Calgary, Alberta, Canada
Discussant: Andrew McKay, MD, BSc, MSc
2:30pm - 5:30pm
Parallel Oral Abstracts H: Pancreas / Transplant / Biliary
Ocean Tower II A-B
Moderators: Christopher D. Anderson, MD; Juan Francisco Guerra, MD
O-H.01. PANCREATIC FISTULAS AFTER PANCREATICODUODENECTOMIES: ARE PANCREATICO-GASTROSTOMIES SAFER
THAN PANCREATICOJEJUNOSTOMIES ? A QUASI-EXPERIMENT
AND PROPENSITY-SCORE ADJUSTED ANALYSIS
J. Abou Khalil, S. Dumitra, M. Jamal, N. Mayo, P. Chaudhury, P. Metrakos, J. Barkun
McGill University Health Center, Montreal, Quebec, Canada
Discussant: Charles Vollmer, MD
O-H.02. A NOVEL ONCOLYTIC ADENOVIRUS TARGETING C-MET
RECEPTOR INCREASES INFECTIVITY EFFICIENCY AND ONCOLYTIC
ACTIVITY IN HUMAN PANCREATIC ADENOCARCINOMA CELL LINES
Q. D. Chu, G. Sun, L. Liu, B. Li, R. H. Kim, J. M. Mathis
Louisiana State University Health Sciences Center-Shreveport, Shreveport, LOUISIANA
Discussant: Nipun Merchant, MD
82
O-H.03. NEOADJUVANT FOLFIRINOX APPLICATION IN BORDERLINE
RESECTABLE PANCREATIC ADENOCARCINOMA.
A. Paniccia, B. Edil, R. Schulick, C. Gajdos, J. T. Byers, C. Meguid, M. McCarter
University Of Colorado Hospital, Aurora, CO
Discussant: Christopher Wolfgang, MD
O-H.04. PERIOPERATIVE RISK FACTORS FOR DELAYED GASTRIC
EMPTYING IN PANCREATICODUODENECTOMY
J. R. Robinson, P. Marincola, J. Shelton, N. Merchant, K. Idrees, A. Parikh
Vanderbilt University Medical Center, Nashville, TN
Discussant: Daniel Abbott, MD
O-H.05. COST COMPARISON ANALYSIS OF OPEN VS. LAPAROSCOPIC
D. R. Rutz, M. H. Squires, S. K. Maithel, J. M. Sarmiento, J. W. Etra, S. D. Perez,
W. Knechtle, K. Cardona, M. C. Russell, C. A. Staley, J. F. Sweeney, D. A. Kooby
Discussant: Michael D’Angelica, MD
O-H.06. FAILURE OF NARCOTIC WEAN AFTER TOTAL PANCREATECTOMY
WITH ISLET AUTOTRANSPLANTATION
K. A. Morgan, S. M. Owczarski, H. Wang, W. Balliet, J. J. Borckardt, D. B. Adams
Medical University Of South Carolina, Charleston, SC
Discussant: Syed Ahmad, MD
O-H.07. RISK FACTORS FOR DEVELOPMENT OF STEATOSIS AND
STEATOHEPATITIS AFTER PANCREATICODUODENECTOMY
L. K. Fonkoua, R. Tappouni, N. H. Bhayani, E. T. Kimchi, K. F. Staveley-O’Carroll,
J. T. Kaifi, N. J. Gusani
Penn State College Of Medicine, Hershey, PA
83
O-H.08. CASE CONTAMINATION REPORTING IN HPB SURGERY: CAN
A SINGLE WORD CHANGE PUBLIC PERCEPTION OF INSTITUTIONAL
PERFORMANCE?
P. J. Speicher, D. Nussbaum, J. E. Scarborough, R. R. White, C. R. Mantyh, D. S. Tyler,
B. M. Clary
O-H.09. TARGETED INHIBITION OF THE AKT PATHWAY IN
CHOLANGIOCARCINOMA BY MK2206
J. M. Wilson, S. Kunnimalaiyaan, M. Kunnimalaiyaan, T. Gamblin
O-H.10. ARE GENERAL SURGERY RESIDENTS ADEQUATELY PREPARED
FOR HEPATOPANCREATICOBILIARY (HPB) FELLOWSHIPS?
QUESTIONNAIRE BASED STUDY
H. Osman, J. Parikh, S. Patel, D. Jeyarajah
Methodist Dallas Medical Center, Dallas, TX; Indiana University Hospital,
Indianapolis, IN
Discussant: Paul D. Hansen, MD
O-H.11. PORTAL VENOUS SYSTEM DECOMPRESSIVE PROCEDURES DURING
PANCREATIC RESECTION: PERIOPERATIVE AND LONG-TERM OUTCOMES
M. J. Truty, R. M. Thomas, J. E. Lee, M. H. Katz, J. B. Fleming
Mayo Clinic College Of Medicine, Rochester, MN; University Of Texas MD Anderson
Cancer Center, Houston, TX; University Of Florida College Of Medicine, Gainseville, FL
O-H.12. COST-EFFECTIVENESS AFTER PANCREATICODUODENECTOMY:
BOLSTERING THE VOLUME ARGUMENT
J. M. Sutton, G. C. Wilson, K. Wima, R. C. Quillin, I. M. Paquette, D. J. Hanseman,
J. J. Sussman, M. J. Edwards, S. A. Ahmad, S. A. Shah, D. E. Abbott
University Of Cincinnati Medical Center, Cincinnati, OH
Discussant: David Kooby, MD
84
O-H.13. PANCREATICODUODENECTOMY IN FLORIDA: DO 20 YEAR TRENDS
DOCUMENT SALUTARY BENEFITS OF CENTRALIZATION OF CARE?
T. W. Wood, S. B. Ross, A. E. Smart, C. E. Ryan, P. B. Sukharamwala, A. S. Rosemurgy
Discussant: Mark Bloomston, MD
O-H.14. AJCC STAGING FOR RESECTED HILAR CHOLANGIOCARCINOMA:
7TH EDITION BETTER THAN 6TH, BUT NOT AN INDEPENDENT
PROGNOSTIC FACTOR
B. Groot Koerkamp, J. K. Wiggers, P. J. Allen, O. R. Busch, M. I. D’Angelica,
R. P. Dematteo, Y. Fong, D. J. Gouma, T. P. Kingham, T. M. Van Gulik, W. R. Jarnagin
Memorial Sloan-Kettering Cancer Center, New York, NY; Academic Medical Center
Amsterdam, Amsterdam, Noord-Holland
Discussant: David Kooby, MD
O-H.15. HIGH-VOLUME SURGEONS VERSUS HIGH-VOLUME HOSPITALS:
ARE BEST OUTCOMES MORE DUE TO WHO OR WHERE?
P. G. Toomey, S. B. Ross, A. N. Igartua, M. DeGori, A. F. Teta, K. Luberice,
P. B. Sukharamwala, A. S. Rosemurgy
Florida Hospital Tampa, Tampa, FL; University Of South Florida, Tampa, FL
Discussant: Sharon Weber, MD
2:30pm - 4:00pm
Clinical Trials in Progress II: Pancreas
Ocean Tower II C
Moderator: John C. Mansour, MD; Adam Yopp, MD
1. Randomized Phase II Trial of Pre-Operative Gemcitabine
and nab-Paclitacel with or with out the Autophagy Inhibitor Hydroxychloroquine In Pancreatic Adenocarcinoma
Herbert J. Zeh, MD
University of Pittsburgh, Pittsburgh, PA
2. A MultiCenter Mayo Initiated Prospective Randomized Controlled trial to Comparing Pancreatic Leaks after TissueLink vs SeamGuard After
Distal Pancreatectomy (PLATS)
Florencia G Que, MD
Mayo Clinic, Rochster, MN
85
3. Neoadjuvant Folfirinox and Chemoradiation Followed by Definitive
Surgery and Postoperative Gemcitabine for Patients with Borderline
Resectable Pancreatic Adenocarcinoma: An Intergroup Single-Arm,
Phase II Trial
Syed A. Ahmad, MD
The University of Cincinnati, Cincinatti, OH
4. Evaluation of the Novel Imaging Modality Simultaneous Positron
Emission Tomography Magnetic Resonance Imaging (PET-MRI) in
Patients with Pancreatic Adenocarcinoma
Ryan C. Fields, MD
Washington University School of Medicine, St. Louis, MO
5. Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing
the Role of Excision Repair Cross-Complementing Gene-1 (ERCC1) in
Treatment Decisions
Malcolm H. Squires, MD
6. Phase I Trial of Chemoimmunotherapy and Hypofractionated
Radiation Therapy for Borderline Resectable and Locally Advanced
Pancreatic Adenocarcinoma
Pippa Newell
Providence Cancer Center, Portland, OR
7. A Randomized Prospective Multicenter Trial of Pancreatic
Resection with and without Routine Intraperitoneal Drainage
William E. Fisher, MD
Baylor College of Medicine, Houston, TX
8. FOLFIRINOX Plus PF-04136309 in Patients With Borderline
Resectable and Locally Advanced Pancreatic Adenocarcinoma
Dominic E. Sanford, MD
Washington University School of Medicine, St. Louis, MO
86
4:00pm - 5:30pm
Surgical Innovation Committee Symposium
Simulation: Transforming the Training, Techniques
and Safety of HPB Surgery
Support for this session provided by Intuitive Surgical
Ocean Tower II C
Moderator: A. James Moser, MD
Preoperative and Intraoperative Use of Virtual & Augmented Reality Technologies: Patient-Specific Simulation
Professor Luc Soler
Surgical Simulation, Validated Assessment and the Drive to Enhance
Patient Safety in Minimally Invasive Surgery
L. Michael Brunt, MD
Radical Curricular Reform: New Concepts in Training
Richard K. Reznick, MD, MEd
5:30pm - 6:30pm
AHPBA Business Meeting (members only)
Ocean Tower I A-C
6:15pm - 7:45pm
Oral Poster Presentations II
Mona Lisa
Moderators: Quyen D. Chu, MD, MBA; Martin Palavecino, MD
GROUP: LIVER III
OP-II.01. EXPRESSION OF FATTY ACID BINDING PROTEINS
IN A MOUSE MODEL OF OBESITY-ASSOCIATED HCC
K. J. Thompson, S. S. Nazari, D. A. Iannitti, I. H. McKillop, D. Sindram
87
OP-II.02. SURVIVAL FOLLOWING MULTIDISCIPLINARY MANAGEMENT
OF EXTENSIVE COLORECTAL LIVER METASTASES
J. Pasko, J. Wagner, O. Lafi, B. Sheppard, S. Orloff, G. Vaccaro, C. Lopez, K. G. Billingsley
Oregon Health and Sciences University, Portland, OR
OP-II.03. PROSPECTIVE ANALYSIS OF TACE AS PRIMARY THERAPY
IN HCC MANAGEMENT
K. Collins, N. Saad, N. Vachharajani, K. Fowler, K. Korenblat, M. Doyle, W. Chapman
OP-II.04. MINIMALLY INVASIVE MICROWAVE ABLATION OF EARLY
STAGE HEPATOCELLULAR CARCINOMA
F. Alemi, K. Specht, K. Kowdley, A. Siddique, R. Crane, E. Hauptmann, M. Fotoohi,
A. Alseidi, T. R. Biehl, S. Helton, F. G. Rocha
Virginia Mason Medical Center, Seattle, WA
OP-II.05. LIVER RESECTION WITH HEPATIC VEIN RECONSTRUCTION
IS A VIABLE OPTION IN SELECTED PATIENTS
R. Smoot, J. Conneely, P. Serrano, D. Cavallucci, I. McGilvray
OP-II.06. NOVEL RADIOFREQUENCY ABLATION SYSTEM
INCORPORATING MAGNETIC TRACKING IN PORCINE MODEL
M. Brown, M. A. Cassera, W. Johnston, C. W. Hammill
Hepatobiliary And Pancreatic Surgery Program, Portland, OR
OP-II.07. PATTERNS OF RECURRENCE FOLLOWING MARGINPOSITIVE RESECTION OF COLORECTAL LIVER METASTASES
C. W. Michalski, J. Wagner, B. Sheppard, S. L. Orloff, G. Vaccaro, C. Lopez,
K. G. Billingsley
Oregon Health And Science University, Portland, OR
OP-II.08. THE SLIPPERY SLOPE OF CROSS CLAMPING VS OPEN SURGERY:
IS THE CHOICE OBVIOUS?
T. Dominioni, J. Viganò, L. Cobianchi, A. Peloso, J. Ferrario, A. D’addiego, I. Benzoni,
P. Dionigi, M. Maestri
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
88
OP-II.09. TREATMENT RESPONSE OF HEPATOCELLULAR CARCINOMA
BY ETIOLOGY OF LIVER DISEASE
R. M. Seshadri, D. J. Niemeyer, J. Lee, R. Z. Swan, D. Sindram, J. B. Martinie, M. Russo,
D. A. Iannitti
OP-II.10. REDUCUCTION OF COMPLICATIONS: THE PROGRESSION
OF LAPAROSCOPIC LIVER RESECTION
A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil, J. Buell
GROUP: LIVER IV
OP-II.11. AN ENHANCED RECOVERY IN LIVER SURGERY (ERILS)
PATHWAY FOR MINIMALLY INVASIVE AND OPEN HEPATIC RESECTION
DEMONSTRATES EARLIER RETURN TO NORMAL FUNCTION AND
INTENDED ONCOLOGIC THERAPIES
T. A. Aloia, A. Cooper, C. Conrad, J. Vauthey, V. Gottumukkala
University of Texas MD Anderson Cancer Center, Houston, TX
OP-II.12. COST EFFECTIVE ANALYSIS OF ALTRUS VERSUS CUSA FOR
LIVER RESECTIONS
G. R. Beck, K. P. Croome, R. Hernandez-Alejandro
University Of Western Ontario, London Health Science Centre, London, Ontario,
Canada
OP-II.13. IMMUNOHISTOCHEMICAL TUMOR MARKERS IN THE
DIAGNOSTICS OF FOCAL LIVER LESIONS
J. Vilmanis, I. Strumfa, A. Ozolins, R. Stucka, J. Gardovskis, .
Pauls Stradins Clinical University Hospital, Riga, Latvia
OP-II.14. LAPAROSCOPIC MANAGEMENT OF CYSTIC DISEASE
OF THE LIVER
A. Hauch, S. Lee, E. Kane, E. Kandil, J. Buell
89
OP-II.16. WHEN SURGICAL SHUNTING IS THE BEST OR ONLY OPTION:
A CASE SERIES
L. M. Louwers, V. Raofi, S. Cohn, A. Koffron
Henry Ford Health System, Detroit, MI; Beaumont Health System/Oakland University
School Of Medicine, Royal Oak, MI
OP-II.18. EPIDEMIOLOGY OF METASTATIC COLON CANCER
AMONG SAUDIS
F. Al-alem, E. Simoneau, T. A. Traiki, N. Al-malki, K. Alkhayal, A. Zubaidi, O. Obaid,
M. Hassanain
King Saud University, Saudi Arabia, Riyadh; McGill University Health Center, Montreal,
Quebec, Canada
OP-II.19. MALIGNANT MASQUERADE OF PET-CT AVID HEPATIC ADENOMA
F. Alemi, T. Mohammed, P. Sicuro, K. Kowdley, A. Siddique, A. Alseidi, T. Biehl,
S. Helton, F. Rocha
OP-II.20. MELD PREDICTS MORTALITY IN CONSERVATIVELY MANAGED
CIRRHOTICS WITH PNEUMATOSIS
F. Karipineni, J. Pang, A. Parsikia, J. Ortiz
Albert Einstein Medical Center, Philadelphia, PA
GROUP: PANCREAS III
OP-II.23. PANCREATICODUODENECTOMY IN THE OLDEST OF OLD:
RESULTS BEYOND OPERATIVE MORTALITY
R. C. Langan, P. R. Bucciarelli, W. Chapman, K. Oza, C. Fehring, P. G. Jackson, T. M.
Fishbein, R. Jha, N. Haddad, F. Al-Kawas, J. Carroll, J. Hanna, A. Parker, W. B. Al-Refaie,
L. B. Johnson
Georgetown University Hospital, Washington, DC
OP-II.24. ANALYSIS OF PATENCY RATES IN PORTOMESENTERIC
VENOUS RECONSTRUCTION DURING PANCREATIC RESECTION
M. Brown
Providence Portland Medical Center, Portland, OR
90
OP-II.25. TIME TO ADJUVANT THERAPY FOR LAPAROSCOPIC
PANCREATIC RESECTION
T. Sachs, M. Cooper, T. Pawlik, M. Choti, L. Zheng, J. Herman, D. Laheru, J. Cameron,
C. Wolfgang, M. Makary, M. Weiss
Johns Hopkins Medical Institution, Baltimore, MD
OP-II.26. IMPACT OF MULTIDISCIPLINARY HEPATO-PANCREATO-BILIARY
CASE CONFERENCE ON THE MANAGEMENT OF PANCREATIC CANCER
K. Mayer, Y. Kuo, J. M. Davis, A. Adams, O. Cabasso, J. J. Vernick, E. J. Hagopian
Jersey Shore University Medical Center, Neptune, NJ; Robert Wood Johnson Medical
School, New Brunswick, NJ
OP-II.28. IS THERE A “JULY EFFECT” FOR HPB CASES?
S. Patel, S. Cheek , T. Winston , H. Osman , D. Jeyarajah
Methodist Dallas, Dallas, TX
OP-II.29. THE USE AND UTILITY OF ABDOMINAL CT SCANS IN THE
IMMEDIATE POSTOPERATIVE PERIOD FOLLOWING PANCREATIC
RESECTIONS
S. Zenoni, P. Veldhuis , S. Eubanks, S. G. De La Fuente, P. Arnoletti
OP-II.30. GROOVE PANCREATITIS: A RARE MIMICKER OF PANCREATIC
CANCER WHICH CAN BE TREATED WITH PANCREATICODUODENECTOMY
S. Rabi, J. Cameron, M. Makary, K. Hirose, N. Rezaee, T. Pawlik, R. Hruban,
C. Wolfgang, . , M. Weiss
The Johns Hopkins Hospital, Baltimore, MD
GROUP: PANCREAS IV
OP-II.31. SURVIVAL BENEFIT OF ADJUVANT THERAPY FOR BORDERLINE
RESECTABLE (BLR) PANCREATIC CANCER (PC) TREATED WITH
NEOADJUVANT THERAPY
K. Duelge, A. N. Krepline, A. Mahmoud, B. George, P. S. Ritch, B. A. Erickson,
E. J. Quebbeman, K. K. Turaga, F. M. Johnston, T. C. Gamblin, K. K. Christians,
D. B. Evans, S. Tsai
Medical College of Wisconsin, Milwaukee, WI
91
OP-II.33. PERIOPERATIVE MORBIDITY AND MORTALITY AFTER
PANCREATECTOMY: A SYSTEMATIC REVIEW OF PREDICTION SCORES,
MODELS AND NOMOGRAMS
J. Aubin, R. Lapointe, F. Vandenbroucke-Menu, G. Martel
The Ottawa Hospital, University Of Ottawa, Ottawa, Ontario, Canada;
Hôpital Saint-Luc, CHUM, Montreal, Quebec, Canada
OP-II.34. THE IMPACT OF ABERRANT ANATOMY OF THE HEPATIC ARTERY
ON RESECTION MARGIN STATUS IN PANCREATICODUODENECTOMY
P. Casey, R. De Souza, S. Lapsia, Z. Ali, K. Elhadd, A. Kausar, D. Chang, A. Krige,
J. Thomas, D. Subar
Royal Blackburn Hospital, Lancashire, United Kingdom
OP-II.35. DIFFERENCES IN OUTCOMES IN PANCREATICODUODENECTOMY
(PD) IN THE MODERN ERA: DOES A MALIGNANT DIAGNOSIS MAKE
A DIFFERENCE?
S. Cheek, S. Patel, H. Osman, D. Jeyarajah
OP-II.36. THE BENEFITS OF LAPAROSCOPIC PANCREATECTOMY:
IT DOES MAKE A DIFFERENCE
S. Cheek , S. Patel, H. Osman , D. Jeyarajah
OP-II.37. LONG-TERM SURVIVAL AFTER RESECTION OF PANCREATIC
CANCER: SIGNIFICANCE OF EARLY DETECTION AND HISTOLOGICALLY
CURATIVE RESECTION
T. Yamamoto, H. Kinoshita, Y. Sakamoto, K. Okada, K. Inoguchi, S. Yao, S. Kaihara,
R. Hosotani, S. Yagi
OP-II.38. SOCIOECONOMIC STATUS AND SURGICAL OUTCOMES AFTER
TOTAL PANCREATECTOMY
H. Schmidt, E. M. Kilbane, A. P. Turner, M. G. House, N. J. Zyromski, A. Nakeeb,
C. M. Schmidt, E. P. Ceppa
Indiana University School Of Medicine, Indianapolis, IN
92
OP-II.39. OUTCOMES IN OPEN VERSUS LAPAROSCOPIC DISTAL
PANCREATECTOMY
R. Pieretti- Vanmarcke, J. Wargo, C. Fernandez-Del Castillo, H. Zheng, A. Merrill,
S. Thayer, K. Lillemoe, C. R. Ferrone
Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital,
Boston, MA; Harvard Medical School, Boston, MA
OP-II.40. OUTCOME AFTER REVISION OF THE
PANCREATICOJEJUNOSTOMY: A SINGLE INSTITUTION EXPERIENCE
A. I. Gagnon, R. Birkett, T. Schnelldorfer
Lahey Clinic, Burlington, MA
GROUP: TRICKS OF TRADE
OP-II.43. 10 STEPS TO SALVATION - CONTROLLING AN IVC BLEED
DURING MAJOR HEPATECTOMY
J. B. Conneely, S. Jayaraman
University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre, Toronto,
Ontario, Canada
OP-II.44. SAFE AND EASY PRINGLE FOR LAPAROSCOPIC LIVER RESECTION
M. M. Dua, D. J. Worhunsky, K. J. Hwa, B. Siu, G. A. Poultsides, J. A. Norton,
B. C. Visser
Stanford University School Of Medicine, Stanford, CA; VA Palo Alto Health Care
System, Palo Alto, CA
OP-II.45. TRICKS OF THE TRADE: OPERATIVE MANAGEMENT
OF PORTAL ANNULAR PANCREAS IN PATIENTS UNDERGOING
A. V. Maker, V. K. Maker
University Of Illinois At Chicago, Chicago, IL
93
OP-II.46. TRANCYSTIC BILIARY DESCOMPRESSION WITH INTERNALEXTERNAL BILIARY DRAINAGE PLACED LAPAROSCOPICALLY AFTER
BILE DUCT EXPLORATION. PRELIMINARY REPORT OF AN INNOVATIVE
TECHNIQUE.
G. E. Pfaffen, P. Barros Schelotto, P. Romero , G. E. Gondolesi
Fundacion Favaloro, Buenos Aires, Argentina
OP-II.48. INTRAHEPATIC CHOLANGIOJEJUNOSTOMY FOR THE
TREATMENT OF COMPLEX BILIARY STENOSIS AFTER PEDIATRIC
LIVING-DONOR LIVER TRANSPLANTATION
R. Sanchez Clariá, F. A. Alvarez, N. Resio, E. De Santibañes, M. Ciardullo
Hospital Italiano De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
OP-II.49. ULTRASOUND-GUIDED INTRAOPERATIVE TRANSDUODENAL
PANCREATIC HEAD BIOPSY – A SAFE AND EFFECTIVE PROCEDURE
TO EXCLUDE MALIGNANCY FOR OBSTRUCTIVE JAUNDICE PATIENTS:
TECHNICAL NOTE
N. Ikoma, T. Karahashi, Y. Hosoda
Saitama Social Insurance Hospital, Kitaurawa, Saitama, Japan
OP-II.50. CONCEPT OF THE MESOPANCREAS: COINING A NEW SURGICAL
ANATOMICAL SPACE
S. Patel, S. Cheek , H. Osman, D. Jeyarajah
GROUP: BILIARY
OP-II.51. FACTORS PREDICTIVE OF CHOLEDOCHOLITHIASIS.
OPTIMIZING MANAGEMENT STRATEGIES
C. Rengifo, D. Chang, R. Watson, A. Kausar, D. Subar
Royal Blackburn Hospital, Lancashire, United Kingdom
OP-II.53. COMPLICATIONS AFTER SURGICAL REPAIR OF BILE DUCT INJURY
D. Zamora-Valdés, M. Vilatoba, A. G. Contreras, I. Dominguez-Rosado, A. L. Carrete,
M. Gonzalez, C. Kaufmann, E. M. Saucedo, S. Mier, M. A. Mercado
Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, México
D.F., México
94
OP-II.54. COMPLICATIONS OF PERCUTANEOUS CHOLECYSTOSTOMY
TUBE (PC) IN THE TREATMENT OF ACUTE CHOLECYSTITIS (AC)
A. D. Guerron, A. Abdel Azim, M. Moorman, G. McLennan, M. Loor
OP-II.55. PREDICTING (AVOIDING) INCIDENTAL GALLBLADDER CANCER
K. Patel, A. Sautter, T. Buddensick, B. Wu, H. Ferdosi, D. Narducci, M. Siddique, L.
Setiawan, H. Shaukat, G. Sulkowski, S. O. Farooqui, G. C. Kowdley, S. C. Cunningham
Saint Agnes Hospital And Cancer Institute, Catonsville, MD
OP-II.56. SHORT TERM PHYSIOLOGICAL EFFECTS OF
A HEPATOPANCREATICOBILIARY RESERVOIR
A. Yusuf, B. Asiyanbola
University Of Maryland, Easton Memorial, Easton, MD; Johns Hopkins Center
For Talented Youth, Baltimore, MD
OP-II.57. NEUROENDOCRINE NEOPLASMS OF THE EXTRAHEPATIC
BILE DUCT: REPORT OF SIX CASES
N. Hong, H. Kim
Asan Medical Center, University Of Ulsan College Of Medicine, Seoul, Songpa-Gu,
South Korea
OP-II.58. INCIDENTAL GALLBLADDER CANCER ON CHOLECYSTECTOMY:
IS THERE MORE THAN MEETS THE EYE?
S. Patel, S. Cheek , T. Winston , H. Osman, D. Jeyarajah
OP-II.59. NOVEL STRATEGY FOR SUSPECTED PT2 GALLBLADDER
CARCINOMA BY LAPAROSCOPIC APPROACH
O. Itano, G. Oshima, M. Shinoda, M. Kitago, Y. Abe, T. Hibi, H. Yagi, S. Aiko,
Y. Kitagawa
Keio University School Of Medicine, Tokyo, Japan; Eiju General Hospital, Tokyo, Japan
OP-II.60. CHOLECYSTECTOMY IN CIRRHOTIC PATIENTS. WHEN TO
OPERATE?
L. SAROTTO, J. PALEARI, H. TODESCHINI, P. FERRAINA, .
Instituto Quirurgico Del Callao, Capital Federal, Buenos Aires, Argentina; Universidad
De Buenos Aires, University Of Medicine, Capital Federal, Buenos Aires, Argentina
95
7:45pm - 9:30pm
Parallel Educational Dinner Symposia: PNET Update
Ocean Tower 1 A-C
Moderator: Matthew H. Katz
Surgery for Non-Functional pNET: Open and Laparoscopic Techniques
Clifford S. Cho, MD
Hepatectomy, Transplantation and Non-invasive Liver Directed
Therapies for Metastatic Neuroendocrine Tumors
Mark Bloomston, MD
Targeted and Systemic Strategies for Advanced Neuroendocrine Tumors
Matthew Kulke, MD
Management of Hereditary pNET: The Surgeon’s Role
Jeffrey E. Lee, MD
7:45pm - 9:30pm
Parallel Educational Dinner Symposia: Thermal Ablation:
An Update of Techniques and Outcomes
Ocean Tower II A-B
Moderator: David Sindram, MD
Introduction
David Sindram, MD
Ice and Alcohol, A Good Start
Ramanathan Seshadri, MD
RFA True and Tested, But Still?
Paul D. Hansen, MD
Actual Data Behind MWA
Ryan Groelsch, MD
8:00pm
Oral Poster Presentations II – Teardown
Mona Lisa
96
Sunday, February 23, 2014
7:00am - 8:30am
Continental Breakfast
7:30am - 1:00pm
7:30am - 11:00am
San Marino
7:30am - 8:30am
Parallel - Competitive Videos A: Liver
Ocean Tower 1 A-C
Moderators: Thomas A. Aloia, MD; Felipe Jose Fernandez Coimbra, MD
CV-A.01. TOTALLY LAPAROSCOPIC RIGHT HEPATECTOMY BY
CAUDATE HEPATOTOMY TECHNIQUE
C. U. Corvera, V. Kuo
University Of California San Francisco, San Francisco, CA
CV-A.03. LAPAROSCOPIC RIGHT POSTERIOR SEGMENT LIVER RESECTION
M. M. Augustine, T. P. Kingham
Memorial Sloan Kettering Cancer Center, New York, NY
CV-A.04. ROBOTIC-ASSISTED RIGHT HEPATECTOMY
E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares,
R. Caruso, R. Ceron, J. Plaza
CV-A.05. LAPAROSCOPIC LEFT HEPATECTOMY COMBINING CUSA
AND HARMONIC SCALPEL DISSECTION
J. B. Conneely, R. Smoot, S. Cleary
Toronto General Hospital, Toronto, Ontario, Canada
97
7:30am - 8:30am
Parallel - Competitive Videos B: Pancreas / Biliary
Ocean Tower II A- B
Moderators: Nicholas J. Zyromski, MD; Juan Pekolj, MD
CV-B.01. COMPLETION RADICAL CHOLECYSTECTOMY AND PORTAL
LYMPHADENECTOMY: MINIMALLY INVASIVE TECHNIQUES FOR
MANAGEMENT OF INCIDENTAL GALLBLADDER CARCINOMA
S. Lee, M. I. D’Angelica, W. R. Jarnagin, T. P. Kingham
Memorial Sloan-Kettering Cancer Center, New York , NY
CV-B.02. SURGICAL ASPECTS OF THE MESENTERICOPORTAL VENOUS
RESECTION IN HEPATO-BILIO-PANCREATIC SURGERY
E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz, I. Fabra, C. Oliva, S. Olivares,
R. Caruso, R. Ceron, A. Cubillo, J. Plaza
CV-B.03. PANCREATIC NEUROENDOCRINE TUMOR WITH CELIAC
AXIS INVOLVEMENT
V. M. Cano Busnelli, F. A. Alvarez, J. Pekolj
HPB Surgery Section And Liver Transplant Unit. Hospital Italiano De Buenos Aires,
Buenos Aires, Argentina
CV-B.04. LAPAROSCOPIC COMMON BILE DUCT EXPLORATION
FOR IMPACTED CHOLEDOCHOLITHIASIS
S. Jayaraman
CV-B.05. LAPAROSCOPIC PARTIAL SLEEVE DUODENECTOMY (PSD)
FOR DUODENAL ADENOMA
J. A. Stauffer, H. J. Asbun
Mayo Clinic, Jacksonville, FL
98
8:30am - 9:30am
Surgical Volunteerism Update:
The 3rd AHPBA Symposium on Humanitarian Medical Outreach
Teams: Supporting Local Chapters with Capacity Building
Ocean Tower 1 A-C
Moderators: Sean P. Cleary, MD & Nestor Gomez, MD
International Relations Committee Travel Awards
W. Scott Helton, MD, William C. Chapman, MD & Sean P. Cleary, MD
AHPBA Outreaach Team in Ecuador
David M. Nagorney, MD
AHPBA Outreach Team in Costa Rica
AHPBA Outreach Team in Nicaragua
Quyen D. Chu, MD, MBA
AHPBA Outreach Team in Honduras
Wesley P. Francis, MD
9:30am - 10:30am
Parallel Debates: Transplantation for Neuroendocrine Tumors
Ocean Tower 1 A-C
Moderator: Christopher D. Anderson, MD
Pro: Nipun Merchant, MD
Con: Christopher J. Sonnenday, MD
9:30am - 10:30am
Parallel Debates: Should We Limit the Number of
HPB Fellowships?
Ocean Tower II A-B
Moderator: D. Rohan Jeyarajah, MD
99
Pro: Elijah Dixon, MD
Con: Paul D. Greig, MD
10:30am - 12:30pm
Parallel Mini Oral Abstracts A: Liver / Transplant
Ocean Tower 1 A-C
Moderators: Henry B. Randall, MD; Niraj Gusani, MD, MS
MO-A.01. OVERALL SURVIVAL BY PATTERN OF RECURRENCE FOLLOWING
CURATIVE INTENT SURGERY FOR COLORECTAL LIVER METASTASIS
A. N. Kulaylat, J. R. Schubart, A. L. Stokes, E. T. Kimchi, K. F. Staveley-O’Carroll,
N. J. Bhayani, J. T. Kaifi, N. J. Gusani
Penn State Hershey Cancer Institute, Hershey, PA
MO-A.03. ALTERATIONS IN HIPPO SIGNALING PATHWAY DURING
LIVER REGENERATION
J. Grijalva, M. Huizenga, F. Camargo, G. Sadri-Vakili, K. Vakili
Boston Children’s Hospital, Boston, MA; Massachusetts General Hospital, Charlestown,
MA
MO-A.04. VALIDATION OF THE SELECTION CRITERIA FOR SAFE
HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: ANALYSIS OF 312
CONSECUTIVE HEPATECTOMIES.
M. Donadon, F. Procopio, M. Cimino, G. Costa, D. Del Fabbro, A. Palmisano, A. Gatti,
G. Torzilli
Humanitas Clinical And Research Center, Rozzano, Milan, Italy
MO-A.05. READMISSION AFTER HEPATIC RESECTION AT A QUATERNARY
ACADEMIC CENTER
A. Ejaz, G. Spolverato, D. Lucas, M. Weiss, C. Wolfgang, K. Hirose, M. Choti,
T. M. Pawlik
Johns Hopkins Hopsital, Baltimore, MD
MO-A.06. QUALITY OF LIFE AFTER RESECTION OF INTRA- AND
EXTRA-HEPATIC METASTASES FROM COLORECTAL ADENOCARCINOMA
IN A MULTI-CENTER PROSPECTIVE PHASE II TRIAL
P. E. Serrano, N. G. Coburn, K. S. Devitt, C. Moulton, S. P. Cleary, C. Law, P. D. Greig,
S. Gallinger, A. C. Wei
University of Toronto, Toronto, Ontario, Canada
100
MO-A.07. INTRAOPERATIVE ULTRASOUND AND SURGICAL STRATEGY
IN HEPATIC RESECTION: WHAT DIFFERENCE DOES IT MAKE?
R. Jrearz, R. S. Hart, S. Jayaraman
University Of Toronto, Toronto, Ontario, Canada; St. Joseph’s Health Centre, Toronto,
ON
MO-A.08. RELIABILITY, SAFETY AND ONCOLOGICAL SUITABILITY OF
INTRAOPERATIVE ULTRASOUND CRITERIA FOR HEPATIC VEINS SPARING
ONCE IN CONTACT WITH COLORECTAL LIVER METASTASES AT THE CAVAL
CONFLUENCE: VALIDATION ON AN INTENTION TO TREAT ANALYSES
F. Procopio, M. Donadon, M. Cimino, D. Del Fabbro, G. Costa, A. Gatti, A. Palmisano,
G. Torzilli
University Of Milan-School Of Medicine, Humanitas Clinical And Research Center,
Rozzano, Milan, Italy
MO-A.09. PREOPERATIVE PREDICTIVE MODEL OF SURVIVAL AFTER
RESECTION FOR INTRAHEPATIC CHOLANGIOCARCINOMA (IHCC)
A. Schneck, D. Subar, R. Memeo, F. Vittore, P. Compagnon, A. Laurent, D. Azoulay
APHP Henri Mondor Hospital, Créteil, Val De Marne, France; Royal Blackburn Hospital,
Lancashire, United Kingdom
MO-A.10. OUTCOMES OF UNRESECTABLE SOLITARY HEPATOCELLULAR
CARCINOMAS SIZED 5 TO 8 CM TREATED BY RADIOFREQUENCY
ABLATION VERSUS TRANSARTERIAL CHEMOEMBOLIZATION
W. Dai , T. Cheung, R. Poon
The University Of Hong Kong, Hong Kong, China
MO-A.11. THE ASSOCIATION OF HYPOPHOSPHATEMIA WITH POSTHEPATETCTOMY LIVER FAILURE AND RECOVERY
J. Hallet, F. Zih, J. Wong, E. Cheng, S. Hanna, P. Karanicolas, N. Coburn, C. Law
University Of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre,
Toronto, Ontario, Canada
101
MO-A.12. VALIDATION OF OUR POLICY OF LONG-TERM DRAINS
MAINTENANCE AFTER HEPATIC RESECTION: RESULTS OF A PROSPECTIVE
COHORT ANALYSIS.
M. Donadon, G. Costa, F. Procopio, M. Cimino, D. Del Fabbro, A. Palmisano, A. Gatti,
G. Torzilli
University Of Milan-School Of Medicine, Humanitas Clinical And Research Center,
Rozzano, Milan, Italy
MO-A.13. LIVER CANCER IN TEXAS: ENVIRONMENTAL RISK FACTORS
CONTRIBUTING TO HIGHER INCIDENCE RATE
D. Zorzi, G. Curcuru’, C. Rhoads, V. Gazis, C. Rastellini, L. Cicalese
UTMB, Galveston, TX; University Of Palermo, Palermo, PA
MO-A.14. (SIGMA-2/SMAC) IS A STRONG ENHANCER OF GEMCITABINE
SENSITIVITY IN PANCREATIC ADENOCARCINOMA
Y. Hashim, D. Spitzer, S. Vangveravong, P. Goedegebuure, M. Hornick, R. Mach,
W. Hawkins
Washington University School Of Medicine, St Louis, MO; University Of Pennsylvania,
Philadelphia, PA
MO-A.16. HIGH UTILIZATION OF LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA: IS IT CONCERNING?
A. E. Alsina, K. Vu, J. Arrobas, E. Franco, N. Kemmer, G. W. Neff, A. Valencia,
S. Houston
Tampa General Hospital, Tampa, FL; University Of South Florida, Morsani College
Of Medicine, Tampa, FL
MO-A.17. REOPERATION FOR BLEEDING FOLLOWING LIVER
TRANSPLANTATION
D. A. DuBay, D. T. Redden, M. A. Thompson, L. Glueckert, A. B. Smith, J. H. Crawford,
K. A. Jones, S. H. Gray, J. White, D. E. Eckhoff
University Of Alabama At Birmingham, Birmingham, AL
102
MO-A.18. THE IMPACT OF PRE-TRANSPLANT HOSPITALIZATION ON POSTOPERATIVE LENGTH OF STAY AND COST OF LIVER TRANSPLANTATION
S. J. Knechtle, L. I. Brummett, C. Devroy, R. Subramanian, A. B. Adams, J. Magliocca,
J. Spivey
Emory University School Of Medicine, Atlanta, GA
MO-A.19. SURVIVAL OUTCOMES IN LIVER TRANSPLANT RECIPIENTS
WITH MELD OF 40 AND HIGHER –A DECADE LONG EXPERIENCE
H. J. Panchal, J. Patterson, J. Durinka, J. Ortiz
Mount Sinai School Of Medicine, NY, NYLincoln Medical And Mental Health Center,
NY, NYAlbert Einstein Healthcare Network, Philadelphia, PA
MO-A.20. THE USE OF VENOUS JUMP GRAFTS IN PANCREAS
TRANSPLANTATION IS NOT ASSOCIATED WITH INCREASED
GRAFT FAILURE OR MORTALITY
E. Siskind, M. Akerman, S. Ashburn, E. Molmenti, A. Basu, J. Ortiz
North Shore Long Island Jewish Health System, Manhasset, NY; Albert Einstein Medical
Center, Philadelphia, PA
10:30am - 12:30pm
Parallel Mini Oral Abstracts B: Pancreas / Biliary
Ocean Tower II A-B
Moderators: John B. Martinie, MD; Hernan A. de la Fuente, MD
MO-B.01. IS CHROMOGRANIN A PROGNOSTIC FOR RESECTED
PANCREATIC NEUROENDOCRINE TUMORS?
M. A. Shanahan, C. S. Cho, P. A. Rudnitzky, G. Leverson, E. R. Winslow, S. M. Weber
University Of Wisconsin School Of Medicine & Public Health, Madison, WI
MO-B.02. DETECTION OF SOMATIC MUTATIONS IN DIAGNOSTIC FINE
NEEDLE ASPIRATES OF PANCREATIC CANCER WITH NEXT-GENERATION
SEQUENCING
V. Valero, T. J. Saunders, R. H. Hruban, J. L. Cameron, J. M. Herman,
C. A. Iacobuzio-Donahue, C. L. Wolfgang
The Johns Hopkins University School Of Medicine, Baltimore, MD
103
MO-B.04. COMPARISON OF ROBOT VERSUS OPEN
B. A. Boone, S. Downs-Canner, J. Steve, M. S. Zenati, M. E. Hogg, A. J. Moser,
D. L. Bartlett, H. A. Choudry, H. J. Zeh, A. H. Zureikat
University Of Pittsburgh, Pittsburgh, PA; Beth Israel Deaconess Medical Center,
Boston, MA
MO-B.05. GENERAL SURGERY RESIDENT PARTICIPATION IN
COMPLEX PANCREATIC PROCEDURES
Y. Tilahun, P. Veldhuis, S. Eubanks, P. Arnoletti, S. G. De La Fuente
MO-B.06. DIAGNOSTIC LAPAROSCOPY SHOULD BE PERFORMED BEFORE
DEFINITIVE RESECTION FOR PANCREATIC CANCER: A FINANCIAL
ARGUMENT
T. T. Jayakrishnan, H. Nadeem, R. T. Groeschl, B. George, J. P. Thomas, P. S. Ritch,
K. K. Christians, S. Tsai, D. B. Evans , S. G. Pappas, T. C. Gamblin, K. K. Turaga
Medical College Of Wisconsin, Milwaukee, WI; Loyola University Medical Center,
Maywood, IL
MO-B.07. THE EFFECT OF MARGIN STATUS ON SURVIVAL FOLLOWING
D. J. Niemeyer, R. M. Seshadri, R. Z. Swan, D. Sindram, R. Nazemzadeh,
J. B. Martinie, D. A. Iannitti
MO-B.08. NEOADJUVANT RADIATION IS EQUIVALENT TO ADJUVANT
RADIATION FOLLOWING PANCREATICODUODENECTOMY FOR STAGE II
AND III ADENOCARCINOMA
D. J. Niemeyer, R. M. Seshadri, R. Z. Swan, D. Sindram, A. J. Crimaldi, J. B. Martinie,
D. A. Iannitti
104
MO-B.09. RISK FACTORS FOR PANCREATIC FISTULA AFTER
ROBOTIC PANCREATICODUODENECTOMY
P. M. Polanco, M. E. Hogg, M. Shakir, M. S. Zenati, M. Choudry, B. A. Boone,
D. L. Bartlett, H. Zeh, A. H. Zureikat
University Of Pittsburgh Medical Center, Pittsburgh, PA
MO-B.10. IN-HOSPITAL MORTALITY FOLLOWING
PANCREATICODUODENECTOMY.
J. He, M. Weiss, J. Cameron, N. Ahuja, K. Hirose, T. Pawlik, C. Wolfgang, .
Johns Hopkins Medical Institutions, Baltimore, MD
MO-B.11. HOSPITAL READMISSION AFTER PANCREATICODUODENECTOMY
IN A HIGH VOLUME CENTER
J. Rose, F. B. Rocha, A. Alseidi, T. B. Biehl, S. Helton
MO-B.12. QUANTITY AND QUALITY: A HIGH VOLUME PANCREATIC
CENTER’S ADHERENCE TO HIGHLY VALIDATED QUALITY MEASURES
OF PANCREATIC CANCER CARE
M. Ongchin, J. Steve, D. Bartlett, M. Choudry, K. Lee, W. Marsh, A. Tsung, A. Zureikat,
H. Zeh, M. Hogg
University Of Pittsburgh, Pittsburgh, PA
MO-B.13. TUMOR STAGE AT PRESENTATION AND ACCESS TO SURGERY
IS NOT INFLUENCED BY RACE IN PANCREATIC CANCER PATIENTS
Y. Tilahum , X. Zhu , S. Litherland, P. Veldhuis , D. A. Decker, S. Eubanks, A. Simmonds,
P. Arnoletti, S. G. De La Fuente
MO-B.15. PANCREATECTOMY IN PATIENTS ON CHRONIC DIALYSIS:
IS IT TOO RISKY?
S. W. Cho, J. S. Cardinal
West Virginia University Hospitals, Morgantown, WV
105
MO-B.16. ADJUVANT CHEMOTHERAPY PROVIDES BETTER
OVERALL SURVIVAL AFTER RADICAL RESECTION FOR PANCREATIC
ADENOCARCINOMA.
S. Hurton, F. MacDonald, S. Ayloo, M. Molinari
Dalhousie University, Halifax, Nova Scotia, Canada
MO-B.17. LEARNING CURVE FOR ROBOTIC DISTAL PANCREATECTOMY
M. Shakir, M. Khreiss, P. M. Polanco, B. A. Boone, M. Zenati , M. Hogg, M. H. Choudry,
D. L. Bartlett, H. Zeh, A. H. Zureikat
University Of Pittsburgh Medical Center, Pittsburgh, PA
MO-B.18. OBESITY IS AN INDEPENDENT PREDICTOR OF BILE DUCT
INJURIES IN PATIENTS UNDERGOING CHOLECYSTECTOMY
H. Aziz, A. Amini, V. Pandit, T. Jie, E. Ong
University Of Arizona, Tucson, AZ
MO-B.19. A SYSTEMATIC REVIEW AND META-ANALYSES OF HEPATIC
ARTERY BASED THERAPIES FOR UNRESECTABLE INTRAHEPATIC
CHOLANGIOCARCINOMA
L. Boehm, T. Thayyil Jayakrishnan, J. Miura, K. K. Turaga, F. M. Johnston, S. Tsai,
T. C. Gamblin
MO-B.20. HOSPITAL READMISSIONS RATES FOLLOWING OPEN
AND LAPAROSCOPIC CHOLECYSTECTOMY
L. Watkins, P. Veldhuis , S. Eubanks, P. Arnoletti, S. G. De La Fuente
12:30pm - 1:00pm
Closing Address and Raffle
Incoming President: Elijah Dixon, MD
Ocean Tower 1 A-C
106
SPECIAL THANKS
TO OUR
BRONZE SPONSOR
107
Speakers and faculty
Reid B. Adams
UVA Health System
Rodolfo Alejandro
Diabetes Research Institute,
University of Miami
Noaman S. Ali
Cleveland Clinic
Thomas A. Aloia
Christopher D. Anderson
University Of Mississippi
Medical Center
Horacio J. Asbun
Mayo Clinic Jacksonville
Chad G. Ball
University Of Calgary
Eren Berber
Cleveland Clinic Foundation
Dario Eduardo Berkowski
Clinicas Hospital,
University of Buenos Aires
Mark Bloomston
Ohio State University
Daniel Brown
Vanderbilt University
L. Michael Brunt
Washington University Institute
Eugene P. Ceppa
Indiana University School of Medicine
108
William C. Chapman
School of Medicine
Clifford S. Cho
University Of Wisconsin School
of Medicine And Public Health
Quyen D. Chu
Louisiana State University Health
Sciences Center - Shreveport
Bryan M. Clary
Pierre-Alain Clavien
University Hospital Zurich
Sean P. Cleary
Toronto General Hospital
Amanda B. Cooper
Sebastian G. de la Fuente
Florida Hospital Orlando - UCF
Elijah Dixon
University Of Calgary
Maria B. Majella Doyle
School of Medicine
Ryan C. Fields
School of Medicine
Mary E. Fischer
Memorial Sloan Kettering
Cancer Center
continued
Jason B. Fleming
University of Texas MD
Anderson Cancer Center
Ellen J. Hagopian
Jersey Shore University Medical
Center
Katherine Fowler
Washington University St. Louis
Chet Hammill
The Oregon Clinic
Wesley P. Francis
Princess Margaret Hospital
Erin M. Hanna Baker
Steven Gallinger
University Health Network
Paul D. Hansen
Providence Portland Medical Center
O. James Garden
Royal Infirmary of Edinburgh
W. Scott Helton
David A. Geller
Alan W. Hemming
University Of California, San Diego
Octavio Gil
Sanatorio Allende
Mary Beth Henry
University of Wisconsin Hospital
Chris Giordano
University of Florida - Gainesville
Paulo Herman
University Of Sao Paulo
Medical School
Nestor Arturo Gomez
Universidad De Guayaquil
Gabriel Eduardo Gondolesi
Fundacion Favaloro
Vijaya Gottumukkala
Paul D. Greig
University Of Toronto
Ryan Groeschl
Medical College Of Wisconsin
Pamela J. Hodul
Moffitt Cancer Center
Melissa E. Hogg
Medical Center
William R. Hutson
University of Maryland
David A. Iannitti
Oscar Cesar Imventarza
Hospital Argerich/Hospital Garrahan
109
William R. Jarnagin
Memorial Sloan Kettering
Cancer Center
Nicolas P. Jarufe Cassis
Pontificia Universidad Catolica
De Chile
D. Rohan Jeyarajah
Methodist Hospital Dallas
Ivan Kangrga
Matthew H. Katz
Matthew Kulke
Dana Farber Cancer Institute
Jeffrey E. Lee
David C. Linehan
School of Medicine
110
continued
Erin Maynard
University of Kentucky
Erin McIntyre
University of Colorado Hospital
Miguel Angel Mercado
Instituto Nacional de la Nutricion
Nipun B. Merchant
Vanderbilt University
Michele Molinari
Dalhousie University
Katherine Morgan
Medical University of South Carolina
A. James Moser
Beth Israel Deaconess Medical Centre
David M. Nagorney
Mayo Clinic College of Medicine
Nathan Ogilvie
Wake Forest Baptist Health
Kevin Lowe
Akron General Medical Center
Susan L. Orloff
Oregon Health & Science University
Lindsey Manos
The Johns Hopkins Hospital
Timothy M. Pawlik
Johns Hopkins
John Mansour
University of Texas Southwestern
Medical Center
Srinevas K. Reddy
School of Medicine
Robert C. G. Martin, II
University of Louisville
Kaye M. Reid Lombardo
Mayo Clinic
John B. Martinie
Carolinas Healthcare System
Richard Reznick
Queen’s College, Canada
continued
Flavio G. Rocha
Mark S. Talamonti
NorthShore University HealthSystem
Lauren Rorabaugh
Carolinas Healthcare System
Allan Tsung
University Of Pittsburgh
Medical Center
Rodrigo Sanchez Claria
Hospital Italiano Buenos Aires
C. Max Schmidt
Indiana University School Of Medicine
Roderich E. Schwarz
IU Health Goshen Center
for Cancer Care
Ramanathan Seshadri
Shimul A. Shah
University of Cincinnati
Mohd Raashid Ali Sheikh
University of Illinois Chicago
Margo C. Shoup
Cadence Health
David Sindram
Charles M. Vollmer
University Of Pennsylvania
School of Medicine
Susanne G. Warner
University of Michigan
Andrew L. Warshaw
Massachusetts General Hospital
Sharon M. Weber
University of Wisconsin Hospital
Alice C. Wei
University Health Network,
University Of Toronto
Rebekah White
Duke University
Allan E. Siperstein
Cleveland Clinic
Christopher L. Wolfgang
Johns Hopkins University
School Of Medicine
Luc Soler
IRCAD, France
Gazi B. Zibari
Willis Knighton Health System
Christopher J. Sonnenday
University of Michigan
Nicholas J. Zyromski
Indiana University
Steven M. Strasberg
111
The power to offer new hope
to your patients with liver metastases
Download our iPad App for
comprehensive information
about Selective Internal
Radiation Therapy (SIRT).
Visit www.sirspheresmicrospheres.com
In the US, SIR-Spheres microspheres are FDA approved for the treatment of unresectable metastatic liver tumors
from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine).
SIR-Spheres microspheres are approved for use in Australia, the European Union (CE Mark), New Zealand,
Switzerland, Turkey and several other countries in Asia (e.g. India, Korea, Singapore and Hong Kong) for the
treatment of unresectable liver tumors. SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.
Sirtex
Park Drive, Woburn,19–23,
MA 01801 2014
888.474.7839| www.sirtex.com
112Medical Inc., 300 Unicorn
February
Miami
771-U-1013
You have the target. We have the weapon.
Beach, FL — Eden Roc
FLOORPLANS
&
EXHIBIT
INFORMATION
113
hotel floorplans
HIBISCUS
BAYSHORE
PALLADIIUM
STAR
Mezzanine Level
PALM
Lower Lobby Level
EXECUTIVE
BOARDROOM
LIL GORCE
KEY
BISCAYNE
A
KEY
BISCAYNE
B
BUSINESS
CENTER
114
RIVO
ALTO
Conference Level
FISHER
A
BELLE
FISHER
B
SAN
MARCO
SAN
MARINO
GROUP
OFFICE
RESTAURANT
MONA LISA
POMPEII
BALLROOM
A
MONA LISA
FOYER
B
LOBBY
PROMENADE
ROOM
RECEPTION
Lobby Level
PROMENADE
FOYER
WATER
VEIW
TERRACE
OCEAN
BALLROOM
IA
OCEAN
BALLROOM
IIA
OCEAN
BALLROOM
IB
OCEAN
BALLROOM
IIB
OCEAN
BALLROOM
IC
OCEAN
BALLROOM
IIC
Ocean Tower
115
LAPIDUS
WATSON
SUNNY
ISLES
BAL
HARBOUR
Penthouse Floor
exhibit hall diagram
VIDEO
PRESENTATIONS
Support provided by Ethicon, Inc.
BAR
SHOW
ENTRANCE
Visit our medal-level sponsors!
116
EXHIBITORS
20 Ethicon, Inc.
GOLD SPONSOR
15 BK Medical
SILVER SPONSOR
1&2
Medtronic Advanced Energy
SILVER SPONSOR
23 Hitachi Aloka Medical, Ltd.
BRONZE SPONSOR
5 & 6 Intuitive Surgical
BRONZE SPONSOR
13 Onyx Pharmaceuticals / Bayer HealthCare
BRONZE SPONSOR
21 Edwards Lifesciences
BRONZE SPONSOR
12 Sirtex Medical, Inc.
BRONZE SPONSOR
14 Angiodynamics
SPONSOR
9 Covidien
SPONSOR
19 Pathfinder Technologies, Inc.
SPONSOR
117
16 & 17 BTG
30 CanLiv Foundation
4 Carefusion
37 CAScination
22 ERBE USA
3 NeuWave Medical, Inc.
10 Novadaq Technologies, Inc.
26 RedPath Integrated Pathology
11 Sanofi
29 The Cholangiocarcinoma Foundation
24 Thompson Surgical Instruments, Inc.
Exhibitor Showcase
Location: Pompeii/Promenade
Exhibit Hours
Thursday
5:15pm – 6:45pm
Friday
7:00am – 2:00pm and 5:00pm – 7:15pm
Saturday
7:00am – 11:15am
EVENTS HELD IN EXHIBIT HALL
Thursday
5:15pm – 6:45pm
Welcome Reception
Friday
7:00am – 8:00am Continental Breakfast
10:00am – 10:30am
Morning Beverage Break
1:00pm – 2:00pm
Boxed Lunch & Video Presentations
6:30pm – 7:15pm
Saturday
7:00am – 8:00am
Cocktail Reception & Highlighted Videos
10:45am – 11:15am
Morning Break & Video Presentations
Continental Breakfast
EXHIBITOR PASSPORT
Visit the exhibitors, complete your passport and enter a chance to win some
wonderful raffle prizes, including an iPAD Air, complimentary 2015 meeting
registration, a VIP Miami gift basket, and other exciting prizes. Visit our top
sponsors and qualify for an extra raffle! Passport cards must be turned in to
the AHPBA registration desk by Saturday afternoon.
118
AHPBA Exhibitors & Sponsors
Angiodynamics
BTG
SPONSOR
BOOTH #14
14 Plaza Drive
Latham, NY 12110
www.angiodynamics.com
BOOTH #16 & 17
Five Tower Bridge, Suite 800
300 Barr Harbor Drive
West Conshohocken, PA 19428
www.btgplc.com
AngioDynamics Inc. is a leading
provider of innovative, minimally
invasive medical devices used by
professional healthcare providers
for vascular access, surgery,
peripheral vascular disease and
oncology. AngioDynamics’ diverse
product lines include market-leading
ablation systems, fluid management
systems, vascular access products,
angiographic products and
accessories, angioplasty products,
drainage products, thrombolytic
products and venous products.
BTG plc is an international specialist
healthcare company developing and
commercializing products targeting
acute care, oncology and vascular
diseases. We sell our products direct
to customers in the US and elsewhere
principally through distribution
partners. We are focused in three
business areas: Interventional
Medicine, Specialty Pharmaceuticals
and Licensing.
Interventional Medicine comprises
Interventional Oncology and
Interventional Vascular products
including drug-device combinations. Our Interventional Oncology
products include embolization,
chemoembolization and
radioembolization beads which
are used to treat patients with liver
tumors.
BK Medical
SILVER SPONSOR
BOOTH #15
8 Centennial Drive
Peabody, MA 01960
www.bkmed.com
The BK Medical Flex Focus 800
premium ultrasound system from
Analogic is designed for the surgical
suite. Supporting a comprehensive
range of sterilizable transducers,
it is compact, lightweight, and can
be battery powered.
119
CanLiv Foundation
CAScination
BOOTH #30
164 Market Street, Suite 129
Charleston, SC 29401
www.canliv.org
BOOTH #37
3014
Bern, Switzerland
www.cascination.com
CanLiv’s vision is to be the catalyst
that brings together patients and their
families affected by cancers of the
bile duct, gall bladder, and liver with
doctors, researchers and partners; and
to create a community of stakeholders
that will work together to advance
research,
improve patient outcomes, and search
for the cure CAScination AG manufactures
and markets surgical navigation
systems for soft tissue surgery,
which enable precision guidance of
surgical instruments during surgical
interventions on the liver.
Carefusion
BOOTH #4
1500 Waukegan Rd.
McGaw Park, IL 60085
www.carefusion.com
CareFusion delivers clinically proven
products and services that measurably
improve the productivity and safety
of healthcare globally. The Pleurx®
catheter system is the easy-to-use
and effective choice for the home
Management of recurrent pleural
effusions and malignant ascites. With
the PlerX In-dwelling catheter and
vacuum bottles, patients can manage
fluid accumulation through intermittent
drainages at home, with minimal
physician intervention.
120
continued
Covidien
BOOTH #9
15 Hampshire Street
Mansfield, MA 02048
www.covidien.com
Covidien is a $10 billion global
healthcare products leader dedicated
to innovation and long-term growth.
Covidien creates innovative medical
solutions for better patient outcomes
and delivers value through clinical
leadership and excellence. Please visit
http://surgical.covidien.com/
Edwards Lifesciences -
Ethicon, Inc.
SPONSOR
BOOTH #21
1 Edwards Way
Irvine, Ca 92614
www.edwards.com
GOLD SPONSOR
BOOTH #20
4545 Creek Road
Cincinnati, Ohio 45242
www.ethicon.com
Post-Surgical Recovery Resource
Center: An initiative of Edwards
Lifesciences…This Resource Center is
designed to help you reduce the risk of
post-surgical complications (including
anastomotic leaks, AKI, SSI, UTI)
in moderate to high-risk surgeries. Explore the data that support the
standardization of Hemodynamic
Optimization through Perioperative
Goal-Directed Therapy; and see
how this can work in conjunction
with your ERAS or NSQIP initiative.
Visit Edwards.com/PGDT to access
resources immediately.
The ETHICON brand is used for
the products of Ethicon, Inc. and
Ethicon Endo-Surgery, Inc., two
companies with long histories of
medical innovation, which provide
globally a broad range of surgical
technologies and products (including
energy devices, sutures, staplers,
clip appliers, trocars and meshes)
used to treat colorectal and thoracic
conditions, women’s health conditions,
hernias, cancer and obesity. Ethicon,
Inc. and Ethicon Endo-Surgery, Inc. are
part of the Johnson & Johnson Family
of Companies.
ERBE USA
Hitachi Aloka Medical, Ltd.
BOOTH #22
2225 NW Parkway
Marietta, GA 30067
www.erbe-med.com
BRONZE SPONSOR
BOOTH #23
10 Fairfield Boulevard
Wallingford, CT 06942
www.hitachi-aloka.com
ERBE USA presents the ERBEJET®
2, a unique modality for selective
tissue dissection with precise, gentle
pressure rather than intense heat.
Using an extremely thin laminar water
jet, it forces softer, more water-soluble
tissue to separate, while fibrin-rich
structures are spared. This optimizes
the preservation of vessels, and ducts.
121
continued
Hitachi Aloka Medical’s commitment
to ultrasound for surgeons offers a
wide range of consoles and specifically
designed transducers to meet the
needs of every surgeon. Recognized
for our superior image quality, system
reliability and use of cutting edge
technology, we remain the standard in
the field of ultrasound for surgeons.
Intuitive Surgical
BRONZE SPONSOR
BOOTH #5 & 6
1266 Kifer Road
Sunnyvale, CA 94086
www.intuitivesurgical.com
Intuitive Surgical is the global leader
in robotic-assisted, minimally invasive
surgery. Its da Vinci® System enables
general surgeons to offer complex
procedures minimally invasively. da
Vinci is used for bariatric, esophageal,
colorectal and gallbladder surgery.
da Vinci Single-Site is FDA cleared for
cholecystectomy, providing gallbladder
patients with virtually scarless results.
Medtronic
Advanced Energy
SILVER SPONSOR
BOOTH #1 & 2
180 International Drive
Portsmouth, NH 03801
www.medtronic.com
Medtronic Advanced Energy products
deliver proprietary Transcollation®
technology, a combination of
radiofrequency (RF) energy and
saline that provides hemostatic
sealing of soft tissue during surgery.
The advanced energy product
line has evolved from monopolar
electrosurgical devices used in liver
and pancreatic resection to the
Aquamantys® System, which includes
a bipolar electrosurgical generator and
handheld disposable devices.
122
continued
Medtronic’s monopolar and bipolar
sealers have been used to treat
patients across a wide range of
surgical procedures, including surgical
oncology, orthopaedic reconstruction,
and spine surgery.
NeuWave Medical, Inc.
BOOTH #3
3529 Anderson Street
Madison WI 53704
www.neuwavemedical.com
NeuWave Medical offers an enhance
portfolio, the CertusPR Ablation Probe
is designed to produce ablations
with limiting overall length. Each
component of the device was
designed with a specific clinical need
in mind. The Certus 140 System
maximizes synchronized power
deliver to soft tissue, minimizes
invasiveness, and provides a simple
and ergonomically optimized user
interface. Advanced features include
Tissue Specific Probes, TissuLocTM Technology and Clic n’ GoTM
connections. Don’t imagine the future
see it now. February 19–23, 2014 | Miami Beach, FL — Eden Roc
NewLink Genetics
Corporation
SPONSOR
2503 South Loop Drive
Suite 5100
Ames, IA 50010
www.linkp.com
NewLink Genetics Corporation
is a biopharmaceutical company
focused on discovering, developing
and commercializing novel
immunotherapeutic products to
improve treatment options for
cancer patients. NewLink’s portfolio
includes biologic and small-molecule
immunotherapy product candidates
intended to treat a wide range of
oncology indications. NewLink’s
product candidates are designed to
harness multiple components of the
immune system to combat cancer
without significant incremental
toxicity, either as a monotherapy
or in combination with other
treatment regimens. NewLink’s lead
product candidate, algenpantucel-L
(HyperAcute® Pancreas) is being
123
continued
studied in a Phase 3 clinical trial in
surgically resected pancreatic cancer
patients (under a Special Protocol
Assessment with the U.S. FDA) as
well as in a separate study in locally
advanced pancreatic cancer patients.
NewLink has recently launched
an adaptive design Phase 2B/3
clinical trial of tergenpumatucel-L
(HyperAcute® Lung) in patients with
non-small cell lung cancer. NewLink
is developing indoximod, a smallmolecule, orally bioavailable product
candidate from NewLink›s proprietary
indoleamine-(2,-3)-dioxygenase
pathway inhibitor technology.
NewLink is studying indoximod
in various chemotherapy and
immunotherapy combination studies
independently and in collaboration
with the National Cancer Institute. For
more information please visit http://
www.linkp.com. Patient information
is available at http://www.
pancreaticcancer-clinicaltrials.com.
Novadaq Technologies, Inc.
BOOTH #10
11091 Corsia Trieste Way, Unit 201
Bonita Springs, FL 34135
www.novadaq.com
Enabling surgeons with clinicallyrelevant, innovative fluorescence
imaging solutions to enhance the
lives of patients and their surgeons,
while reducing health care costs,
is Novadaq’s global mission. SPY
fluorescence imaging technology
provides surgeons with real-time
visualization, leading to improved
outcomes and reduced costs without
exposing the patient to radiation.
More than 75 peer-reviewed
publications demonstrate that the use
of SPY during complex surgery, leads
to fewer post-operative complications
and lower hospital costs.
The SPY Imaging System is United
States Food and Drug Administration
(“FDA”) 510(k) cleared for use for
use in seven surgical specialties. The
endoscopic version of SPY called
PINPOINT®, combines the capabilities
of SPY Imaging with high definition
(“HD”) visible light visualization
offered by conventional endoscopes.
Our unique business model of
partnering with market-leading
companies to drive adoption of our
fluorescence imaging technology,
while building our own commercial
infrastructure is the cornerstone of
our corporate strategy for growth.
124
continued
Onyx Pharmaceuticals /
Bayer HealthCare
BOOTH #13
249 E. Grand Avenue
South San Francisco, CA 94080
www.onyx.com
Bayer HealthCare and Onyx
Pharmaceuticals are committed
to cancer research and treatment
options. We continually apply our
experience,
knowledge and passion to develop
new cancer therapies.
Pathfinder Technologies, Inc.
SPONSOR
BOOTH #19
2969 Armory Drive, Suite 100A
Nashville, TN 37204
www.pathnav.com
Pathfinder Technologies offers
state-of-the-art computer-assisted
navigation and 3D surgical planning
tools, enabling the optimal course
of therapy for soft-tissue abdominal
procedures.
RedPath Integrated
Pathology
BOOTH #26
2515 Liberty Ave
Pittsburgh, PA 15222
www.redpathip.com
RedPath Integrated Pathology
is a Pittsburgh-based molecular
diagnostics laboratory focused on
providing novel solutions for clinicians.
Our patented PathFinderTG® platform
produces mutational profiles to help
physicians resolve complex diagnostic
dilemmas in patients who are at risk of
cancer. RedPath performs all clinical
testing and R&D in its state-of-the-art,
CLIA-certified and CAP-accredited
laboratory.
RedPath’s platform is supported by
more than 20 years of scientific and
clinical research, and studies using
it have been published in more than
200 peer-reviewed journals including
The New England Journal of Medicine.
Two recent healthcare economic
studies demonstrate that the use of
PathFinderTG significantly reduces
healthcare costs. Based on the strong
clinical data supporting our platform,
RedPath has received positive
coverage decisions from Medicare and
several private payers.
RedPath is committed to
offering cutting-edge molecular
diagnostic services to support
gastroenterologists, pathologists, and
other physicians by improving clinical
management of patients.
125
continued
Sanofi
BOOTH #11
www.sanofi.us
Sanofi Biosurgery is a global strategic
business unit of Sanofi. It develops
and markets innovative, biologically
based products for osteoarthritis
relief, adhesion prevention, temporary
endovascular occlusion of blood
vessels, cartilage repair, and severe
burn treatment. Sanofi, a global
and diversified healthcare leader,
discovers, develops and distributes
therapeutic solutions focused on
patients’ needs. Sanofi has core
strengths in the field of healthcare
with seven growth platforms: diabetes
solutions, human vaccines, innovative
drugs, rare diseases, consumer
healthcare, emerging markets and
animal health. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York
(NYSE: SNY).
BOOTH #12
300 Unicorn Park Drive
Woburn, MA 08101
www.sirtex.com
Sirtex, headquartered in Australia
and with U.S. operations in Woburn,
Mass., is a global life-sciences
company that develops and delivers
effective oncology treatments using
novel small particle technology.
Sirtex is committed to developing
new procedures for the treatment of
cancer while expanding the availability
of Selective Internal Radiation
Therapy (SIRT), also known as
radiobmbolization to those in need.
Sirtex manufactures SIR-Spheres®
microspheres, biocompatible resin
microspheres (average 32uM
diameter) that contain the beta
emitting Yttrium 90 to kill cancer
cells. SIRT is a proven technology for
inoperable liver cancer that delivers
doses of radiation directly to the site
of tumors. In a minimally invasive
treatment, millions of radioactive
SIR-Spheres microspheres are infused
via a catheter into the liver where
they selectively target liver tumors
with a dose of internal radiation up
to 40 times higher than conventional
radiotherapy, while sparing healthy
tissue.
For more information and to explore
our new Treatment Center Locator,
visit www.sirtex.com.
126
continued
The Cholangiocarcinoma
Foundation
BOOTH #29
5526 West 13400 South, #510
Salt Lake City, Utah 84096
www.cholangiocarcinoma.org
Founded in 2006, the
Cholangiocarcinoma Foundation
provides help for patients and
caregivers, advocates for those
afflicted and educates those who do
not understand.
The non-profit 501(c)(3) foundation
is run solely by volunteers having lost
a loved one to cholangiocarcinoma or
suffering from cholangiocarcinoma
and surviving.
Our mission is to find a cure and
improve the quality of life for those
affected by bile duct cancer. As
our reach continues to expand, we
examine ways to improve diagnosis
and early detection and advance
therapies for prolonging life.
Thompson Surgical
Instruments, Inc.
BOOTH #24
10170 E. Cherry Bend Road
Traverse City, MI 49684
www.thompsonsurgical.com
Thompson Surgical Instruments,
Inc. is the market leader in surgical
retraction and the manufacturer of
the original table mounted retractor.
SPECIAL THANKS
TO OUR
BRONZE SPONSOR
127
AHPBA
Membership Benefits
Just a few highlights of the many benefits of Fellowship
in the Americas Hepato-Pancreato-Biliary Association!
The Americas Heptao-Pancreato-Biliary Association (AHPBA),
an incorporated, nonprofit organization, was created with a vision of devoting
itself to relieving the human suffering caused by HPB disorders throughout
the world, by improving education, training, innovation, research and patient
care. The AHPBA serves as the American Chapter of the International
Hepato-Pancreato-Biliary Association (IHPBA). Today, more than 1,000
multidisciplinary active members create the energy of our society. Together
with surgeons, residents and fellows, allied health, interventional/diagnostic
radiologists, gastroenterologists, medical and radiation oncologists,
pathologists, transplantation physicians and scientists we meet, have fun and
learn and collaborate. The AHPBA fosters an atmosphere of alliance among
clinicians and scientists to advance both learning and patient care.
Benefits of Membership
Membership in the AHPBA will provide you with an opportunity to belong to
one of the most recognized organizations in the HPB field. Active member
benefits include:
•Discounted registration rates at the annual meeting.
•E-access to subscriptions to the premier journal of
our specialty, HPB.
•State-of-the-art consensus conferences and
chapter meetings that keep you on the cutting edge
of clinical care and research.
•Eligibility to apply for research grants, travel
fellowships and awards.
•Opportunities to develop professional and social
relationships with leaders in the field of gastrointestinal
and HPB surgery.
128
Membership Details
Active Membership Open to any qualified medical practitioner or
scientist actively involved in any of the hepatic,
pancreatic or biliary fields. Annual dues for
Active Membership are $250.
For more information
on application
guidelines or to apply,
please visit www.ahpba.org/join
Candidate Membership Open to Residents of Fellows enrolled in a
program of medical education or research.
Candidate members must convert to active
members at the conclusion of the training.
Annual dues for Candidate Membership are $50.
Allied Health Membership Open to health care providers who are not
physicians or scientists. This includes, but
is not limited to registered nurses, licensed
practical nurses, clinical nurse practitioners,
clinical trial managers, physician assistants, and
technologists. Annual dues for Allied Health are
$100.
/AHPBA
Discounted Combined Memberships
with the Ihpba
The AHPBA serves as the American Chapter
of the International Hepato-Pancreato-Biliary
Association (IHPBA). Combined members enjoy
full membership status in both the AHPBA and
the IHPBA as well as discounted membership
dues. Annual dues for Combined Active
Membership are $217.50. Annual dues for
Combined Candidate Membership are $32.50.
/AHPBA
The AHPBA is a great place for HPB enthusiasts
to meet, learn and collaborate!
129
Join today!
The AHPBA is a great place for HPB enthusiasts
to meet, learn and collaborate!
Americas Hepato-PancreatoBiliary Association
Leawood, KS 66224
130
Telephone: 913-402-7102
Fax: 913-273-9940
/AHPBA
/AHPBA
Web: www.ahpba.org
2013–2014 New Members
As of January 15, 2014
Congratulations and Welcome to our Newest Members
ACTIVE
Daniel E. Abbott, MD - USA
Hector Rodolfo Agnesio, MD Argentina
Jorge Mario Aguirre, MD - USA
Angel E Alsina, MD - USA
Juan Marcelo Alvarez, MD - Argentina
Nayef Alzahrani, MD - Australia
Gustavo Andreoli, MD - Uruguay
Victoria Ardiles, MD - Argentina
Gerardo F. Arroyo, MD - Argentina
Elaine C. Ataide, PhD - Brazil
Glaucio Baechat Costa, MD - Brazil
Christian H. Bertona, MD - Argentina
Gustavo Raul Bianco, MD - Argentina
Ilka FSF Boin, MD - Brazil
Eduardo Miraranda Brandao, MD - Brazil
Fernando Bray Beraldo, MD - Brazil
Jorge Bufaliza, MD - Argentina
Edy Waldemar Caal Melendez, MD Guatemala
Felix Camasco, MD - Peru
Eduardo Jose Cassone, MD - Argentina
Igor Cermetia Farias, MD - Brazil
Manuel Ceron Rodriguez, MD - Mexico
Jose Chaman, MD - Peru
Oscar Chapa, MD - Mexico
Leonardo Simao Coelho Guimarael, MD
- Brazil
Moises Cukier, MD - Panama
Antonio Moris Curry Filho, MD - Brazil
Diego Cutropia, MD - Argentina
Cassio Virgilio C. De Oliveira, MD - Brazil
Vanderson de Oliveira Lemos, MD - Brazil
Martin de Santibanes, MD - Argentina
Raymison Monteiro de Souza, MD Brazil
131
Hong Defei, MD - China
Rafik A. Elsabrout, MD - USA
Alejandro Ettlin, MD - Uruguay
Ji Fan, MD - USA
Marcelo Augusto Faria de Freitas, MD
- Brazil
Mary E Fischer, MD - USA
Eduardo Alesandro Flores Villaba, MD
- Mexico
Fernando César Façanha Fonseca, MD
- Brazil
Charly Franklin Oporto Cossio, MD
- Argentina
Rogerio Aoki Fuziy, MD - Brazil
Gabriel Eduardo Gondolesi, MD
- Argentina
Jose Enrique Gonzalez Herrera, MD
- Mexico
Cesar Gutierrez-Samperio, MD
- Mexico
Angel Luis Guzman Bonilla, MD
- Dominican Republic
Martin Harguindeguy, MD - Uruguay
Hoover Rodyl Henriquez Cooper, MD
- Honduras
Marco Antonio Hernandez-Guedea, MD
- Mexico
Luis Montiel Hinojosa, MD - Mexico
Jimmy Ronald Ixcayau Hernandez, MD
- Guatemala
Roberto Jauregui Brechu, MD - Mexico
Prashant Khullar, MD - USA
Gustavo Kohan, MD - Argentina
Muthusamy Kunnimalaiyaan, MD - USA
Daltro Lemos da Rosa, MD - Brazil
Martin Abelleira Linardi, MD - Uruguay
Roberto Carlos Lopez-Solis, MD - USA
continued
ACTIVE continued
Tamer A. Malik, MD - USA
Rodrigo Maroni Veiga, MD - Argentina
Baltazar Martinez-Navarrete, MD
- Mexico
Erin C. Maynard, MD - USA
Martin McCarter, MD - USA
Lucas Souto Nacif, MD - Brazil
Carolina Nahime, MD - Brazil
Eric Kaoru Nakakura, MD - USA
Juan Jose Nunez, MD - Peru
Ricardo Luis Oddi, MD - Argentina
Lilin Oserio-Molina, MD - Mexico
Houssam Osman, MD - USA
Antonio Sanchez Pablo Jose, MD
- Argentina
Alejandro Eduardo Padilla Rosciano, MD
- Mexico
Haroldo Estuardo Paiz, MD
- Guatemala
Gustavo Andres Pazos, MD - Argentina
Joaquin Pereyra, MD - Uruguay
Rodrigo N. Pinheiro, MD - Brazil
Juan Manuel Ponce-Ayala, MD
- Mexico
David Estuardo Porras, MD
- Guatemala
Vichin Chander Puri, MD - USA
Carla Cecliia Ramirez Cabrera, MD
- Guatemala
Carlos Vicente Ramirez Castillo, MD
- Mexico
Lizka Lorena Richards, MD - USA
Mauricio Rodriguez Bravo, MD
- Panama
Carlos Rodriguez Montalvo, MD
- Mexico
132
Federico Roesch Dietlen, MD - Mexico
Luis Ruso Martinez, MD - Uruguay
Carlos Federico Salas, MD - Argentina
Leonardo Nelson Santamaría, MD
- Panama
Luis Ernesto Sarotto, MD - Argentina
Luke O. Schoeniger, MD, PhD - USA
Victor Audon Serrano, MD - Argentina
Jorge Luis Silva, MD - Argentina
Erick Roberto Soto Solís, MSc, MACG
- Guatemala
Roberto Ricardo Taruselli, MD
- Uruguay
Swee Teh, MD - USA
Rogelio A Traverso, MD - Argentina
Steven D. Trocha, MD - USA
Fabiola Trocoli Novaes, MD - Brazil
Mauro Enrique Tun Abraham, MD
- Mexico
Marcos Alfmejo Uffelmann, MD
- Argentina
Carlos Hector Valenzuela, MD
- Argentina
Roberto Valinas, MD - Uruguay
Jorge Arturo Vazquez Reta, MD
- Mexico
Fernando Viava Hummel Filho, MD
- Brazil
Sandeep Suresh Vijan, MBBS - USA
Mario Vilatoba, MD - Mexico
Bruno Voz de Melo, MD - Brazil
Andrew L. Warshaw, MD - USA
Jared A. White, MD - USA
Gary Xiao, MD - USA
Peter S. Yoo, MD - USA
Kito Young Gonzalez, MD - USA
Daniel Zamora-Valdes, MD - Mexico
continued
ALLIED HEALTH
Marianne Andersen - Denmark
Cesar Aviles - USA
Beverley A. Burnett, RN - Canada
Jenell L. Gilman, PA-C - USA
Mary Beth Henry, NP - USA
Tawana N. Overton - USA
Sarah A. Reed, PA-C - USA
Lori Saathoff, RN - USA
Jose Hector Salazar, MD - Mexico
Leigh Samp - USA
Amit Sastry - USA
Meranda Scherer, BSN, RNFA - USA
Stacey M. Schulte, AGPCNP-BC - USA
Gary Duran Zuniga, MD - Argentina
CANDIDATE
Steven C. Agle, MD - USA
Farzad Alemi, MD - USA
Noaman Syed Ali, MD - USA
Kimon Orson, Isles, Dasent Bonadie,
MB, BS, DM - Canada
Melanie-Antonietta Brown, MD - USA
Jesse Clanton, MD - USA
Kelly M. Collins, MD - USA
Matthew R. Dimon, MD - USA
Alvaro Andres Andres Duarte Garces,
MD - Colombia
Mohamed Hosny Elgamal, MD - USA
Andrew I. Gagnon, MD - USA
Monique A. Gary, MD - USA
Mai-Kim Gervais, MD - Canada
Chad R. Gonczy, MD - USA
Jan Grendar, MD - Canada
Julie Hallet, MD - Canada
Hishaam Ismael, MD - USA
133
Furrukh Jabbar, MD - USA
Maris S. Jones, MD - USA
Sunhawit Junrungsee, MD - USA
Ashwin Kamath, MD - USA
Ahmed Kandeel, MD - USA
Goutham Kumar, MD - USA
Victor Kuo, MD - USA
Jerome M. Laurence, MBChB, PhD Canada
Julie N. Leal, MD - USA
Ahmad Abdullah Madkhali, MD Canada
Maher M. Matar, MD - Canada
Paulo Roberto Mesquita, MD - Brazil
Christoph W. Michalski, MD - USA
Indraneil Mukherjee, MD - USA
Julia Ng, MD - USA
Daniel P. Nussbaum, MD - USA
Puraj Patel, DO - USA
Pejman Radkani, MD - USA
Juan Carlos C. Sabogal Olarte, MD Canada
Teviah Sachs, MD, MPH - USA
Aaron C. Saunders, MD - USA
Kevin Naresh Shah, MD - USA
Murtaza Shakir, MD - USA
Christopher R Shubert, MD - USA
Karen P. Solis, MD - Mexico
Malcolm Hart Squires, MD – USA
Aimee L. Strong, NP - USA
Iswanto Sucandy, MD - USA
Anselm Jingwa Tintinu, MD - USA
Vicente Valero III, MD - USA
George Younan, MD - USA
Kai Zhang, MD - USA
myHPB is an innovative new elearning platform providing
IHPBA members with up-to-date, quality-assured content, including
masterclass videos and key educational resources as well as a meeting
space to discuss the latest developments in our specialty field.
www.myhpb.com
Welcome, David
Search myHPB
myHPB
|
About myHPB
|
Browse Content
| Video Masterclass
Inbox
| Discussions
|
Guidelines
|
Profile
Case of the Month
Logout
|
Fellowships
myHPB provides IHPBA members with up-to-date, quality-assured content including, masterclass videos
and key educational resources, as well as a meeting space to discuss the latest developments in the field.
How myHPB works
1. Browse &
Search Content
View our full library of content. Search for
content that matters to you by keyword or
browse full CPD modules by topic.
FIND OUT MORE
2. Complete CPD
& Create Content
Contribute to the discussion and complete
modules. Earn your CPD points.
FIND OUT MORE
3. Complete your
Profile
Complete your online profile for more
meaningful interactions with other myHPB
users and show your activity.
FIND OUT MORE
This platform has been developed to facilitate access to the highest
quality resources and to enable interaction with like minded individuals.
Join IHPBA and benefit from this new innovative platform
134
www.ihpba.org
IHPBA / Kenneth Warren Foundation
Donors
The Kenneth Warren Foundation promotes collaborative scientific discovery in
hepatic, biliary, or pancreatic diseases through support of clinical or laboratory
research for a young investigator in a laboratory outside the applicant’s own
department and country. Fellowships, funded by the Foundation, support the
recipient’s own salary; further details on the history and goals of the Foundation
are detailed on the IHPBA website, http://www.ihpba.org/42_IHPBA-WarrenFellowship.html.
We are proud to recognize our donors and would like to thank all of the
organizations and individual supporters whose continued generosity allows us to
continue this important work.
Warren Family Circle
Sustainers
$100,000 and up
$10,000 to $24,999
Kenneth Warren
Thomas Warren
Australia and New Zealand Hepatic,
Pancreatic and Biliary Association
(ANZHPBA)
European-African Hepato-PancreatoBiliary Association (E-AHPBA)
O. James Garden
C. Wright Pinson
Henry A. Pitt
Sally Warren
International Life Circle
$50,000 to $99,999
Wiley Blackwell
Research Stewards Circle
$25,000 to $49,999
Americas Hepato-Pancreato-Biliary
Association (AHPBA)
International Hepato-PancreatoBiliary Association (IHPBA)
135
Donors continued
Leaders
Sponsors
$1,000 to $9,999
$250 to $499
Asian-Pacific Hepato-PancreatoBiliary Association (A-PHPBA)
Markus Büchler
John L. Cameron
Carlos Fernandez-del Castillo
Dirk Joan Gouma
W. Scott Helton
Joan E. Kolligan
Joseph W.Y. Lau
Yuji Nimura
James Toouli
George Warren
Christoph Ausch
Mark Callery
John W. Chen
Roland Montenegro Costa
Carlos Florez-Zorilla
Ellen Hagopian
Clem Imrie
Palepu Jagannath
Yoshifumi Kawarada
Basil P. Kekis
Satoshi Kondo
Mickael Lesurtel
Michelle Molinari
Maris Pavars
Alvarao Riart
Karl Sondenaa
Steven Strasberg
Cheng-hsi Su
Miguel Angel Suarez Munoz
Atushi Sugioka
Benefactors
$500 to $999
Michael D’Angelica
Jacques Belghiti
William R. Jarnagin
Chen-guo Ker
Sean Mulvihill
Glenn D Steele
Thomas van Gulik
136
Donors continued
Friends
$100 to $249
Eduardo Akaishi
Mohammed Alsaghier
Taku Aoki
Gerard Aranha
Takehide Asano
Telesforo Bacchella
Giulio Belli
Neil Anthony Berry
Andrew Biankin
Giulio Belli
Christoph Broelsch
Matteo Cescon
Julian Choi
Eduardo de Santibanes
Horacio D’Agostino
Georgios Glantzounis
Mehmet Haberal
Ho-seong Han
Thomas Howard
Oscar Imventarza
Timoleon Kakavoulis
Santeev Kanoria
Wolfram Trudo Knoefel
Nobuaki Kurauchi
Roberto Lauro
Sung-gyu Lee
Michael Ka Wah Li
Fabio Madureira
Sameer Mihrshahi
Kohji Miyazaki
Gareth Morris-Stiff
Satvinder Mudan
Akimasa Nakao
Attila Nakeeb
Leslie Nathanson
Overgaard Nielson
Gregory Nolan
Stefano Puleo
Guntars Pupelis
Renyi Qin
Samuel Ramos Linaje
Norbert Senninger
Harjit Singh
Shin Takasaki
Jorge H. Tobar de Leon
Guido Torzilli
Evangelos C. Tsimoyiannis
Tjarda van Heek
Andrew Warshaw
Robin Williamson
To make a donation, please go to the IHPBA website
http://www.ihpba.org/48_Charitable-Donations.html ,
or do so when renewing your IHPBA dues.
137
disclosures
ABSTRACT AUTHORS
The following Abstract Authors provided information to be disclosed.
Jean-Michel Aubin
Covidien Canada
Role: Research Bursary
Steven Bokshan
Pathfinder
Role: Dr. William Chapman is President of Pathfinder,
3D image guidance company.
Fernando Dip
Karl Storz
Received: Funding and equipment provided by Karl Storz
Yuri Genyk
Takeda
Role: Employee
Major Lee
ACS (not For Profit)
BLH Is A Paid Consultant To The (not-for-profit) ACS
As A Director Of NSQIP
Zhenyu Xiao
Vasculox, Inc. St Louis
Role: Co-founder, Stockholder And Employee Of Vasculox, Inc,
A Biotech Start-up Company That Is Developing Protein
Therapeutics For Several Indications.
138
disclosures
continued
SPEAKERS, MODERATORS, DISCUSSANTS
The following Speakers/Moderators/Discussants provided information to be disclosed.
Mark Bloomston
Ohio State University
Role: Presenter
Consultant - Covidien
William Chapman
Role: Presenter
President Of Pathfinder Therapeutics,
Inc - A company for 3D image
guidance
Sean Cleary
Role: Moderator
Consultant - Roche
Sebastian de la Fuente
Florida Hospital Orlando and
Univ of Central Florida
Role: Moderator
Consultant - TransEnterix Speaker’s
Bureau, Novadaq Technologies
Paul Hansen
Providence Portland Cancer Center
Role: Presenter, Moderator
Consultant, Angiodynamics
William Hutson
Role: Presenter
Received: Grant/Research Support
Roche; Ocera
139
David Iannitti
Role: Presenter
Consultant, Covidien
Received: Grant/Research Support Covidien
John Martinie
Department of General Surgery,
Role: Proctor
Intuitive Surgical
A. James Moser
Beth Israel Deaconess/Harvard
Medical School
Role: Presenter, Course Director
Consultant - AbbVie
Sharona Ross
AHPBA Program Committee Member
Received: Women in Surgery Grant
from Covidien
Other: Speaking Honorarium Olympus
Shimul Shah
AHPBA Program Committee Member
Role: Consultant - Covidien, Novartis,
Bayer
Self/Spouse
Role: Presenter
Speaker’s Bureau - Roche, Novartis
Received: Grant/Research Support Roche
in memoriam
Hector Orozco, MD, 1935-2013
Hector Orozco MD, FACS a lifetime member and active
supporter of the AHPBA passed on September 28th
2013 at his home in Sahuayo Michoacán, Mexico.
Dr. Orozco was born in 1935 in Sahuayo, a small town
near Guadalarjara in Western México. He received his
MD at The Universidad Autonoma de Guadalajara. He
completed a residency in internal medicine followed
Hector Orozco, MD
by surgery at the most prestigious academic center
in Mexico, Instituto Nacional de la Nutricion, Mexico
City. His ambition to become the best possible surgeon
posible led him to pursue additional training in the
United States and so he completed a second surgical
residency at The Graduate Hospital in Philadelphia, Penn. He returned to The
Instituto Nacional de la Nutricion, where he spent the next 40 years of his life
and also became Profesor and Chairman of The Departent of Surgery (19882007). During his tenure developed a world reknowned portal hypertension clinic,
performed more than 1,000 operations for portal hypertension, and was principle
investigator on some of the most important clinical trials ever performed in portal
hypertension. He began the liver transplant program in Mexico and performed
the first heterotopic transplant in 1976 and the first orthotopic liver transplant
in 1985. According to his life long colleague and friend Miguel Mercado, Hector
“became widely recognized as the best and most influential academic surgeon
in Mexico. He was an exceptional human being and surgeon who inspired and
mentored several generations of academic Surgeons”.
One of Dr. Orozco’s life long ambitions was to train and prepare a future
generation of Mexican Surgeons who could best meet the health care needs
of Mexico. He recognized that to elevate clinical excellence would require
better education and training than what was available in Mexico at the time he
became chair of surgery. For this reason, he established a collaboration with The
University of Alabama, Birmingham and a mandatory surgical rotation for his
surgical residents, which continues to this day. In addition, he sent many of his
young faculty to specialized centers around the World to acquire expertise in HPB
disease and Surgery and then hired them to join his faculty. Through these efforts,
Hector recognized the importance and value of academic international exchange
across the Americas. So, when the AHPBA first convened in 1991, Dr. Orozco
140
in memoriam
continued
became one of its original members and remained one of its strongest advocates.
He attended every single anual meeting and was always accompanied by his
lovely wife, Silvia. He inspired his faculty, residents, and other Latin American
Surgeons to attend the AHPBA anual meeting. To further develop and strengthen
academic relationships between the AHPBA and Mexico, Dr. Orozco invited four
or five members of the AHPBA from the United States each year to lecture at the
annual Mexican GI Surgery Symposium held at his hospital in Mexico City. The
social, cultural and intellectual exchange that occured at these meetings over the
years clearly contributed to the growth and success of the AHPBA.
Dr. Orozco was a member of the most important academic societies in Mexico,
President of the Mexican Association of Gastroenterology and the Mexican
Association of Hepatology. He was also an honorary member at The American
Surgical Association and American College of Surgeons.
Hector was an unselfish and caring human and his life time dream was to return to
his native rural community of Sahuayo to practice medicine. So, when he resigned
in 2007 as Chairman from The Instituto Nacional de Nutrición, he returned
home and offered his surgical expertise to the people of Michoacán in the public
hospital named after him. He felt strongly that since he had been given so much in
his life that he would attend only to the poor and underserved and to not charge
for his services. He also lectured and taught medical students at the University
of Guadalajara without compensation. He continued this service for six years up
until his untimely death.
Hector’s life as an academic surgeon symbolizes many of the founding principles
of the AHPBA: scholarship, education, mentorship, outreach and social
engagement. The AHPBA was fortunate to have him as an engaged and active
member. I suspect that if he had a wish for the future for the AHPBA it would
be to continue our efforts at international Academic Exchange and further our
humanitarian outreach efforts throughout The Americas.
Hector Orozco was a friend to everyone he met, a reverred mentor, a passionate
scholar, charismatic leader, a gifted surgeon and ambassodor for Mexican and
Latin American Surgeons. He is survived by his wife Silvia and his three children:
Adrian, Paulo and Julian. While Hector will be sadly missed he will be forever
remembered by the convivient personality and infectious smile he brought with
him every year to the AHPBA.
Submitted by Scott Helton, MD and Miguel Mercado, MD
141
save the date
March 11–15, 2015
Eden Roc in Miami Beach, FL
Annual Meeting
142
AHPBA Future Meetings
2015
AHPBA 2015 Annual Meeting
March 11-15, 2015
Eden Roc, Miami Beach, FL
2016
12th World Congress of the IHPBA
April 19-23, 2016
Sao Paulo, Brazil
Watch the website for updates www.ahpba.org
Leawood, KS 66224
Telephone: 913-402-7102
Fax: 913-273-9940
Web: www.ahpba.org
143
NOTES
144
NOTES
145
NOTES
146
147
148

Program

Transcription

Similar documents

BROCHURE-ACQUALINA MIAMI

You`re invited to the 3nd annual Weenie Roast

EnvisionEd by LEnny KRAviTZ for KrAVITZ DESIGN INc

Fontainebleau

WE`VE TEAMED UP WITH HOYTS TO BRING YOU ON AND OFF

Mrs. House and Mrs. Huba`s STEM Challenge Day

Weenie Roast - Cape Fear Sail and Power Squadron

Sharon Salzberg

Palm Beach - Blue Ocean Apartment

Everglades National Park